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SUMMARY
I compared the expression and activity of integrins in HeLa cells 
between interphase and mitosis. Cultures enriched in mitotic cells (>90%) were 
obtained by thym idine and nocodazole blocks. Early synchronisation 
experiments suggested that serum improved the rate of exit from metaphase in 
nocodazole-blocked cells. This was confirmed by quantification of post­
metaphase cells at different times after release of the nocodazole block.
Im m unoprecipitation and im m unoblotting showed that HeLa cells 
express at least three integrin subunits, probably 015, a v and ft. However, I 
could not detect |33 subunits. Flow cytometry showed that integrins in HeLa 
cells were not expressed differently in mitosis and interphase. However, I 
found that, in spreading assays, cells arrested in m etaphase with the 
m icrotubule inhibitor nocodazole were unable to spread on fibronectin, 
w hereas control in terphase cells spread norm ally in the presence of 
nocodazole. I could just detect spreading of mitotic cells on fibronectin if ImM 
Mn2+ was present in the medium, or on glass surfaces in growth medium if the 
metaphase block was continued for 3-4 hours. Immunofluorescence showed 
that integrins were redistributed in this limited spreading, as well as in the 
process of respreading of non blocked, mitotic cells.
Analysis of fibronectin receptor activity using affinity chromatography 
of detergent extracts on the cell binding fragment of fibronectin showed that 
the mitotic receptor partially loses its activity. No phosphorylation of either 
mitotic or interphase receptors could be detected by immunoprecipitation from 
32P-labelled cells. I further investigated integrin phosphorylation and activity 
in cellular rounding caused by the phosphatase inhibitor calyculin A (CL-A), as 
it offered a possible model for cellular rounding at mitosis. Although fully 
spread HeLa cells did not respond to CL-A at concentrations reported to 
specifically stimulate CDK activity (i.e. l-2nM), cellular rounding was achieved 
at ~50nM CL-A. Fibronectin receptor activity was lost from CL-A-treated cells, 
to a much larger extent than from mitotic cells, but again no phosphorylation 
was detected. Interestingly, low concentrations of CL-A (0.5-2nM) caused small 
but significant improvement of cell spreading, both on haemoglobin and on 
fibronectin, at the early stages (i.e. less than 30 min.). However, this effect was 
reversed on the long term.
Analysis of the biosynthesis of integrins during the cell cycle was also 
carried out using immunoprecipitation from ^S-labelled cells. Asynchronous
cultures were compared with cell populations enriched in Gl+S phases. The 
evidence suggests that, although there is a basal level of synthesis throughout 
the cell cycle, there may be a peak of synthesis in G2, especially of a  subunits. 
The results also show the presence of a large cytoplasmic pool of p subunit.
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CHAPTER 1
INTRODUCTION
1 Introduction
1. EXTRACELLULAR MATRIX
The existence of an extracellular matrix (ECM), the ground substance 
secreted by cells, has been known for many years. Ultrastructural studies were 
able to identify well organised collagen fibrils, the only ECM component 
showing some degree of structural order. Little more advance was achieved 
until the discovery that there were several types of collagen (see below, 1.4. 
collagens), which suggested that there could be different, possibly cell-type 
specific, ECM components (Bernfield, 1989). The discovery of fibronectin and 
the characterization at the molecular level of its interactions (Bernfield, 1989; 
Ruoslahti, et a l, 1981; Ruoslahti, 1988) stimulated many investigators to search 
for more components and it soon became clear that the ECM is extremely 
complex. There are two main types of ECM: the basal lamina and the interstitial 
matrix, each containing collagens as the major components, together w ith 
proteoglycans and glycoproteins (Bernfield, 1989).
I will give a brief introduction to some of the most studied components of 
the ECM: fibronectin, vitronectin, laminin, collagens and proteoglycans, and 
also discuss briefly their interactions w ith cells. I will focus particularly on 
fibronectin and vitronectin, since the work described in this thesis deals with 
receptors for these glycoproteins.
1.1. Fibronectin
One of the m ost studied macromolecules in the ECM is fibronectin. 
Fibronectin is a glycoprotein that mediates both cell anchorage and dynamic 
processes such as m igration and ECM rem odelling in w ound healing and 
embryonic development (Ruoslahti, 1988; Schwarzbauer, 1991; Yamada, 1989).
1.1.1. Fibronectin structure
The amino acid sequence of the fibronectin polypeptide has been 
determined for bovine, rat and hum an species (Hynes, 1990). They share a high 
degree of sequence similarity. The structure of fibronectin is shown in figure
1.1. The actual fibronectin molecule is composed of two subunits linked 
through a pair of disulfide bonds near the COOH-terminus, resulting in a 
dim er of ~550kDa. Each subunit consists of three types of homologous 
sequences term ed I, II and III. These sequences constitute units of folded 
secondary structure, which may assemble to form dom ains w ith  specific 
affinities. For example, four type I and two type II repeats near the N  terminus 
constitute a domain w ith affinity for collagen (see figure 1 .1 ).
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Type I homologies consist of 45 amino acids containing two disulfide 
bonds. The two type II sequences present in fibronectin (see figure 1.1) contain 
two disulfide bonds, as do type I sequences, and are 60 residues long. Type III 
residues are around 90 amino acids long and lack disulfide bonds (Hynes,
1990).
The structure of a type 1 m odule has been elucidated using H  NMR 
(Baron et al. 1990). The main feature is the existence of two anti-parallel p- 
sheets. Both sheets have a right-handed twist and are stacked on top of one 
another, enclosing a hydrophobic core containing three highly conserved 
aromatic residues and the two consensus disulphide bonds. The secondary 
structure of a type III module has also been elucidated using NMR (Baron et al. 
1993). There are seven p-strands in two antiparallel p-sheets, with the RGD 
sequence located on a loop between two P-strands.
The molecular weight of fibronectin varies according to the source, since 
cell type specific alternative splicing occurs w ithin the fibronectin gene 
(Tamkun, Schwarzbaure et al., 1984). Thus, plasma fibronectin, synthesized 
mainly in the liver (Tamkun, Schwarzbaure et a l, 1983), has two subunits with 
different molecular weight and is smaller than fibrillar fibronectin produced by 
other cell types. Alternative splicing is also responsible for at least 20 variants 
of the hum an fibronectin family (Reviewed by K.M. Yamada, 1989).
RGDS
signal CS1 CS5
signal signal
Heparin I 
Fibrin I 
Bacteria
Collagen
(gelatin)
Cell Heparin II H I  CS Fibrin II
|  Type I module Q Type II module |  Type III module
Figure l.l.Structure of fibronectin. Modules I, II and III are assembled into domains with specific 
affinities. IIICS region is regulated by alternative splicing. CS1 signal consists of the octapeptide 
EILDVPST and CS5, which is active in binding to melanoma cells, contains REDV as the active 
sequence. See text for detail. Sekiguchi et al. 1991.
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1.1.2. Cell-fibronectin interactions.
Fibronectin promotes cell adhesion and spreading by binding directly to 
its receptor(s) (see below, integrins section). Some molecular details about this 
interaction have been unveiled. Experiments involving controlled proteolysis of 
the fibronectin molecule and further sequence analysis (Pierschbacher and 
Ruoslahti, 1984; Pierschbacher et a l, 1981) demonstrated that the presence of a 
tetrapeptide (RGDS) is sufficient to promote cell adhesion significantly. This 
sequence is found in a type III repeat (111-10) in the fibronectin molecule, is 
conserved between species and is present also in other extracellular matrix 
components with cell binding capacity, like vitronectin, collagen, thrombin and 
fibrinogen. There are other sites for cell adhesion in the fibronectin molecule in 
the vicinity of III-7 or IH-8 , which act cooperatively with the RGDS sequence 
(Obara et al., 1987; Obara et al., 1988), and in the IIICS (also called V) region. 
This region, which has no homology to any other segment of fibronectin, is 
subject to alternative splicing and is less conserved among species. It has cell- 
attachment activity contained in the sequence REDV (melanoma cells) and in 
the segment CSI (with EILDVPST as the active sequence), in neural crest- 
derived cells and lymphocytes (Humphries et al., 1986; Humphries et al, 1987; 
Yamada and Kleinman, 1992). It has been reported that the heparin-binding site 
at the C-terminal side of 111-10 also has cell-binding capacity, probably through 
the proteoglycans present in the cell surface (reviewed by Hynes, 1990).
Integrins are the best known fibronectin receptors. They are the main 
mediators of fibronectin-induced signals, involving regulation of cell adhesion, 
migration, w ound healing and other processes (see below, integrins section). 
Other cell surface molecules, mainly proteoglycans, may also bind specifically 
to fibronectin. Laterra and Culp (1982) and Stamatoglou and Keller (1982) 
observed the binding of cell surface heparan sulfate, but not other cell surface 
GAGs, to plasma fibronectin, using low salt concentrations in the absence of 
phosphate. However, little is known about the physiological relevance of these 
interactions. It is possible that heparan sulfate is involved in late adhesion 
events or cell spreading, since treatm ent w ith heparinase does not affect 
attachment, although spreading on fibronectin is inhibited (Laterra et al, 1983; 
Mclnnes et a l, 1987).
1.1.3. ECM-Fibronectin interactions
As mentioned above, fibronectins (both plasma and cellular forms) also 
bind to other extracellular matrix components. Their binding to collagen and 
gelatin has been extensively studied. Collagens I, II, III, IV and V all show some
4
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degree of affinity for fibronectin, which is enhanced when heat-denatured 
forms of collagen (gelatin) are used (Engvall and Ruoslahti, 1977; Engvall, 
Ruoslahti et al., 1978). Fibrin and fibrinogen also bind to plasma fibronectin in a 
non covalent way, although covalent cross-linking occurs in the presence of 
blood clotting factor Xllla (Mosher, 1975; Mosher, 1976). K.M. Yamada et al 
(1980) show ed that cellular chicken fibronectin binds reversibly to the 
glycosaminglycans (GAGs) heparin and hyaluronic acid (HA) bu t not to 
chondroitin sulfate.
The interactions of fibronectin w ith other ECM macromolecules to form 
fibronectin-rich matrices are very likely to play central roles in the regulation of 
its structure and function.
1.2. Vitronectin
Early experiments using gel filtration chrom atography to assess the 
spreading activity of serum (Knox and Griffiths, 1980) identified two peaks, one 
corresponding to fibronectin and the other to an unrelated 70 kDa protein 
(serum spreading factor). (Knox and Griffiths, 1980). The same authors (Knox 
and Griffiths, 1980; Knox and Griffiths, 1982) showed that the 70K protein is 
the cell spreading factor under norm al culture conditions, rather than 
fibronectin. Other authors, using different approaches, have identified a serum 
spreading factor, vitronectin, which apparently refers to the same glycoprotein, 
so called because of its affinity for glass beads (Hayman et al 1983; Barnes and 
Silnutzer, 1983).
1.2.1Vitronectin structure and function
The amino acid sequence of vitronectin has been elucidated from cDNA 
(Suzuki et a l, 1985). The study of the gene intron-exon organization (Jenne and 
Stanley, 1987) shows that there are eight exons and seven introns and there is 
no indication of alternative splicing. Vitronectins from different species are in 
the range of 56K-80K (Kitagaki-Ogawacf al, 1990), and there is a substantial 
immunological cross-reactivity betw een porcine, human, horse and bovine 
vitronectins (Preissner, 1991). Unlike fibronectin, vitronectin has no series of 
repeating  dom ains. H ow ever, there are several dom ains w ith  strong 
homologies to other peptides. The most obvious example is the somatomedin B 
domain, at the N terminus (see figure 1.2), so called from its identical sequence 
to the peptide somatomedin B (Suzuki et a l, 1984). Another protein with strong 
homology is the hum an membrane glycoprotein PC-1 (Buckley et al, 1990), 
which contains tandem  repeats of the som atom edin B dom ain w ith eight
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interlinked cysteines in identical positions. The physiological relevance cf those 
domains as independent peptides or as part of other proteins, like vitronectin, 
remains obscure. It is possible that, in vitronectin, the somatomedin B domain 
is released after proteolysis between Thr-44 and Arg-45 or Arg-45 and Gly-46, 
interfering with the activity of the R45-G46-D47 sequence (Preissner, 1991), in 
which the main cell-binding activity of vitronectin resides. This sequence 
constitutes the first three residues of the connecting segment.
f ig p e L Z . Vitronectin structure. The connecting segment starts with the sequence RGD, followed by a 
cysteine-free region from residues 48 to 130. The central domain contains six hemopexin-type repeats (see 
text for details); it also contains the protease-sensitive site between Aig379 and Ala380. Modified from 
Suzuki et al. (1984).
RGD is present in other ECM molecules (see above, fibronectin section) 
and is recognized by many integrins (DSouza et al., 1991; Humphries, 1990), 
which are the main vitronectin receptors identified so far (Humphries, 1990).
The connecting segment also contains a region free of cysteines, between 
residues 48 (just after RGD) and 130, with no homology to  other known 
sequences, and responsible for the collagen-binding activity of vitronectin 
(Gebb et al., 1986; Izumi et al., 1988). As this segment also contains crosslinking 
s ites  at Gin 93 and  tw o  adjacent Gin, th rough  w hich factor 
XIIla/transglutam inase may catalyse the formation of vitronectin oligomers 
(Sane et al., 1988), it is possible that vitronectin may bind irreversibly, via those 
sites, to collagen-rich matrices (Preissner, 1991).
Vitronectin also contains tw o  dom ains homologous to  hemopexin. 
Hemopexin is a serum glycoprotein that binds heme groups and transports 
them  to the liver for salvage of iron. It contains two homologous domains, each 
m ade up of four homologous repeats and connected by a hinge region 
(Takahashi et al., 1985). In the vitronectin molecule, six hemopexin-type repeats 
span from residues 132 to  459, with a putative hinge region around Pro-268, 
suggesting an incomplete four repeat-domain duplication during evolution 
(Preissner, 1991). As with hemopexin, binding of heme groups to vitronectin
Connecting segment
S-S
G1 yeosaminoglycan 
^  binding /
Somatomedi n B Central Domain
6
1 Introduction
may alter its conformation, although it is not known if heme-vitronectin 
interactions have physiological relevance (Preissner, 1991).
Although vitronectin is synthesized as a single chain glycoprotein, some 
plasma vitronectin may appear as two chains (65kDa and lOkDa) when run on 
SDS gels under reducing conditions. This is due to the presence of a protease 
sensitive site at Arg-379/Ala380 (see figure 1.2), near the C terminus (Preissner, 
1991). The possible relevance of this proteolytic site is unknown.
The heparin-binding dom ain participates in cell binding. It binds to 
vessel-wall heparan sulfate and other cell surface GAGs. It consists of a C- 
terminal segment of 40 aminoacids rich in basic residues and containing several 
heparin-binding consensus sequences of the type: X-B-B-X-B-X (B:basic residue) 
(Preissner, 1991). Although the native vitronectin does not bind appreciably to 
heparin, conformational changes increase heparin affinity. This feature is likely 
to have physiological relevance: vitronectin seems to play a role in haemostasis 
via its heparin-binding activity (Preissner et al., 1987b). Various GAGs 
(including heparin) act as cofactors enhancing the inhibition of thrombin and 
other coagulation enzymes (Damus et al, 1973). The heparin-binding ability of 
vitronectin inhibits the heparin-accelerated interaction of thrombin or factor Xa 
w ith antithrombin, thus neutralizing the anticoagulant properties of heparin 
(Preissner, 1991; Preissner and Muller-Berghaus, 1987a; Preissner et a l, 1987b). 
The mechanism involves protecting throm bin from fast inactivation by the 
complex antithrom binlll-heparin. Vitronectin competes directly w ith the 
inhibitor for the binding site on heparin. Heparin-binding forms of vitronectin 
are present in plasma in quantities that suggest that the above mechanism may 
occur in vivo (Preissner, 1991).
Vitronectin m ay also form a ternary complex: vitronectin-throm bin- 
antithrombin, w ith properties still unknow n (Preissner et a l, 1987b; Tomasini 
and Mosher, 1988). Its form ation also involves a change in vitronectin 
conformation, exposing the heparin-binding domain. These ternary complexes 
are recognized by integrins at the vitronectin and possibly the thrombin RGD 
sites. As these complexes are likely to be concentrated in vessel walls, due to 
their affinity for endothelial cell GAGs, it is possible that they have a role in 
integrating integrin- and non integrin- m ediated responses at sites of vessel 
wall injury (Preissner, 1991).
Vitronectin has also been show n to block lytic pore formation by the 
com plem ent system by a m echanism  dependent on the heparin-binding 
domain (Preissner, 1991).
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It is dear from this information that vitronectin cannot be considered just 
as a substrate molecule on which cells adhere and spread. It is rather a versatile 
molecule that links cell adhesion to other processes, particularly those involved 
in immune defense; hemostasis and wound healing.
13 l  Laminin
Laminin is a glycoprotein present in basement membranes, the thin ECM 
surrounding epithelial tissues, nerves, fat cells and musdes. It was initially 
characterised in Englebreth-Holm-Swarm (EHS) m urine tum or (Timpl eta/. 
1979). EHS laminin consists of three large pdypeptide chains, A, B1 and B2. 
Their sizes are 300kDa (440 glycosylated), 205kDa (22.5 glycosylated) and 
185kDa (205 glycosylated) respectively. These subunits are held together in a 
crudform  structure via m any inter- and intra-chain disulfide bonds (Martin 
and Timpl, 1987). Studies with cDNA dones have shown that the A chain has 
three globular domains at the amino terminus separated by three EGF-like 
repeats (see figure 1.3.). The remainder forms part of the long arm and has a 
coiled-coil structure, finishing in a large globular domain. B1 and B2 chains are 
structurally similar, containing two globular domains and two EGF-like repeats 
(reviewed by Kleinman and Weeks, 1989).
A Chain
Figure 1.3. SdK m dkm odd o f la n b a n stra d iie  filled dudes 
represent ^ o b d a r  lin n a iK . N m b o s  im ia f e  protnoiytic 
fragmm ts from pbstw p  l i id m n i t  See t a t  far details.
Aifaptad from M ith a n  199L
Laminin exhibits several biological activities, including promotion of cdl 
adhesion, migration and neurite outgrowth. Several data suggest that laminin 
is central in development. It is synthesised at the two-cdl stage (Mecham, 1987),
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it is able to cause differentiation of mesenchymal cells into epithelium in the 
kidney, and it is localised along the path  of neural crest cell migration in 
developing tissues bu t not in the adult (reviewed by Kleinman and Weeks, 
1989).
The active sites within the laminin molecule have been identified using 
controlled proteolysis (Rao et al. 1982: Edgar et al. 1984: Palm et al. 1985). 
Numbers in figure 1.3. indicate different fragments obtained by digestion with 
elastase. Fragment 1-4 (also El-4), the three short arms, binds to collagen IV and 
promotes the attachment of MCF-7 epithelium-derived cells (Terranova et al. 
1983). Fragment 1 (El; not shown) contains the short arms, except the terminal 
globular domains. It retains cell attachm ent activity, but lacks the collagen- 
binding activity (Terranova et al. 1983). Fragment 8  (E8 ) spans the lower 35 nm 
of the long arm and stimulates neurite outgrowth (Edgar et al. 1984). Fragment 
4 (E4) binds to collagen (Martin and Timpl. 1987). The large globular domain at 
the end of the long arm (C terminus) contains a heparin-binding site (Ott et al. 
1982).
The rod-like segments between the globular domains in the short arms 
exhibit homology to EGF, and fragments 1 and 1-4, both containing EGF-like 
repeats, show growth-factor activity, possibly m ediated through the EGF 
receptor. The evidence for this function comes from studies (Panayotou et al. 
1989) showing that fragments 1 and 1-4 stimulate thymidine incorporation in 
cells expressing EGF receptors but have no effect in cells lacking those 
receptors. However, laminin and its fragments 1 and 1-4 failed to compete with 
the EGF receptor in assays of radioligand inhibition. The authors suggest that 
laminin and its fragments might bind to a different site on the receptor than 
EGF. Alternatively, a receptor co-expressed w ith the EGF receptor might be 
involved.
1.3.1. Laminin receptors
Early studies using affinity chrom atography showed the presence of a 
laminin-binding protein of 67 kDa from tum our cells (Rao et al. 1983; Malinoff 
and Wicha, 1983). Subsequently, several laboratories identified the 67 kDa 
receptor in several other cell types (reviewed by Mecham, 1991). Later on this 
receptor was shown to be identical to the elastin receptor, a galactose-specific 
lectin (Mercurio, 1990). Other lectins have been reported as laminin-binding 
proteins in vitro (reviewed by Mecham, 1991). However, their physiological 
relevance as in vivo receptors for laminin is not yet understood.
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The best characterised laminin receptors belong to the integrin family (see 
below, integrins section). a iP i, 012P1, CX3P1, a $ \ ,  (X7P1 and a vp3 have been 
reported to bind to laminin in vitro (reviewed by Hynes, 1992). Although the 
laminin molecule contains an RGD sequence (see above, fibronectin section) in 
the central EGF-like repeat of the A chain, this sequence is inactive in integrin 
binding. Elastase-derived fragment 8  binds to 013P1 and OC6P1, and fragment 1 
binds to a iP i.
Integrin a 6p4 adheres to the fragm ent 8  of laminin, at least in a colon 
adenocarcinoma-derived human cell line. However, the role of this integrin as a 
laminin receptor in other cell lines remains controversial (Lee et al. 1992).
1.4. Collagens
Collagens are the most abundant components of the extracellular matrix, 
forming the banded fibres seen ultrastucturally in the majority of vertebrate 
tissues (Burgeson, 1988). At present there are fourteen known types of collagen, 
all containing triple helical and globular domains. The triple helix is made up of 
three a  chains, which are left-handed helices w ound together to produce a 
right-handed helix. The overall structure is approximately 1.4 nm in diameter, 
w ith variable length (Burgeson, 1988). Figure 1.4 shows the structure of some 
collagens in a simplified form. Each a  chain consists of more than  1000 
aminoacids. The triple helix-forming sequence is (gly-x-y)n, where x is usually a 
proline and y is a hydroxy proline. The alicyclic nature of both aminoacids 
prevents ro tation around the C-N bond in the peptide backbone, thus 
providing rigidity to the a  chain.
In some cases, the triple helices aggregate in an overlapping way to form 
collagen fibrils, stabilised by intra and intermolecular crosslinking. In further 
levels of organization, collagen fibrils can form fibres which, in turn, associate 
to form fibre bundles (Light and Bailey, 1981; Reid, 1991).
The role of collagens is mainly structural, being the main contributors to 
the determ ination  and stab ilization  of ad u lt tissue architecture. In 
developm ent, collagen degradation is an im portant process, as tissues are 
continuously  being rem odeled. The enzym es responsible for collagen 
degradation fall into three categories: metalloproteinases, neutral proteinases 
and lysosomal cathepsins (reviewed by Reid, 1991). These enzymes are also 
active in w ound healing and in some pathological processes involving 
destruction of connective tissue, such as lytic tumor invasion and rheum atoid 
arthritis (Cawston et a l , 1984; Maciewicz et al, 1989).
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Collagens have multiple receptors. The best characterized are pi and P3 
integrins (see below, integrins section). Syndecan, a proteoglycan, binds also to 
collagens I, III and V (see below, proteoglycans, section). In HeLa cells, four 
proteins of 102, 87, 45 and 38 KDa have been claimed to be integrin-unrelated 
collagen receptors by several criteria (Beacham and Jacobson, 1990; Lu et a l,
1989). In fibroblasts and chondrocytes, anchorin CII has also been characterized 
as a collagen receptor (Fernandez et a l, 1988). It is interesting that so many 
apparently unrelated proteins should act as collagen receptors. Obviously, 
further work will be needed to establish the possible relationships between 
them, and their role in vivo.
Types I, III O  □ ---------------------------------------------------------O
Type II CD  O
Type XI  O
Type V O
Type IV 
Type VII
Type X 
Type IX
Type VIII •  ■ ■" — — —  or
Type VI------------------- ------------------
Type XII
Triple helix
•  O  Globular
Glycosaminoglycan
Figure 1.4 Collagens. Simplified structures of several collagen types. Open rods and circles indicate 
portions removed prior to incorporation into insoluble matrices. The rest of the molecule is indicated 
in closed circles and rods. Modified from Burgesson, 1988.
1.5. Proteoglycans
Proteoglycans are present at the cell surfaces and in the ECM in multiple 
forms. They consist of a protein core covalently bound to glycosaminoglycans,
11
1 Introduction
w hich are large carbohydrates m ade up  of disaccharide repeats. 
Glycosaminpglycans exist in four different forms: hyaluronic add, keratan 
sulfate, chondroitin sulfate and dermatan sulfate, and heparan sulfate and 
heparin (Ruoslahti and Yamaguchi, 1991). They all have strong negative charge 
espedally the sulfated ones, which enable them to  bind to a large number of 
components. However, binding speafid ty  is provided by spedfic carbohydrate 
sequences, rather than by the charge itself. In fact, the potential of carbohydrate 
sequences to  encode bidogic information is remarkable This potential becomes 
obvious if we realize that glucose may form up to  11 different disaccharides 
and 35,560 different tetrasaccharides, against 2 dipeptides and 24 tetrapeptides 
respedively  for am inoadds, although a small subset of digosacccharides 
actually exists.
There is a known hexasaccharide sequence in hyaluronic ad d  which 
confers cell binding activity. It consists of three repetitions of the disaccharide 
glucuronic add-N-acetylglucosamine joined p i—>3 with the di saccharide units 
jd n ed  p i—>4 (Aruffo et al., 1990)
The protein core is variable, in accordance with the diversity of 
d istribution of proteoglycans. Aggrecan, perlecan, versican, decorin and 
fibromodulin are all proteoglycans d  the ECM (Ruoslahti and Yamaguchi,
1991). Syndecan is an integral membrane proteoglycan present in epithelial 
cells. It binds to cdlagens I, III and V, fibronedin and thrombospondin via its 
heparan sulfates (Saunders et al., 1989). It is noteworthy that syndecan may ad  
cooperatively with integrins in its interadion with fibronedin (Saunders and 
Bernfield, 1988). This cocperativity is likely to be important in focal adhesion 
formation (see below, focal adhesions sedion).
Protedglycans have also been shown to bind several growth fadors via 
their glycosaminoglycans, and it is thought that they constitute an ECM 
reservoir for them (Ruoslahti and Yamaguchi, 1991). Proteolytic degradation of 
the  pro teic  core w ould release a d iv e  growth fador-glycosam inoglycan 
complexes (see figure 1.5) (Ruoslahti and Yamaguchi, 1991; Saksela and Rifkin,
1990).
Betaglycan, a cell m em brane proteoglycan, and decorin, an ECM 
proteoglycan, bind to transform ing growth fador p (TGF-p) through their 
proteic cora Interestingly, binding of decorin to TGF-p inadivates the growth 
factor and decorin synthesis is stim ulated in several cell types by TGF-p 
(Ruoslahti and Yamaguchi, 1991).
The role of proteoglycans as growth fador reservoirs in the ECM and /o r 
at the  cell surfaces m ay be im portant in the control of their activity. It is
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possible that immobilization of growth factors is important for keeping growth 
factor activity spatially controlled, helping in the process of formation and 
maintenance of different tissues (Ruoslahti and Yamaguchi, 1991).
From these data it is clear that proteoglycans are extremely interesting 
components of the ECM and cell surfaces, regulating cell adhesion and cell 
growth. A better knowledge of polysaccharide conformational complexity will 
help understand further the physiological roles of proteoglycans.
FGF receptor with kinase 
domain
Cefl membraneFGF complexed 
with a free heparin 
or heparan sulfate
Membrane heparan 
sulphate proteoglycan
FGF complexed 
with proteoglycan
Heparan sulphate proteoglyci 
in matrix J
Figure 1.5. Proteoglycans. Schematic representation of membrane and ECM proteoglycans and their 
role as growth factors reservoirs. FGF: fibroblast growth factor. Adapted from Ruoslahti and 
Yamaguchi (1991).
2. CELL ADHESION MOLECULES
The evolution of mechanisms for cell adhesion was obviously a crucial 
step in the creation of multicellular organisms. During development, adhesion 
events play an im portant role in m orphogenesis. These events involve 
interactions between cells and the ECM, and also between cells, and may be 
functionally divided into different steps: a first specific interaction between a 
cell membrane receptor and its ligand(s) is followed by specific responses, 
w hich may include cytoskeleton reorganization and generation of second
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messengers, activation of kinase cascades and, ultimately, changes in gene 
expression. These responses may result in changes in cell differentiation, or 
specific immune responses, among others.
Next, I will describe the m ain adhesion molecules identified so far, 
including the integrin superfam ily of cell-cell and cell-ECM adhesion 
molecules, the immunoglobulin superfamily of CAMs, cadherins and selectins. 
In section 5 ,1 will focus in more detail on integrin regulation, since it is directly 
relevant to my own research.
2.1. Integrins
Integrins are a superfamily of cell membrane receptors mediating cell-cell 
and cell-ECM interactions. They are heterodimers of noncovalently associated 
a  and P subunits (see Hynes, 1992 for review). At present, at least 8 p and 14 a  
subunits are known, and they m ay associate in more than 2 0  different 
combinations. However, more a  and p subunits and novel associations are 
likely to be discovered, as intense research is currently being focused on 
integrins and the field is relatively new.
There is not a simple method of integrin classification. The most widely 
used is their grouping on the basis of a common p subunit (see table 1.1). The 
major classes, grouping most integrins, are pi, p2 and P3 . However, some a  
subunits may bind to more than one P subun it, complicating the classification. 
For instance, a v may bind to Pi, P3, P5, p6 and p8.
Pi and P3 integrins are expressed in many cell types and mediate cell- 
matrix interactions, although OC2P1 and (X3P1 have been shown to support both 
cell-matrix and cell-cell interactions (Carter et al, 1990; Larjava, et ah, 1990). P3 
are found in a vascular context. anbp3 is essential in platelet activation (see 
below, integrin regulation section). P2 integrins mediate cell-cell adhesion and 
are restricted to leukocytes.
The specificity of integrins for their ligands is not well defined. As seen in 
table 1 .1, some integrins are able to bind to many ligands and, in the same way, 
some ligands may bind to several integrins. The reason why receptor-ligand 
specificities should be "degenerate" is not clear. One possibility is that integrins 
that share the same ligands serve different functions (Humphries, 1990). For 
instance, a fibronectin receptor that is expressed in a cell type at some stage of 
developm ent might promote cell m igration through a loose interaction with 
fibronectin whereas another fibronectin receptor w ith a stronger affinity, 
expressed at a different time, might promote cell attachment to the substrate. 
O bviously, this w ould  im ply the participation  of integrins in signal
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Table 1.1. Integrin subunits and their interactions
Subunits Ligands Binding sites
PI a l CO, LN
a2 CO, LN DGEA*
a3 CO, LN, FN RGD?
a4 FN, VC AM-1 EILDV
a5 FN RGD
a6 LN
a7 LN
a8 ?
av VN,FN? RGD
P2 aL IC AM-1, ICAM-2
aM ICAM-1, FG, factor X, C3b(inact)
aX FG, C3b(inact?) GPRP
P3 allb FG, FN, VWF, VN, TP RGD, KQAGDV
av FG, FN, VWF, VN, TP, OP, CO RGD
P4 a6 LN?
P5 av VN RGD
P6 av FN RGD
p7 a4 FN, VCAM-1 EILDV
alEL ?
P8 av ?
CO: collagens; LN: laminin; FN: fibronectin; C3b(inact): C3b component of complement (inactivated); 
FG: fibrinogen; VWF: von Willebrand factor; TP: thrombospondin; OP: osteopontin.
"This binding site has been defined for type 1 collagen only.
transduction pathways, not as mere anchorage sites for the cell. See below, 
integrin regulation section, for more details of participation of integrins in 
signal transduction pathways.
3.2.2. Integrin structure
Figure 1.6 shows schematically the overall structure of a typical integrin. 
Structurally, all a  subunits are related. They all have short cytoplasmic
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domains and three or four repeats homologous to the Ca2*-binding loop found 
in the EF-hand structure of calmodulin.
Ligand binding
region
Extracel lular doma i n
f i ^ i e  ljfiJntegrin structure. All a  subunits contain raidum- 
binding sites. The large loop in the p subunit is stabilized by 
intrachain disulfide binding (S-S). The p subunit contains 4 
cysteine-rich repeats. Both subunits partidpate in the making of 
the ligand-binding region. The cytoplasmic domains of both 
subunits may be linked to cytoskeletal structures in focal 
adhesion structures. M++ sites make reference to metal binding 
sitesSee text for detail.
However, there is a fundamental difference between these structures and the 
homologous repeats of the integrins. Edwards et al. (1988) drew attention to the 
fact that the Ca2+-binding sites present in a v resembled more the sequence 
found in the so called "lock-washer" (Vyas et al., 1987) structures of the 
bacterial galactose binding protein (GBP). Six carbaxylate oxygens of three 
aspartates and a glutamate, a main chain carbonyl oxygen and an oxygen of a 
water molecule coordinate to each Ca2+ (see figure 1.7). The nine residues of the 
GBP loop are homologous to  the first 9 of the loop of calmodulin and other 
proteins (see table 1 .2 ).
However, co-ordinating position 12 of the lock-washer comes from the 
distant Glu205 residue. Two carboxylate oxygens from the Glu205 coordinate 
with Ca2+ in the same way as the Q u  in position 12 of the EF-hand. This lade of 
coordinating sites at position 1 2  is shared with the integrin subunit a v (see 
table 1.2). The missing carboxylate has to  be supplied from elsewhere and this
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feature is likely to be important in the regulation of integrin activity (see below, 
3 .1 .2 .integrin regulation).
---------------
Figure 1.7. EF-hands and lock-washers. The nine-residue loop in the lock-washer has a similar 
conformation to that of the twelve-residue loop in the EF-hand. Also, the Glu205 from the lock-washer 
is equivalent to the invariant Glu residue at position 12 in the calmodulin loop. The sequence of the 
Ca^+-binding sites in av is homologous to that of the lock-washer structure in GBP (see table 1.2), and 
it is likely to adopt a similar conformation (see text for details).
Some a  subunits (ai, (X2 , ocl, ax and aM) contain an extra segment known 
as I-domain (I for inserted) of about 180 aminoacids, before the homologous 
repeats containing the cation-binding domains. It is homologous to the A-type
Lock-washer 
structure from GBP
Tyr 138
Asn 137
Ca 24-
loop IV of calmodulin
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Table 2. Sequence alignment of €a2+-gbindfos sitfes in EBP 9nd EP-harid loof>2_____
* * * * *  *
142 204
GBP 134 D L N K D G  Q I Q - I E 205 
a v D I D K N G  Y P D L -
Calmodulin
Loop I V 1 2 9 N I D G D G  R V N Y E  E 140 
Troponin C
Loop IV 142 D K N N D G R I P  F D E 153 
The sequences of the lock-washer structure of GBP (Vyas et al. 1987) is compared with two 
EF loops from troponin and calmodulin. In all cases, tne ligand at position 7 is provided by 
the peptide carbonyl oxygen while the others are from side chain oxygens. Adapted from 
Vyas et al. 1987.
repeat found in von Willebrand factor (VWF), cartilage matrix protein and type 
VI collagen (Hynes, 1992). The function of the I domains is unknown, although 
it is possible that they participate in collagen-binding activity, since c^p! and 
a 2pi are collagen receptors and the above molecules may also bind to collagen. 
However, this remains to be proven. Some a  subunits undergo post- 
translational proteolysis so that they consist of a short transmembrane segment 
disulfide-bonded to a larger, extracellular fragment.
Most p subunits have short cytoplasmic domains. The only exception 
known is p4, which has a cytoplasmic domain of -1000 aminoacids. Why this 
m em brane protein should contain such a large cytoplasmic segment is 
unknown. 0 ^ 4  is localized at the basal domain of most epithelial cells, in areas 
free of F-actin (Marchisioef al., 1991), suggesting that it does not participate in 
focal adhesion-like structures (see above, focal adhesions section). It is likely 
that cx6p4 is playing a role in epidermal cell-basement membrane adhesion. 
Sonnenberg et al. (1991) showed in immunoelectron microscopy studies that 
016P4 at the basal epidermal surface localizes to hemidesmosomes, and they 
suggested that the P4 subunit, due to its unusually large cytoplasmic domain, 
may contributes to the formation of the hemidesmosomal cytoplasmic plaque 
(see below, hemidesmosomes section).
Crosslinking experim ents w ith P3 in tegrins (vitronectin receptor and 
glycoprotein Ilb-Illa) show that RGD has discrete interactions near the lock- 
washer repeats in the a  subunits (D'Souza et al., 1988; D Souza et al., 1990; 
Smith and Cheresh, 1988; Smith and Cheresh, 1990a), although it also binds to 
a region on the p subunit, near its N-terminal, with homology (although more 
relaxed than in the a  subunits) to an EF-hand repeat, suggesting that both 
subunits participate in the making of the ligand binding site.
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All p subunits have four repeats rich in cysteine residues, believed to be 
in te rn a lly  d isu lfid e -b o n d ed , w hich cause them  to run  slow er 
electrophoretically under reducing conditions.
2 .2 . Non-integrin cell adhesion receptors.
The m ain non-integrin cell adhesion molecules are involved in cell-cell 
interactions (CAMs) (Albelda and Buck, 1990). However, a few cell-substratum 
non-integrin receptors have also been identified. Cell surface proteoglycans are 
perhaps the best example. As mentioned above, they play important roles in 
cell physiology and may act cooperatively with integrins.
2.2.1. CAMs of the immunoglobulin superfamily
The CAMs of the im m unoglobulin (Ig) superfamily mediate Ca2+- 
independent cell-cell interactions (Williams and Barclay, 1988). N-CAM, Ng- 
CAM, and fasciclin II are examples of homophilic receptors (acting as both 
receptor and ligand), in neural tissues. N-CAM is present in many vertebrate 
species. It exists in three alternatively spliced forms, which differ in the length 
of the cytoplasmic region (C-terminus). They all contain polysialic acid (PSA), 
which varies during development and its amount correlates inversely with the 
binding strength of the receptor (Albelda and Buck, 1990). N-CAM is first 
detected in gastrulae. In chicken and frog the PSA content is low during early 
embryonic stages, increases during later embryonic development, and returns 
to a low content in the adult (Sunshine et al, 1987). The authors suggest that the 
low content in PSA provides strength in cell-cell interactions during initial 
morphogenesis, and stabilization in adult tissues. A higher content of PSA 
would allow more flexibility in establishing cell-cell contacts, essential during 
histogenesis.
Many of the functions of the immune system also depend on CAMs from 
the Ig superfamily (Springer, 1990). CD2 (LFA-2) from T cells and LFA-3 in 
erythrocytes (also present in non hematopoietic cells) bind to each other and 
are examples of heterophilic receptors (Albelda and Buck, 1990). They are part 
of the Lymphocyte Function-related Antigens (LFA), together w ith LFA-1 
(a Lp2)/ a member of the integrin family (see above). CD2/LFA-3 interaction is 
inhibited in resting T cells mainly by charge repulsion due to the presence of 
sialic acid on the cell membrane (Springer, 1990). These repulsive interactions
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are reduced in activated T lymphocytes. Interestingly, the presence of polysialic 
acid in N-CAM also regulates its binding capacity (see above).
ICAM-1 and ICAM-2, also Ig members, are receptors for LFA-1. 
Expression of ICAM-1 is induced in inflammation in a wide variety of cells. 
However, ICAM-2 is not responsive to inflammatory m ediators (Springer, 
1990).
2.2.2. Cadherins and morphogenesis
Embryonic m orphogenesis is brought about by a complex series of 
interconnected processes. Selective cell-cell and cell-ECM interactions may 
trigger cellular responses leading to differentiation, m igration or cell 
aggregation. Cadherins have been shown to play important roles in some of 
those processes. They are calcium-dependent CAMs, mediating preferentially 
homophilic interactions (Geiger and Ayalon, 1992). There are three major 
groups: N-cadherins, found in adult neural tissues and muscle, E-cadherins, in 
adult epithelial cells, and P-cadherins, expressed transiently in development in 
several tissues, and present in placenta and epithelial cells (Albelda and Buck, 
1990).
A classic paper by Townes and Holtfreter (1955) showed that dissociated 
cells tend to cluster according to their histogenetic origin and form 
characteristic tissue patterns. Recent work has shown that cadherins may play a 
role in those histogenetic segregation processes. When N-cadherin and E- 
cadherin expressing cells are mixed, a preference for homotypic interactions is 
found, although weaker, heterotypic contacts are also detectable (Volk etal., 
1987).
Cadherins are also involved in cell condensation, the transition of cell 
populations from a dispersed pattern to a compact one. Uvomorulin seems to 
play a role in cell compaction in the mouse morula (Hyafil et al., 1980).
Cadherins are closely associated with transm em brane-cytoskeleton 
interactions, in the so called adherens-type junctions (AJs), which are structures 
typical of epithelia. In polar epithelial cells AJs are part of a junctional complex, 
w ith the more apical tight junctions and the more basal desmosomes (see figure 
1.8). The transition from mesenchyme to epithelium is another morphogenetic 
process in which cadherins are involved. Many studies have shown that 
mesenchymal cells transfected with cadherin cDNA undergo epithelialization 
(reviewed by Geiger and Ayalon, 1992). Remarkably, transfection of fibroblasts 
with cadherin cDNA also induces epithelialization.
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AJs have some similarities w ith focal adhesions (Geiger, 1989). For 
example, many of the cytoskeletal components of AJs are the same, and both 
contain proteins linking the actin filaments to the integral membrane 
components. However, there are proteins that associate selectively with FAs or 
AJs (i.e. talin versus plakoglobin; Geiger and Ayalon, 1992).
E-cadherin is required for the form ation of tight junctions, AJs and 
desm osom es, as m easured by the inhibitory effect of specific antibodies 
(Gumbiner et al, 1988).
Fig 1.8.Cell-cell adhesion structures in polar epithelial cells. Adherent 
junctions contain cadherins as key components, linking cytoskeleton 
to the extracellular area (see text for details). Gap and tight junctions 
are sites of electrical conductanceand metabolic coupling between 
cells, and control of the extracellular space, respectively; in 
desmosomes, electron dense plaques are present in the intercellular 
space (25-35nm wide) and in the cytoplasm. These are attached to 
tonofilaments, usually of cytokeratin (Garrod, 1984). Figure modified 
from Garrod, 1984.
2.2.3. Selectins
Selectins are a class of integral m em brane proteins involved in 
lymphocyte and neutrophil interaction w ith vascular endothelium  (Springer, 
1990).
Apical
surface
Microvilli
Tight Junctions
ieai!!!! Adherent Junctions
B  Gap Junctions
Basal lamina
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They are expressed in leukocytes and endothelial cells. They contain an 
N-terminal lectin-like domain, followed by an EGF-like module and several 
repeats characteristic of complement-binding proteins. They contain a single 
transmembrane domain and a short cytoplasmic tail (Belvilacqua et a/. 1991).
To date, three different selectins have been described. L-selectin was 
previously known as the lymph node homing receptor LEC CAM-1, LECAM-1, 
LAM-1 or the MEL-14, Leu-8, TQ1 and DREG.56 antigens originally described 
on lym phocytes (Bevilacqua et at. 1991). It functions as a lymphocyte 
recirculation receptor and contributes to neutrophil emigration at inflammatory 
sites (Springer, 1990). P-sdectin (or CD62), previously known as GMP-140 or 
PADGEM, is stored in a-granules of platelets and in Weibd-Palade bodies of 
endothelial cdls. Stimulation by thrombin causes mobilization to the surface of 
these cdls, where it participates in adhesion of neutrophils and monocytes. E- 
selectin was previously known as ELAM-1, and is also present in activated 
endothelial cells (Bevilacqua et al. 1991), and participates in neutrophil 
adhesion.
3l  CELL-ECM JUNCTIONS 
3L1- Focal adhesions
Many cdls in culture interact with their substrate through well delimited 
regions called focal adhesions (FAs), adhesion plaques or focal contacts 
(Burridge et al., 1988). In these sites, actin filament bundles are anchored to 
specialized areas of the cell surface membrane; and the cell-substrate contact is 
dosest. FAs were first described in electron microscope studies (Abercrombie et 
at., 1971) and w ere confirmed as focal contacts by interference reflexion 
microscopy (IRM), a method devised by Curtis (1964) (Izzard and Lochner, 
1976; Abercrombie and Dunn, 1975).
FA formation can be divided in different stages: first, attachment of cells 
occurs on ECM components. Subsequent spreading is then accompanied by the 
formation of subm embranous microfilament bundles, which assodate with 
discrete areas of the membrane, in what can be considered as FA precursors. 
Finally, the microfilament bundles may enlarge to form fully developed stress 
fibers, firmly anchored to  the membrane, possibly through other cytoplasmic 
components such as talin, vinculin and a-actinin, which concentrate at FAs 
concomitantly with actin (Burridge and Connell, 1983; Burridge and FeramiscQ 
1980; Woods etal., 1986).
22
1 Introduction
3.1.1. FA components
Since the early descriptions of FAs, many of their components have been 
identified, mainly using immunofluorescence microscopy. These components 
have been extensively reviewed by Burridge et al. (1988). In the ECM, the first 
component identified was fibronectin (FN). However, FN is present only when 
serum -free m edium  is used (Grinnell, 1986). In the presence of serum, 
vitronectin (VN) is the detectable ECM component. Since cells are normally 
cultured in the presence of serum, it is possible that VN is the critical ECM 
component of FAs (Burridge et a l, 1988). Cell surface proteoglycans have also 
been shown to act cooperatively in FA formation in the presence of fibronectin 
(Culp et a l, 1986). However, integrins are the m ain cell surface components. 
They are the obvious candidates for the role of linking cytoskeletal structures 
w ith  the ECM since, apart from their role as receptors for specific ECM 
com ponents, their cytoplasmic dom ains also allow interaction w ith  the 
cytoskeleton (see below, integrins section).
Talin and vinculin are cytoplasmic components of FAs (Burridge and 
Connell, 1983; Burridge and Feramisco, 1980). Although they may distribute 
differently in several cell types (Burridge et a l, 1988), they have been shown in 
smooth muscle to bind to each other w ith high affinity (Burridge and Mangeat, 
1984). A vinculin-binding component has been identified, consisting of two 
bands of 150kDa and 200 kDa. This component was nam ed tensin and is 
thought to cap the ends of actin filaments, although its particular role in FA 
formation is not yet clear (Burridge et a l, 1988). Fimbrin and a-actinin are the 
only actin-binding proteins so far identified in FAs. Fimbrin is present in 
microvilli and crosslinks actin filaments in vitro, whereas a-actinin is more 
w idely distributed and its actin-crosslinking activity is lower (Bennett et a l, 
1984; Bretscher, 1981).
Figure 1.9 summarizes the m ain FA components identified so far, and 
their in vitro interactions. It should be noted, however, that other components 
are likely to be involved, and that in vitro interactions m ight represent 
experimental artifacts rather than in vivo equivalents (Burridge et a l, 1988).
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Figure 1.9. Focal adhesions. Schematic representation of the main FA components identified so far. a  
and P are integrin subunits. VN: vitronectin; FN: fibronectin; aA: a-actinin; TN: talin.
3.2.2 Physiological relevance of focal adhesions
The role of FAs in vivo is not well established. Although they are present 
in m any cultured cells, FA-like structures w ithin whole organisms have been 
reported in very few cases. The dense plaque of smooth muscle cells involves a 
link between ECM and cytoskeleton via integrins, and vinculin and talin are 
also present (Geiger et al., 1981; Geiger et a l, 1985). a-actinin has also been 
reported, although other laboratories have failed to identify it, and its presence 
has been questioned (Small, 1985).
Similarly, the myotendinous junction of skeletal muscle represents an FA- 
like structure, with a link between the tendon and actin filaments via integrins. 
Vinculin and talin are present, although the presence of a-actinin, as w ith the 
dense plaque, remains controversial (Tidball, 1987). Other examples are the 
postsynaptic region of neurom uscular junctions and the zonula adherens 
junctions between epithelial cells, both w ith some components also present in 
FAs (reviewed by Burridge et al. 1988).
The similarities between these structures and FAs have been established 
mainly on the basis of their components, and physiological links are difficult to 
verify. Recently, it has been shown that focal adhesions may be involved in 
signal transduction  pathw ays triggered  by ECM-cell interactions. As 
mentioned above (see integrin regulation section), tyrosine phosphorylation of 
several components occurs upon interaction of ECM with integrins, the best 
characterized of which is a protein of ~125kDa. Interestingly, phosphorylation 
of this protein correlates with FA formation, rather than w ith cell adhesion or
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spreading. An in vivo equivalent of ppl20 FA-dependent phosphorylation is 
found in platelets (see above, integrin regulation section).
A lthough it is increasingly clear that integrins may transduce signals 
from the ECM to the cytoplasm both in vitro and in vivo, , it is far from obvious 
that the FAs, as seen in cultured cells, are necessary for those signal 
transductions to occur.
3.2 Hemidesmosomes
Hemidesmosomes are cell-substrate adhesion junctions formed between 
the basal surface of stratified epithelia and the underlying basement membrane. 
They resemble desmosomes structurally (see above, cadherins section) in a few 
details, including the anchorage of IF bundles to defined (< 0.4 pm diameter) 
plaque-bearing areas of the m em brane (Schwarz et al. 1990). However, 
antibodies raised against desm osom al com ponents do not react w ith 
hemidesmosomes (Jones et al. 1986).
Hemidesmosomes are resistant to Ca2+ depletion (Owaribe et al. 1990). 
However, extracellular Ca2+ and calmodulin are required for the formation of 
new hemidesmosomes (Trinkaus-Randall and Gipson 1984).
3.2.1. Hemidesmosome components
To date  there  is only one w ell characterised  com ponent of 
hem idesm osom es, a po lypeptide localised at the plaque, of ~230kDa, 
recognised by autoantibodies from patients suffering from bullous pemphigoid 
and therefore called bullous pem phigoid antigen (Stanley et al. 1981). This 
com ponent is not present in desmosomes or in plaques of cell-substrate 
junctions of single-layered epithelia, indicating that not all asymmetric plasma 
membrane plaques represent the same type of hemidesmosome (Schwarz et al. 
1990).
The integrin 0C6p4 (see above, integrins section) has also been shown to 
associate w ith hemidesmosomes (Stepp et al. 1990; Sonnenberg et al 1991). It 
has been suggested (Sonnenberg et a l 1991) that the large p4 cytoplasmic 
domain could play a role in assembling IFs to the hemidesmosomal plaque.
4. PROTEIN MODULATION BY PHOSPHORYLATION
Reversible covalent modifications of proteins are major regulatory 
mechanisms in a wide variety of processes (Uy and Wold, 1977). Reversible
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phosphorylation, methylation, acetylation and S-S/SH interconversions are 
perhaps the best known examples. Of these, phosphorylation has proved the 
m ost interesting, since the regulation of m any fundam entally different 
processes is based on this reversible modification. Since early experiments 
show ing that enzyme phosphorylation was a regulatory m echanism in 
glycogen metabolism (Fischer and Krebs, 1955; Sutherland and Wosilait, 1955), 
it has become clear that phosphorylation is also important in cell division (see 
below), gene expression (Meisner and Czech, 1991) and indeed in almost every 
process involving outside-inside signal transduction (Taylor et a l, 1992). 
Protein phosphorylation is brought about by enzymes called protein kinases, 
which catalyze the transfer of a phosphate group from a nucleotide, typically 
ATP, to the target substrate (Krebs and Beavo, 1979).
There are two major classes of protein kinases: those whose specific 
substrates are Ser a n d /o r  Thr and those w ith specificity for Tyr. However, 
there is at least one kinase able to phosphorylate Ser/Thr and Tyr. w eel (see 
below, cell cycle section) is one example. MAP protein kinase (MAP-KK) 
activators may also belong to the family of dual-specificity protein kinases. 
G row th factor treatm ent of cells resu lts in the activating Tyr and Thr 
phosphorylation of MAP-PKs. Either the activator(s) are dual-specificity 
kinases or they induce autophosphorylation in Thr and Tyr by MAP-KK 
(Lindberg et al. 1992). However, evidence for this dual role in most cases comes 
from studies on autophosphorylation in vitro,, and physiological relevance of 
these results in all cases remains to be proven.
There is also a great diversity in terms of subcellular localization, size and 
mechanism of activation. For example, regulators of kinase activity include 
Ca2+, cAMP, phorbol esters and diacylglycerol (Hunter, 1987).
Despite the great diversity of protein kinases, all of them share a catalytic 
core of approximately 260 residues (Taylor et a l, 1992; Taylor et al, 1993). The 
conserved motifs are, starting from the N-terminus (see figure 1.10), a glycine- 
rich loop followed by Lys72, both involved in stabilizing the portion of MgATP 
not directly involved in phosphotransfer, and Aspl84, which chelates the Mg2+ 
ion that bridges the p and y  phosphates (Taylor et a l, 1993).
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Figure 1.10. Protein kinases. The conserved catalytic core is shown in black. The catalytic subunit of 
cAPK contains 350 amino acids and the core extends from residue 40 to 300. Regions thought to be 
important for regulation are cross-hatched. The putative membrane-spanning segment in the EGF 
receptor is stippled. Small black rectangles indicate three conserved sequence motifs corresponding to 
the glycine-rich loop. Lys72 (filled circles) and Aspl84 (filled squares) are also indicated. W  refers to 
N-terminal myristoylation. A. Sei/Thr kinases. B. Tyr kinases.
Am ong the S er/T hr protein  kinases, one of the first to be fully 
characterized was the cAM P-dependent protein kinase (cAPK), and its 
structure can serve as a general template for the entire protein kinase family 
(Taylor et ah, 1993). It consists of two regulatory subunits (R, which is the 
prim ary cAMP receptor), and two catalytic (C) subunits. The activating 
mechanism is as follows: R2C2 + 4cAMP —> R2(cAMP)4 + 2C. The two catalytic 
subunits can now phosphorylate cytoplasmic proteins containing the consensus 
sequence RRXSY (X: any aminoacid; Y: hydrophobic aminoacid) (Taylor et al., 
1993). Protein kinase C (PKC) is a cytoplasmic kinase reversibly associated with 
membranes. It is activated by Ca2+, diacylglycerol, phosphatidylserine and 
phorbol esters, all of them acting at major regulatory sites near the catalytic 
core (N ishizuka, 1988). Ca2+/calm odulin-dependent protein kinases are 
normally specific for one substrate and present a great structural diversity. 
Thus, m yosin light chain kinase (MLCK) is a monomer, and glycogen 
phosphorylase kinase is a hexadecamer (Taylor et ah, 1992). Cdc2 kinase is one 
of the smallest kinases (34kDa). It is essential for cell division and its activity is 
regulated by phosphorylation/dephosphorylation and association with other 
proteins whose expression is cell cycle regulated, cyclins (see below, cell cycle 
section).
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The first protein tyrosine kinase to be identified was pp60v-src/ the 
transform ing protein of Rous sarcoma virus (Hunter and Sefton, 1980). The 
authors suggested for the first time that tyrosine phosphorylation might be 
related to the process of cell transformation. Indeed, this is the case in many 
instances. Particularly interesting are the receptors w ith tyrosine kinase 
activity. M any growth factors and horm ones act via these receptors, thus 
activating signal transduction pathways involving tyrosine phosphorylation. 
The epiderm al growth factor (EGF) receptor , the insulin receptor and the 
platelet-derived grow th factor (PDGF) receptor families are all examples of 
receptor tyrosine kinases (Hunter, 1987). They all contain an extracellular, 
glycosylated ligand-binding domain, a single transmembrane region and the 
catalytic dom ain, w hich resides in the cytoplasm (Ullrich and Schlessinger,
1990). Their mechanism of activation usually involves oligomerization upon 
ligand binding. This provides the intracellular conform ational changes 
necessary to activate the catalytic dom ain, thus triggering the cellular 
responses. Recently, several of the components of the signal transduction 
pathw ay from receptor tyrosine kinases to Ras have been described. The first 
components in the cascade of events are proteins containing SH domains (Src 
Homology domains). One example is the protein Grb2, which contains SH2 and 
SH3 domains, which have been identified in several proteins involved in signal 
transduction. SH2 has affinity for phosphotyrosine phosphoproteins, and SH3 
has affinity for proline-rich regions. Grb2 binds to the active phosphotyrosine- 
containing receptor via the SH2 domain, and uses its SH3 domains to bind to 
the next component in the pathway, which is a Ras activator, Sos, thus forming 
a complex: receptor-Grb2-Ras activator. Bound Ras activator converts inactive 
RasGDP to the active RasGTP. The sequence of event is then as follows: first, 
binding of the ligand causes oligomerization and autophosphorylation of the 
receptor. Newly formed phosphotyrosine-rich domains in the receptor bind to 
proteins containing SH2 domains, i.e. Grb2. The activated complex receptor- 
Grb2 binds to Sos which, in turn, binds to RasGDP, initiating a kinase cascade 
(McCormick, 1993).
Reversibility of protein phosphorylation implies the existence of enzymes 
able to remove the phosphate from kinase targets, although there are a few 
examples of direct reversal of protein kinase-catalyzed reactions (Krebs and 
Beavo, 1979). Those enzymes are called phosphatases and their characterization 
is obviously essential for an understanding of phosphorylation-dependent 
processes. As with kinases, phosphatases can be classified, according to their 
substrate specificity, as Ser/Thr (PSP) or Tyr (PTP) phosphatases (Tonks, 1990).
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PSPs can be divided in four groups. Types 1, 2A 2B and 2C (reviewed by 
Cohen, 1989). Of these, only 2B (caldneurin) responds directly to  a second 
messenger, Ca2+ in this case, and is involved in signal transduction pathways 
Types 1, 2A and 2B are structurally related, whereas 2C derives from a different 
gene family (Tonks, 1990). PSP1 and 2A are involved in cell cycle regulation, 
a lthough their exact roles are still unclear. It is possible that PSP1 
dephosphorylates phosphothreonine 161 in cdc2 kinase (see below, cell cycle 
section), allowing, in conjunction with cydin degradation, exit from metaphase 
(Pallen et al., 1992). Evidence from studies in Xencpussuggests that PSP1 is also 
involved in mitosis initiation, as addition of inhibitor-2, a spedfic PSP1 
inhibitor, induces cdc2 activation, and addition of FSP1 causes mitosis 
retardation (Walker et a/., 1992). PSP-2A is required for entry into mitosis. Its 
exact r d e  could be to maintain cdc25 in a dephosphorylated form (see below, 
cell cycle section), thus blocking th rl4  and tyrl5  dephosphorylation of cdc2, 
since treatm ent of interphase Xencpus extracts with okadaic add, a PSP-2 A 
in h ib ito r  th a t a cce le ra te s  e n try  in to  m itosis, causes cdc25 
hyperphosphorylation, stimulating its cdc2 phosphatase activity (Kumagai and 
Dunphy, 1992).
PTPs can be divided into non-receptor and receptor-like phosphatases. 
All PTPs share a common segment of -240 aminoadds, which contains the 
catalytic domain (Charbonneau and Tonks, 1992). The receptor-like PTPs have 
a highly conserved cytoplasmic domain where tw o tandem catalytic domains 
reside, a single transmembrane segment, and a variable extracellular region. 
CD45 is in d u d ed  in this group. It is a surface glycoorotein restricted to 
hem atopo ie tic  cells, w ith a ro le  in signal transduction  involving 
dephcsphorylation of phosphotyrosyl residues. Its adivity is necessary for the 
increased phosphatidylinositol turnover observed upon stimulation of the T- 
cdl receptor (Koretzky et al., 1990).
Non-receptor PTPs contain a single catalytic domain and unrelated 
regulatory sequences, whose main function is to  dired the enzyme to spedfic 
subcdlular compartments (Charbonneau and Tonks, 1992).
There is also a dual-spedfidty phosphatse; cdc25 (see below, cell cyde 
section). Although it is remarkable that cdc25 should have threonine and 
tyrosine as substrates, as PSPs and PTPs bear no sequence similarity, the 
experim ents give overwhelming evidence of this double role for cdc25 
(Kumagai and Dunphy, 1991; Millar and Russell, 1992). This is a dear 
difference from the dual-spedfidty kinases (see above), wnose ability to  ad  on
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S er/T hr and Tyr residues has been proved solely in autophosphorylation 
experiments.
5. REGULATION OF INTEGRINS
5.1. Role of lock-washer structures in integrin ligand-binding activity
Ca2+ a n d /o r  M g2+ binding is a prerequisite for integrin ligand-binding 
activity. The divalent metal cation-binding sites present in the a  subunits are 
thus essential structures on the integrin molecule.
Remaining unexplained is the ability of Mn2+ to induce spreading of cells 
even in the absence of adhesive ligands. As it is very likely that Mn2+ binds also 
to the lock-washer dom ains of integrins (Gailit and Ruoslathi, 1988), the 
possibility remains that cation binding to the receptor is the key step for its 
activation, rather than the interaction w ith the adhesive ligand (Edwards et al, 
1987), i.e., the role of RGD and other adhesion motifs w ould be to fold the 
putative metal-binding sequences in order to generate complete co-ordinating 
sites for Ca2+ or Mg2+, whose binding would then, in some sense, switch on the 
receptor, involving a series of conformational changes. The fact that much 
higher concentrations of Mn2+ are necessary for activation of cell spreading in 
the absence of adhesive ligands (Edwards et a l, 1987; Rabinovitch and 
DeStefano, 1973) may be explained if the role of RGD and other adhesion 
motifs were to fold the integrin metal binding sites in a cooperative way 
(Edwards et a l, 1988).
The lack of co-ordinating sites at position 12 of the m etal-binding 
sequences (see above, integrin structure) present in a  subunits offers a possible 
mechanism for RGD-like activity. Edw ards et al (1988) proposed that the 
receptor binding to its ligand could alter its conformation thus draw ing a 
distant Glu to the position 12. In RGD dependent integrin activity, it would also 
be possible that the missing carboxylate is supplied by the Asp in the RGD 
sequence itself.
It is remarkable that other sequences from ECM glycoproteins that have 
been show n to be active in integrin binding share the presence of an Asp 
res id u e . The best charac te rized  of these are REDV, LDV and  
HHLGGAKQAGDV. This Asp might provide the missing coordinating group 
in Ov (Humphries, 1990).
A potential role in integrin cation dependence has also been proposed for 
P subunits. Integrins a vPi and a vp3 respond in different ways to Ca2+ in the
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presence of Mg2+ and use different cations for binding to their ligands. Since 
they share the same a  subunit, it is possible that the p subunit somehow 
m odulates the cation binding activity (Kirchhofer et al, 1991). The authors 
suggest that the missing Glu at position 12 from the metal-binding sequence 
might be provided by the p subunit so that different subunits might account for 
different cation affinities.
As mentioned above, sequences with homology to those forming lock- 
washer structures are present in all a  subunits, and the presence or absence of 
the appropriate cations will determine an active or inactive conformation for 
the receptor. However, the definition of active or inactive is not simple. 
Integrins may have a wide range of affinities for their ligands according to 
different environments, and regulation of cation seems unlikely to account for 
those different affinities in vivo. Moreover, different integrins present in the 
same cell could not be differently regulated by the same cation environment. So 
we could say that the presence of cations is indispensable for integrin activity, 
bu t additional mechanisms are needed for a fine regulation of that activity. In 
fact, there are several known m echanisms which may m odulate integrin 
affinities, as part of im portant transduction pathways relevant to cell growth, 
immune response, cell migration, wound healing or development.
5.2. Role of integrins in focal adhesion formation
Integrins are im portant components of focal adhesions (see above, focal 
adhesions section). It was recently reported that the phosphorylation of a 120 
kDa protein (ppl20) is induced by the interaction between fibronectin and pi 
integrin receptor(s) in NIH3T3 cells (Guan et al, 1991). The p i cytoplasmic 
dom ain was necessary for phosphorylation of ppl20. This phosphorylation was 
independent of soluble growth factors, was immediately prior to cell spreading, 
and cell rounding reversed the effect. A homologous protein from rat testis 
cells was later shown to be a protein tyrosine kinase, FadK (Hanks et al, 1992). 
The authors suggested that aggregation of integrins at focal adhesions would 
induce autophosphorylation of FadK (ppl20), which would become active, 
phosphorylating other substrates in a transduction system leading to cell 
spreading. Schaller et a l (1992) reported a similar protein (ppl25FAK) in 
chicken embryo cells.
Thus, a model is possible in which interaction between fibronectin and its 
in teg rin  receptor(s) m ay change in tegrin  conform ation, possibly  via 
oligomerization, at the cytoplasmic region, leaving the cytoplasmic domain of 
the P subunit w ith increased affinity for ppl20. The bound pp l20  w ould
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phosphorylate itself and subsequently other substrates. W hen fibronectin 
detaches from its receptor(s) (cell rounding), integrin conformation would 
reverse, releasing ppl20, which would become dephosphorylated and inactive, 
interrupting any further signal into the cytoplasm. Alternatively, a cytoplasmic 
signal could reverse the transduction pathw ay, the final effect being the 
inactivation of fibronectin-receptor interaction. However, these considerations 
are merely speculative.
It is interesting that RGD-containing peptides cannot trigger ppl20 
phosphorylation (G uan et al, 1991) and that central regions of fibronectin, 
including the cell-binding dom ain, induce only interm ediate levels of 
phosphorylation. Only w hen both the cell-binding domain and the heparin- 
binding dom ain were present, high levels of pp l20  phosphorylation were 
detected. This requirem ent is also necessary for the form ation of focal 
adhesions, which are not seen w hen the cell-binding domain of fibronectin 
alone is present as substrate (Woods and Couchman, 1992), even though cells 
seem to spread well.
This correlation betw een ppl20  phosphorylation and focal adhesion 
formation is likely to be relevant for the role of ppl20. It is also possible that, if 
focal adhesions are simply artifacts in these systems (see above, FAs section), 
the phosphorylation of ppl20 may also be part of those artifacts. On the other 
hand , focal adhesions are likely to have some equivalent in vivo, in 
circumstances probably involving strong cell attachment, w hen structures 
similar to focal adhesion are likely to develop . However, a role for the action of 
pi integrins on ppl20 in vivo remains to be discovered.
5.3. Role of integrins in platelets and the immune system
In spite of the current controversy about focal adhesion relevance in vivo, 
integrins have been shown to be physically and functionally the link between 
insoluble ECM and the cytoskeleton in m any systems, independently of their 
possible involvement in focal adhesions. Also, in other instances, they seem to 
transduce signals in pathw ays involving soluble second m essengers, 
functioning similarly to growth factor receptors (see below, this section).
An excellent example of integrin participation in relevant physiological 
processes is given by the immune system. Interactions of cells from the immune 
system with other cells and with the ECM are essential for a rapid response to 
infections. Integrins, selectins and immunoglobulins are the three families of 
receptors regulating those interactions (Springer, 1990).
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Integrins are im portant in the dynamic regulation of adhesion and 
m igration in the im m une system (Springer, 1990). Their activity can be 
modulated, mainly through induced changes of conformation. Integrins of the 
immune system are the p2 integrins (aijfc/ «Mp2 and a xp2), whose expression is 
restricted to leukocytes. They may bind to a variety of ligands in activated 
leukocytes (see table 1 .1 ). Changes of conformation are also involved in 
different states of integrin activation. There are several mechanisms by which 
p2 integrins may be activated. One example relatively well understood is that of 
(XlP2 in lymphocytes. Naive T lymphocytes may be induced by specific antigens 
to become memory lymphocytes. The process is characterized by the increased 
and persistent expression of several cell surface molecules, including the 
integrin oclP2, also known as LFA-1 (lymphocyte function-related antigen-1). In 
T cell activation, T cell receptor/C D 3 in the T lymphocyte recognizes the 
antigen presented by the major histocompatibility molecules in the antigen- 
presenting cell. This specific interaction activates oclP2 on the T cell, which will 
b ind avidly to ICAM-1 in the antigen-presenting cell, providing a stronger 
adhesion between both cells. How cclP2 is activated is unclear, although some 
evidence points to a change of conformation induced by a protein kinase C 
(PKC)-dependent m echanism (van Kooyk et a l, 1989). Deletions in the 
cytoplasmic domain of p2 inactivate the receptor (Hibbs et al., 1991), suggesting 
a regulatory  role for this dom ain. M echanisms for signalling from the 
cytoplasmic regions of (XLp2 may include phosphorylation or interaction with 
soluble cytoplasmic messengers or with the cytoskeleton, similarly to the case 
of the aiibP3 integrin (see below, this section). In fact, Buyon et al. (1990) 
reported the phosphorylation of p2  in  neutrophils and monocytes upon 
activation by PMA.
Clearly, further research will be needed to elucidate the mechanisms of 
activation of p2 integrins.
Pi integrins are expressed in many cell types. On lymphocytes, they were 
called the VLA (very late antigen) family of integrins, because some are 
expressed in lymphocytes 2-4 weeks after antigen stimulation in vitro (Springer,
1990). However, they are constitutively expressed in many other cell types.
In the immune system, they mediate adhesion betw een the ECM and 
lymphocytes and are im portant for m igration of activated lymphocytes in 
tissues during immune responses (Springer, 1990). As w ith  other immune 
system integrins, pi integrins may acquire different states of activity, brought 
about by conformational changes. Anti-Pi antibodies strongly enhance binding 
of U-937 myelomonocytic cells to fibronectin (Arroyo et a l, 1992). They showed
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tha t VLA-4 and VLA-5 are the m ediator integrins in this response. 
Furtherm ore, the same antibody induced the ability of VLA-4 to bind to 
VC AM-1 and fibronectin. PMA had a comparable effect on these interactions, 
although with different morphological effects, suggesting the existence of more 
than one transduction signal for U-937 adhesion. As with previous examples, 
evidence points to a conform ational change, directed through the pi 
cytoplasmic domain, to explain VLA activation, and this change might also 
involve the a  subunit, since specific antibodies against VLA a  subunits 
abrogated the effects m ediated by the anti-P antibody. It is likely that 
connection w ith cytoskeleton is needed, as its disruption cancels this effect. 
Interestingly, an active Na+/ H + antiporter was also required, suggesting that 
alkalinization of the cytoplasm is necessary, as with an tp 3 . This pH rise is likely 
to have implications in the modulation of other integrins activities (see below).
The platelet integrin antp3 is important in platelet activation. Although 
fibrinogen and VWF are present in blood at concentrations that would saturate 
an active antP 3 / this integrin in circulating platelets is inactive. When platelets 
are activated, through an agonist-induced pathway, an tP 3 undergoes a 
conform ational change and binds to its soluble ligands. There is also an 
agonist-independent activation. Platelets exposed to the subendothelial matrix, 
after vessel damage, will bind to immobilized fibrinogen and VWF, and these 
interactions will induce aiibP3 binding to soluble adhesive ligands.
The mechanisms by which an tp 3 conformation is changed in platelet 
activation is unknown. Deletion of the cytoplasmic region of aiibconstitutively 
activates the receptor (O'Toole et a l, 1991), suggesting that this dom ain is 
central in the regulation of the receptor affinity for its ligands, possibly through 
m odulated interactions w ith the cytoskeleton or soluble messengers in the 
cytoplasm . Platelet activation involves G protein activation, rises in 
intracellular pH  and Ca2+ and activation of protein kinases (Shattil and Brugge,
1991). One possibility is that cytoplasmic domains of an $ 3  are phosphorylated. 
Indeed, p 3 is phosphorylated in S er/T hr, although w ith  such a low 
stoichiometry (less than 3 %) that it is likely to have no physiological relevance.
The cytoplasmic tail of p3 has a Tyr in position 747 w ith homology to 
tyrosine phosphorylation sites in EGF and insulin receptors, and pp60src 
phosphorylates this residue in vitro. However, tyrosine phosphorylation has 
never been detected in aiibp3 in intact cells.
O n the other hand, phosphorylation may have an im portant role in 
transducing a signal to the cytoplasm through an $ 3, since its activation and 
binding to fibrinogen, together w ith platelet aggregation, are necessary for
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tyrosine phosphorylation of several proteins upon platelet activation by 
thrombin, including ppl25FAK (Brugge and Shattil, 1990; Burridge et al, 1992).
Other data are available about platelet and an $ 3  activation (Shattil and 
Brugge, 1991), although the overall picture is far from clear. Obviously, further 
investigation will be needed to understand how conformational changes in 
an tP 3 are brought about after platelet activation, and where they fit in the 
platelet activation process itself.
5.4. Changes in gene expression induced by integrins
O ther studies involving occupancy of receptors w ith antibodies or 
synthetic peptides have provided some insight into the the role of integrins in 
other systems For instance, Werb et al. (1989) have reported that binding of a 
monoclonal antibody to as pi blocks initial adhesion of fibroblasts to fibronectin 
and induces gene expression of the ECM-degrading metalloproteinases 
collagenase and strom elysin. H ow ever, unlike w ith  phorbol esters, 
cytochalasins and growth factors, which also may induce metalloproteinase 
expression, the addition of the anti-aspi antibody in solution to cells spread on 
collagen or serum adhesion proteins does not cause changes in morphology or 
actin organization. It is interesting that fibronectin cannot trigger the same 
effects as this antibody, bu t RGD peptides derived from the sequence of 
fibronectin itself can.
These data suggest that asP i can m ediate signal transduction from 
outside the cell to the nucleus. It is not difficult to imagine a situation in 
development in which interaction of integrins with ECM components triggers 
the expression of some proteases which will change ECM composition, and this 
in turn might modulate the pattern of integrin expression, giving place to a new 
stage in development.
Menko and Boettiger (1987) have also reported interesting results on the 
role of integrins in development, using the monoclonal antibody CSAT, which 
recognizes pi. Chicken embryo myoblasts treated with CSAT fail to fuse and do 
not produce muscle-specific myosin. The removal of the antibody reverses this 
effect. Thus, occupation of pi integrins seems to be responsible for the 
w ithdraw al from the cell cycle, changes in gene expression and production of 
multinucleate myotubes typical of myogenesis. The authors suggest that pi 
integrins function in this case analogously to horm one or grow th factor 
receptors and that integrin-ECM interactions permit signal transduction to the 
nucleus. However, it is possible that this transduction is downstream  of cell 
adhesion, and not necessarily an effect of antibody occupancy of the integrin.
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The use of RGD-containing peptides prevents gastrulation in Drosophila 
embryos. Naidet et al. (1987) reported that Drosophila embryos injected with 
RGD peptides at the syncytial blastoderm stage have a phenotype characterised 
by dorso-ventral simmetry and, later on, there will be no muscular movement 
or organogenesis, presumably due to the RGD inhibition of ventral furrow 
formation.
Another example was provided by Mackrell et al. (1988) w hen they 
reported that a pi integrin subunit was involved in the lethal (1 ) myospheroid 
m utation [l(l)mys] in Drosophila melanogaster. Embryos carrying this mutation 
appear normal until the first muscular contractions occur. Then the dorsal 
suture breaks and muscles detach from the ECM and become spheroidal. 
Besides these apparently  mechanical effects on the m utant embryos, 
experiments using cells in culture show that myoblasts explanted from l(l)mys 
embryos fail to fuse (Donady and Seecof, 1972), as occurs in the experiments by 
Menko and Boettiger (1987). This similarity suggests a common mechanism in 
both cases and also that integrins are central in signal transduction pathways 
modulating development.
A dam s and W att (1990) show ed that term inal differentiation of 
keratinocytes in vitro is accompanied by loss of adherence to several ECM 
molecules, including fibronectin, and precedes, by several hours, the loss of 
(X2P1, OC3P1 and a 5pi integrins from the cell surface. They also showed that 
inactivation of (X5P1 occurs prior to its removal from the cell surface. Their 
results also suggest that OC2P1 and (X3P1 m ight equally be inactivated. It is 
tempting to speculate that these inactivations might cause loss of cell adherence 
to the basal layer, facilitating m igration out of it and causing changes in 
integrin expression and other molecules relevant to terminal differentiation.
5.5. Role of integrins in cytoplasmic pH modifications
Other investigations have tried to understand integrin participation in 
transduction systems using a different approach. It has been known for some 
time that cytoplasm alkalinization is necessary for growth in a variety of cell 
types (Moolenaar, 1986). A similar pH modification has been reported by 
Schwartz et al. (1989) for a different process. They showed that cell spreading 
induced cytoplasmic alkalinization via the Na+/ H + antiporter. Integrins are 
likely to be involved since modification of spreading using anti-integrin 
antibodies and RGD peptides correlates with modifications in cytoplasmic pH. 
It is interesting that the constitutive action of ras and src oncoproteins (which 
localize in the plasma membrane) bypasses the necessity of cell spreading for
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cytoplasmic alkalinization, suggesting that integrin-dependent pH rise in this 
system could be transduced via src and ras cellular homologues.
Complementary studies using capillary endothelial cells and defined 
media (Ingber et al, 1990) showed clearly that fibronectin can induce DNA 
synthesis and cytoplasmic alkalinization independently of the presence of 
growth factors. More importantly, they showed that activation of the Na+/H + 
antiporter, rather than alkalinization itself, is the key step for inducing DNA 
synthesis.
Further work on the role of integrins in cell alkalinization (Schwartz et a l,
1991) revealed that clustering of as Pi by insoluble fibronectin activated the 
Na+/ H + antiporter. However, fibronectin failed in this case to induce DNA 
synthesis, even at high doses. The same authors (Schwartz and Lechene, 1992) 
reported that platelet-derived growth factor (PDGF) activates the N a+/ H + 
antiporter through a protein kinase C dependent pathway, only after cells have 
spread, although the participation of integrins in this case was not assessed.
These results are im portant since they establish a link betw een cell 
spreading (probably integrin dependent) and a single molecular event, namely 
cytoplasm alkalinization. As this event is also found in transduction pathways 
led by  growth factors, it seems reasonable to speculate about the existence of 
in teg rin -d riven  transduction  pathw ays involving second m essangers, 
analogous to those led by the "classical" growth factors.
The work described in this thesis shows that fibronectin receptor activity 
is m odulated  betw een m itosis and  interphase (see below, Results and 
Discussion chapters). I will return  to the subject of integrin regulation at 
interphase -> mitosis transition in the Cell Cycle section in this chapter, and in 
the Discussion chapter.
6. CELL CYCLE
The cell cycle is the sequence of events leading to the duplication of cells. 
This sequence may be divided in four different stages: Gi, S (DNA synthesis 
phase), G2 and  M (Mitosis). Classically, Gi and G2 have been considered as 
m ere gaps betw een the two easily identifiable mitotic and  DNA synthesis 
phases (see figure 1.11). Biochemical and genetic research in  the last decade has 
proved that cell cycle phases are intimately interconnected, and structural and 
functional details of several cell cycle-dependent processes, such as DNA 
replication, organization of the mitotic spindle, nuclear envelope breakdow n
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and others have been unveiled (Hartwell and Weinert, 1989). I will discuss in 
this section the most recent advances in our understanding of how the cell cycle 
is regulated.
Figure 1.11. Phases of the cell cycle. A typical animal 
tissue cell in culture commited to the cell cycle takes 
-24 hours to complete its division in two daughter 
cells. Quiescent cells are usually arrested in G i, in a 
stage often called Gq (Pardee, 1989).
6.1. Regulation of the cell cycle
Understanding the molecular events of the cell cycle proved difficult over 
many years. Geneticists isolated num erous cell division cycle (cdc) mutants 
from the fission (Schizosaccharomyces pombe; Hayles and N urse, 1986)and 
budding (Saccharomyces cerevisiae) yeast (Hartwell and Weinert, 1989). One of 
those genes, cdc2+, in Schizosaccharomyces pombe, was found to be of particular 
interest due first to its activity both at the onset of DNA synthesis and again at 
the transition G2—>Mitosis, and second because some alleles resulted in 
prem ature m itosis (wee phenotype; N urse and Bissett, 1981). A gene in 
Sacharomyces cerevisiae, CDC28, was found to be homolog of cdc2+. In fact, 
CDC28 rescues cdc2+ mutations, and vice versa (Beach et al, 1982). Both genes 
encode Ser/T hr protein kinases of ~34KDa (p34/cdc2 kinase), themselves 
susceptible to phosphorylation (Simanis and Nurse, 1986).
Subsequently, CDC28 homologues were found in clam, Xenopus, mouse 
and hum an (Draetta and Beach, 1988; Draetta et a l, 1989; Gautier et al, 1988; 
Lee and Nurse, 1987) and, in fact, in all species so far studied, suggesting that 
this kinase forms part of a very well conserved mechanism by which GI cells 
are driven into S phase and then into mitosis. Indeed, it soon became clear that
M
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the cdc2  kinase was the catalytic subunit of a protein complex, called 
maturation-promoting factor (MPF), first described in amphibian oocytes and 
responsible for the regulation of G2/M itosis transition in eukaryotic cell cycle 
(Draetta, et a l, 1989; Gautier et al, 1988; Kishimoto and Kanatani, 1976). The 
enzyme is maximally active during metaphase and is abruptly inactivated at 
the transition metaphase-anaphase (Draetta, 1990; Draetta and Beach, 1988).
Other components of the MPF are the cyclins. Mitotic cyclins are proteins 
that accumulate during interphase to undergo degradation at the end of 
mitosis, resulting in a cell cycle oscillation regulated by proteolysis at the 
metaphase-anaphase transition (Evans et al, 1983). Draetta et al. (1988) showed 
that, in HeLa cells, they associate w ith cdc2 kinase, and proposed a model for 
the relationship between cdc2  kinase and cyclins in which newly synthesized 
cyclin binds to cdc2 to form new MPF, a prerequisite for entry into mitosis.
There are in fact several types of cyclins. In budding yeast, G1 cyclins 
C lnl, Cln2 and Cln3 act at the Gl-S transition (Reed, 1991), and mitotic B-type 
cyclins (Bl, B2, B3 and B4) act at the G2-mitosis transition (Surana et a l, 1991). 
In higher organisms the picture is more complex. Cyclins A, Bl and B2 are 
active at the G2-mitosis transition. Cyclin A is also active at Gl-S, binding not 
only to cdc2, but also to transcription factors E2F and DRTF1 and to the 
retinoblastom a protein (Elledge et a l, 1992). The situation  is fu rther 
complicated, since different cyclin-dependent protein kinases may play the role 
of cdc2 kinase at the Gl-S transition. In Xenopus, a cdc2-like protein of ~32KDa 
is responsible for this transition and binds to two cyclin-like proteins of 
~54KDa and to cyclin A (Fang and Newport, 1991). In hum ans, the kinase 
CDK2 (cyclin-dependent kinase 2) binds also to cyclin A and there is some 
evidence that this complex has some role in S phase (Elledge et a l, 1992). Both 
kinases have a high degree of homology with cdc2  and it is proposed that they 
are its functional homologues in G l/S . Indeed, there seems to be a family of 
cdc2-like kinases, called cyclin-dependent-kinases (CDK)* of which cdc2 is the 
prototypic member (Elledge et a l, 1992; Nigg, 1993).
Cyclin B is also known to be phosphorylated by mitotic cdc2 in vitro 
(Draetta and Beach, 1988; Morla et a l, 1989), and cyclin A is phosphorylated on 
Tyr in m ouse cells (Hall and Vulliet, 1991). However, the physiological 
relevance of these phosphorylations is presently unknown.
In spite of the wealth of data about the regulation of cyclins during the 
cell cycle, why cells need several types of cyclins remains unclear. It seems
* I will use the terms CDK and cd c2 , as described by the different authors, although it is now  
clear that the cdc2 described in many papers does not correspond to p34/cdc2, and the term 
CDK activity seems more appropiate.
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possible that different cyclins may provide different specificities, so that certain 
combinations of cyclin/CDK w ould phosphorylate only certain subsets of 
substrates. Further work will be needed before the full role for cyclins becomes 
apparent.
Cyclins are not the only proteins to regulate CDK activity. As mentioned 
above, cdc2 itself may undergo phosphorylation. Although Ser, Thr and Tyr 
residues have been shown to become phosphorylated (Draetta and Beach, 1988; 
Gould and N urse, 1989), Thr and Tyr phosphorylation/dephosphorylation 
cycles seem to be the key elem ents in  cdc2 activation. In particular, 
dephosphorylation of phosphothreoninel4  and phosphotyrosinel5 , well 
conserved throughout evolution, activate the enzyme at the G 2/M  transition 
(Gould and Nurse, 1989; Morla et a l, 1989). The enzymes involved are the 
w eel kinase, which phosphorylates Tyrl5 and possibly Thr 14, holding cdc2 
inactive, and cdc25 phosphatase, which is responsible for both phosphotyrosyl 
and phosphothreonyl dephosphorylation (Kumagai and Dunphy, 1991; Millar 
and Russell, 1992). w eel and cdc25 genes have been shown to determine the 
timing of mitosis in fission yeast, w eel as an inhibitor and cdc25 as an activator 
(North, 1989). It has also been reported that cyclins Bl and B2 enhance cdc25 
phosphatase activity 5-fold in vitro, suggesting that cdc25 may act on specific 
cdc2/cyclin complexes (Galaktionov and Beach, 1991). Further work in Xenopus 
(Kumagai and Dunphy, 1992) has established that cdc25 is itself a substrate for 
phosphorylation by cdc2 (see figure 1 .1 2 ), being maximally active w hen 
phosphory la ted  in its N -term inus (corresponding w ith  m itosis), thus 
es tab lish in g  a positive  feedback. cdc25 is w eak ly  active w hen 
unphosphorylated  (interphase), at which time the w eel tyrosine kinase 
capacity on cdc2 is superior, resulting in a nett phosphorylated state for Tyrl5. 
As for w eel regulation, recent work (Coleman et al, 1993) has shown that a 
protein kinase, n im l, also known as cdrl, directly phosphorylates w eel at its C- 
terminus, causing its inactivation as a cdc2 tyrosine kinase. However, since the 
n im l protein is not essential for viability (Russell and Nurse, 1987), there must 
be o ther com ponents involved in  the regu la tion  of cdc2  tyrosine 
phosphorylation.
In summary, a clearer picture emerges from all these data, although there 
is obviously much still to be learned:
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Figure 1.12. Regulation of cdc2 kinase. Binding of cyclin induces 
phosphorylation of Thrl61, Tyrl5 and Thrl4. A novel kinase, CAK, is 
responsible for Thrl61 phosphorylation (Solomon, 1993). weel accounts for 
Tyrl5 and Thrl4 phosphorylations. Full activation of cdc2 requires 
participation of cdc25, itself activated by phosphorylation by cdc2, thus 
establishing a positive feedback.
6.2.2. Substrates for mitotic CDKs
Much of the regulation of CDK activities has already been elucidated (see 
figure 1.12). Further work will eventually lead to the primary signal(s), internal 
and environmental, triggering mitosis. However, much less is known about the 
targets of such kinase activities. It is w idely accepted that the structural 
reorganization of eukaryotic cells that takes place at the G2-Mitosis transition is 
b rought about by specific CDK activities. This reorganization includes 
chromosome condensation, disassembly of nuclear laminae, rearrangement of 
cytoskeletal components and arrest of endom em brane traffic, among other 
events. Also, most mitotic cells in culture show a typical rounded morphology 
that will remain so until early anaphase, when daughter cells will respread (see 
Results and Discusion chapters). Much work has been focussed on the possible 
role of CDK activity in each of these processes. Early work showed the 
phosphorylation of mitotic histone H I, coinciding in time with chromosome 
condensation (Gurley et a l, 1974). More recently, the mitotic histone H I kinase 
was shown to be identical to cdc2/cyclin (Arion et a l, 1988). However, a causal 
re la tionsh ip  betw een histone H I phosphory la tion  and chrom osom e 
condensation remains unproven. The recognition sequence for cdc2 in histone 
H I was show n to be S/TPXK. Since then, the study of candidate CDK 
su b s tra te s  has show n th a t the req u irem en t for C D K -dependent
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phosphorylation is the presence of a proline residue immediately after the 
phosphorylated serine or threonine (Draetta, 1990).
Other mitotic substrates include the endosome-associated ras-like GTP- 
binding proteins rab l and rab4, which are phosphorylated by CDK/cyclin B, 
coinciding with the inhibition of endomembrane traffic (Thomas et a l, 1992). 
Caldesmon, a protein of 83 KDa which binds to actin and greatly enhances its 
b inding  to tropom yosin, is phosphorylated in m itosis by cdc2  kinase 
(Yamashiro and Matsumura, 1991; Yamashiro et a l, 1991). It has been suggested 
(Yamashiro and M atsum ura, 1991) that this phosphorylation causes the 
dissociation of caldesmon from microfilaments, and that this w ould lead to 
rounding-up at mitosis. The authors suggest two possible hypothesis. First, 
caldesmon dissociation from microfilaments is accompanied by its inactivation 
as an  actomyosin ATPase inhibitor, resulting in the contraction of the actin- 
myosin system and eventual rounding. Alternatively, as tropomyosin-bound 
caldesmon inhibits the severing activity of actin by gelsolin, it is possible that 
its dissociation restores gelsolin activity, leading to the disassembly of stress 
fibres which, the authors claim, would induce cellular rounding. However, as 
disassembly of stress fibers is not necessarily followed by cell rounding, the 
possible role of caldesmon on stress fibers is unlikely to be relevant in mitotic 
rounding-up.
The mechanisms by which cells round up at mitosis are particularly 
relevant to the work described in this thesis, where one of the questions 
addressed is the possibility that integrins participate in mitotic rounding-up 
(see Results and Discussion chapters). To date, there is no published evidence 
that integrin activity is m odulated during the cell cycle. However, it has been 
reported that a serine from the cytoplasmic dom ain of Pi, in a s p \, becomes 
phosphorylated in mitosis, and that mitotic ot5pi does not bind to fibronectin 
(unpublished data by Grandori and Hynes, quoted in Hynes (1992); see also 
Discussion chapter).
It is unlikely that 015 pi is phosphorylated directly by cdc2, as it does not 
contain the consensus sequence P-S/T in either of its subunits (Chan et al 1992; 
Marcantonio et a l 1990; but see Discussion chapter).
pp60c*src is another substrate for cdc2  that may be relevant for mitotic 
rounding-up. Two steps are required for pp60c_src activation. Firstly, residues 
Thr34 and Ser72, both conserved in frog, chicken, mouse and human, become 
phosphorylated by cdc2. Then, dephosphorylation of phosphotyrosine527 is 
further required for activation. W hen cdc2-induced phosphorylation of Thr34 
and Ser72 is blocked by site-directed m utagenesis, pp60c' src is partially
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inhibited, suggesting that cdc2  somehow participates in dephosphorylation of 
phosphotyrosine527. (Shenoy et a l, 1992). Downstream  pp60c src substrates 
might include components controlling cytoskeletal architecture an d /o r cell 
shape, known to be altered in transformed cells, as well as in mitosis (Shenoy et 
al, 1992). In particular, changes in those components mighl cause the mitotic 
rounding-up.
Myosin-II regulatory light chain is claimed to be a substrate for 
CDK/Cyclin B, although it does not contain the S/TP consensus present in all 
other substrates (Satterwhite et a l, 1992). This phosphorylation inhibits 
actom yosin ATPase activity and, accordingly, it is postulated that this 
inhibition w ould delay contractile ring form ation until CDK /Cyclin B 
inactivation.
As for the mitotic micro tubule reorganization, microtubule dynamics and 
centrosome-nucleating activity can be modulated by addition of CDKs to cell- 
free systems, although the actual substrates have not yet bee a identified (Nigg, 
1993). N evertheless, som e m icro tubule-associa ted  p ro teins become 
phosphorylated in mitosis, and localize to the spindle fibers, in HeLa cells 
(Vandre et a l, 1991), and it is possible that they are CDK substrates.
Vimentin, an intermediate filament (IF) protein, is phosphorylated by 
cdc2 in mitosis (Chou et a l, 1991; Chou et a l,  1990). Also, phosphorylation of 
polymerized vimentin IFs in intro by cdc2 causes their disassembly.
Another important event at the G2-Mitosis transition is nuclear envelope 
breakdown, which requires nuclear laminae A,B and C disassembly, brought 
about by CDK/ Cyclin B phosphorylation (Heald and McKeon, 1990; Luscher 
et a l 1991). However, lamina phosphorylations are not sufficient for envelope 
breakdown, which probably requires additional CDK/cyclin B-directed action 
(Nigg, 1993).
The proto-oncogene c-myb is also a substrate for cdc2/ cyclin B (Luscher 
and Eisenman, 1992). Myb is a DNA binding protein involved in transcriptional 
regulation. Its phosphorylation correlates with reduced DNA-binding ability. It 
has been suggested that its release from DNA might be necessary for an 
efficient chromosome condensation (Luscher and Eisenman, 1992).
6.1.2. Substrates for G1 and S CDKs
As m entioned above, CD K /cyclin activities also control the G l/S  
transition. Candidate substrates include tum or supressor gene products. In 
particu lar, the retinoblastom a protein  (pRb) contains m ultiple CDK 
phosphorylation sites. pRb is kept inactive by hyperphosphorylation by
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CDK/cyclin D2 on those sites in late G1 (Nigg, 1993), allowing progression 
through the cell cycle. p53 (Hartwell, 1992), is phosphorylated by CDK / p60 
and CDK/cyclin B at Ser315 (Bischoff and Friedman, 1990), close to the onset of 
DNA replication. p53 is a tumour-supressor. When DNA is damaged, p53 
acumulates and switches off replication, to allow for time for repair. If the 
repair fails, p53 triggers apoptosis (Lane, 1992).
CDK/Cyclin A and CDK/Cyclin B also participate in DNA synthesis 
control (Girard et a l, 1991). The only substrate identified so far is the 32-34 KDa 
subunit of the single-stranded DNA-binding replication protein A (RPA), a 
p ro tein  required  for the unw inding of origin DNA. Both complexes 
phosphorylate RPA during S and G2, and CDK/cyclin B stimulates origin 
unwinding and DNA replication in G1 cell extracts (Dutta and Stillman, 1992).
Table 1.3 contains the known substrates for CDK /cyclin complexes, at 
least in vitro,, at different stages of the cell cycle. Further investigations will 
clarify their exact relevance in vivo, and new substrates will no doubt be 
identified.
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G1 substrates
p53
pRb________________
G2 substrates
cyclin B
cdc25 phosphatase 
S substrates 
SV40T
DNA polymerase a (?) 
Mitotic substrates 
Nuclear lamins 
Vimentin
Myosin regulatory LC
Caldesmon
Neurofilament H
Histone HI
p60src
pl50abl
Casein kinase II (a/|3)
SW15
c-myb
oct-1 (?)
c-fos/jun (?)
Rabl/Rab4 
EF-ly
RNA polymerase a (?)
Table 1.3. Substrates for CPK/cyclin complexes
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1. MATERIALS
1.1. Media for cell culture
Analar grade reagents were used.
Hepes saline (HS)
NaCl
KC1
D-glucose
Hepes
0.5% phenol red 
pH  7.5
140mM
5mM
5mM
lOmM
0.003mM
Hanks' Hepes (HH)
NaCl
KC1
CaCl2 (2H20 ) 
MgCl2(6H20) 
D-Glucose 
Hepes
0.5% phenol red 
pH  7.5
140mM
5mM
Im M
Im M
5mM
lOmM
0.003mM
These buffers are dispensed in 100 ml aliquots, autoclaved and 
stored at 4°C.
Hepes is N-hydroxethylpiperazine-N '-2-ethane sulphonic acid.
Versene
NaCl
KC1
N a2H P 0 4
k h 2p o 4
EDTA
0.5%phenol red
140mM
2.5mM
8 mM
1.5mM
0.5mM
0.003mM
EDTA is ethylenediaminetetra-acetic acid.
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This salt solution is dispensed in 20ml aliquots, autoclaved and 
stored at 4°C.
Trypsin
2.5% sterile trypsin (Gibco) was dispensed in 2 ml aliquots and 
stored at -20°C. 0.5ml of this solution w ere added  to 20ml versene 
(trypsin/versene solution) for the suspension of cell monolayers.
Ham's F10 medium
Hepes water
X10 HamsFlO (Gibco)
NaHCOs
GPSA
TPB
Foetal calf serum
180ml, 120mM 
2 0 ml 
lm l 
5ml 
2 0 ml 
2 0 ml
Tryptose Phosphate Broth (TPB)
29.5g/l TPB (Gibco) in double deionised water was dispensed in 
20ml aliquots, autoclaved and stored at 4°C. 
pH  7.4
GPSA
G lutam ine
Penicillin
Streptom ycin
Fungizone (Am photerisin B)
114mM 
1905U/ml 
1905U/ml 
11.9 pg /m l
Bicarbonate
N aH C 03 7% (w /v)
Sterilised by M illipore u ltra  filtration and d ispensed in 20ml 
aliquots.
Phosphate Buffered Saline (PBS)
NaCl
KC1
N a2H P 0 4
KH2P 0 4
CaCl2
170mM
3.4mM
lOmM
1.8mM
Im M
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MgCl2 Im M
pH  7.4
1.2. Tissue culture vessels
Plastic tissue culture flasks and Petri dishes w ere from Greiner 
(Germany) or Sterilin (U.K.).
1.3. Solutions and reagents used for synchronization
Nocodazole
M ethyl (5-(2-thienylcarbonyl)-lH -benzim idazol-2yl) carbam ate 
(nocodazole) was from Sigma. It was used from a stock solution of 1.5mg 
in 1ml DMSO, kept at 4°C.
T hym id in e
Thymidine (cell culture tested) was from Sigma. It was used from a 
filter-sterilized stock solution 200mM in HH  and kept at -20°C.
1.4. Reagents used for Polyacrylamide Gel Electrophoresis
M aterials and m ethods were as described by Laemmli (1970). 
E le c tro p h o re s is  p u r i ty  re a g e n ts  w e re  u s e d . N ,N ,N ',N ' 
-tetram ethylenediam ine (TEMED) and Sodium Dodecyl Sulphate (SDS) 
were from Sigma. All other reagents were from BDH.
1.5. Antibodies
Antibodies were used for im m unofluorescence, flow cytometry, 
im m u n o p rec ip ita tio n  and  im m unob lo tting  as described  below . 
Lyophilized rabbit anti-hum an integrin a s  Pi and rabbit anti-hum an 
integrin a v p3 polyclonal antibodies were from Telios (U.S.A.), and were 
redissolved in physiological buffer as indicated by the m anufacturers. 
They were dispensed in 10 |il aliquots and kept at -70°C. Rabbit anti-
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hum an integrin p3 subunit polyclonal antiserum  was from Chemicon 
International, Inc., USA. It was dispensed in 10 |il aliquots and kept at 
-70°C. Mouse anti-phosphotyrosine (PY20) and TRITC-conjugated anti­
rabbit IgG w ere from  Sigma; FITC-conjugated anti-rabbit IgG and 
preim m une rabbit serum  were from the Scottish Antibody Production 
Unit (SAPU), U.K.
1.6. Solutions and reagents used for Western blotting
Electroblotting buffer
Tris base 250mM
Glycine 2M
M ethanol 20%
Milk block buffer
Tris base lOmM
N aCl 150mM
Dry milk 4%
pH  8
Tween buffer
Tris base lOmM
N aCl 150mM
T w een 0.2%
Tween is polyoxyethylenesorbitan.
1.7 Solutions and reagents used for immunoprecipitation
lysis buffer
Tris base 50mM
NaCl 150mM
MgCl2  (6H 2 O) 3mM
N H 4 VO3  Im M
N aN 3  0.02%
PMSF (added just before use) 100pg/ ml
Leupeptin (added just before use) lp g /m l
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Triton X-100 1 %
N aF 5mM
Adjust pH  to 8
PMSF (phenylmethylsulphonyl fluoride)
Used fresh for each experiment. The stock solution was made by 
dissolving 20mg of PMSF in 1ml DMSO (dimethyl sulfoxide), dispensed 
in 50 pi aliquots and .stored at -20°C.
Leupeptin
Used fresh for each experiment. The stock solution was m ade by 
dissolving 2mg of leupeptin in 1ml H H  and aliquoted and stored as with 
PMSF.
Iodogen
lm g  of l,3,4,6-Tetrachloro-3a, 6 a,-diphenylglycoluril (iodo-gen™) 
was placed in a glass universal. 1ml chloroform was then added and left 
overnight to evaporate.
Iodine-substituted HH  
N al 
KC1
CaCl2 (2H20 )
MgCl2 (6H20 )
Hepes 
N aN 3 
pH  8
Protein A-agarose
Protein A was from Sigma, insolubilized on cross-linked 4% beaded 
agarose, in a suspension 0.5M NaCl containing 0.02% thimerosal. 1ml of 
this suspension had a binding capacity of 20-25 mg hum an IgG.
140mM
5mM
Im M
Im M
5mM
0 .01%
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1.8. Solutions and reagents used for affinity chromatography
Urea 
urea 
Tris 
pH 7.5
Citrate buffer 
N a2H P04 
KH2P 0 4 
NaCl
Sodium Citrate 
pH 7.2
Digestion buffer 
Tris 
NaCl 
EDTA 
pH 7.6
Chymotrypsin
Chym otrypsin was from Sigma. The stock solution was m ade to 
lm g /m l in digestion buffer and stored at -70°C in 200|il aliquots.
DPCCI2
Diphenylcarbamyl chloride was from Sigma. The stock solution was 
made to 1M in ddH 20  and stored at -70°C in 200pl aliquots.
Lysis buffer
MnCl2 Im M
GOG lOOmM
NaF 5mM
N H 4 VO3 Im M
NaCl 150mM
Tris 50mM
PMSF 3mM
pH 7.3
PMSF was added just before the cell extraction.
lOmM
50mM
0.5mM
lOmM
1.5mM
0.15M
lOmM
8 M
50mM
52
2_______Materials & M ethods
fiOG is n-octyl-fi-glucopyrannoside.
Washing buffer
Similar to lysis buffer, with fiOG 25mM instead of lOOmM.
Eluting buffer
Similar to  washing buffer, without divalent cationi: and with 20m M 
EDTA.
NaF and NH4 VO3 were used as phosphatase inhibitors and in some 
experiments were omitted.
1.9- M aterials and reagents used  for spreading assays
Square glass coverslips were from Chance Propper Ltd. Coomassie 
blue was from Sigma and was used as a 1% solution in methanoLdistilled 
water.glacial acetic acid 50:50:7. All reagents used in cell suspensions were 
of Analar grade. Lyophilized, sterile colchicine was from Sigma and w as 
dissolved aseptically in HH to  a concentration of 100 [xg/ml and kept at 
4°C. Hem oglobin was from Sigma and fibronectin w as isolated as 
described below (see M ethods section).
110 R adioactive m aterials
1251 was supplied by Am ersham  International pic. U.K., as Nal in 
dilute sodium  hydroxide solution, ~17C i/m g pH 7-11. It was diluted in 
HH to  a radioactive concentration of 4mCi/ml.
Tran35s-label™ was from ICN Biomedicals Ltd. U.K., and contained 
-70% L-methionine (3 5S) and -15% L-Cysteine (35S). It was diluted in 
m ethionine and cysteine-deficient m edium  to  a concentration of 0.5 
m C i/m l.
32P w as supplied  by  A m ersham  In tern a tio n a l pic. U.K., as 
o rthophosphate in acid free solution, 8500-9120Ci/mmol. It was diluted 
in HH to 5mCi/ml.
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1.11 Calyculin A
Calyculin A, a phosphatase inhibitor, was the kind gift of Dr. L. 
Gasmi. A stock solution of 1 |ig /m l in ethanol was kept at -70°C.
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2. METHODS
2.1. Cell culture and growth conditions
HeLa cells were grown as monolayers on plastic, in Ham's F10 
m edium  contain ing  7.5% foetal bovine serum  and 10% tryptose 
phosphate broth, and checked periodically for mycoplasma. Cells were 
subcultured w hen almost confluent, usually every 3-4 days, depending 
on  the initial num ber seeded. To obtain  cells in suspension , cell 
monolayers were washed twice with HS and trypsin/versene suspension 
was added for 1 minute. Excess fluid was poured off and cells left at 37°C 
until rounded. Ham 's m edium  was then added to stop trypsin activity. 
Cell suspensions were centrifuged for 5 min. at 1,000 r.p.m., resuspended 
in  H H  and aspirated  in a Pasteur p ipette  to achieve single cell 
suspensions.
Stocks of frozen cells were kept at -70°C and prepared as follows: cell 
suspensions were centrifuged for 5 min. at 1,000 r.p.m., resuspended at a 
concentration of 5x106 cells per ml in  foetal calf serum  containing 10% 
DMSO, aliquoted in cryotubes and kept at -70°C. For recovery, cells (1 ml) 
were thaw ed in a 37°C bath, added to 10ml of Ham's F10 medium, and 
centrifuged as indicated above. Cells were then resuspended in fresh 
medium, seeded in a 25cm2 culture flask and kept at 37°C.
2.2. Fluorochrome staining for mycoplasma
105 cells per well were grown overnight on 13 mm coverslips in a 
5x5 wells sectored box. Next day cells were fixed for 2 m inutes in glacial 
acetic acid:methanol 1:3. The fixative was removed and more fixative was 
added for a further 10  minutes. Cells were then rinsed twice with distilled 
water. W ater was rem oved and fluorochrom e bis benzim ide "Hoechst 
33258" (50 |ig/m l) was added and incubated for 30 m inutes at 37°C. 
C overslips were then  rinsed  thoroughly  w ith  d istilled  w ater and 
m ounted on slides with PBS/glycerol 1:1 and examined using a Vickers 
Photoplan fluorescence microscope, using filters as for fluorescein.
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2.3. Cell synchronization
Populations enriched in mitotic cells were obtained basically as 
described (Zieve et al. 1980). Briefly, aliquots of 4x106 cells were seeded in 
175 cm2 culture flasks and incubated for 16-18 hours w ith  2.5 mM 
thymidine. Cells were then washed twice w ith HH, incubated for seven 
hours w ith  norm al m edium  and finally 0.05 |ig /m l nocodazole were 
added for a further 8  hours. This treatm ent gave a population highly 
enriched in  mitotic cells, w hich could be easily detached from the 
substrate by shaking off. Each flask yielded ~106 cells w ith a mitotic index 
of >95%, as m easured by flow cytom etry. For im m unofluorescence 
experiments, the same treatm ent was applied using 2 .5  cm tissue culture 
dishes instead of culture flasks.
Interphase Mitotic
cell cell
16 hours incubation with Thymidine (2.5mM) 
i  Most cells in Gi and SGrowth medium T
8 hours incubation with normal mediumTissue culture 
dish Most cells in Go and late S
fl D  H
I  5 hours incubation with Nocodazole (0.05|ig/ ml 
"  Most cells in Mitosis
' L D  n  Q ~ 0 ,
shake
off
i " ^ ° o
H— • n
Figure 2.1. Synchronization of HeLa cells by thymidine and nocodazole blocks. See text for details.
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2.4. Spreading assays
2 ml cells at 25xl03 / ml in HH, harvested as indicated above, were 
norm ally used for all spreading experiments. 2 2  mm square coverslips 
w ere cleaned in an acid bath  (sulphuric acid, nitric acid 1 :1 ) for 30 
m inutes, rinsed thoroughly w ith  tap  water, then rinsed twice w ith 
ddH 2 0 , placed in 2.5 cm Petri dishes and precoated w ith  fibronectin 
(40pg/m l in HH), calf serum  (1% in HH) or haem oglobin (0.5m g/m l in 
HH). These solutions w ere left for at least 30 m inutes at room  
tem perature and the dishes were washed twice w ith H H  before plating 
the cells.
Various additions to the cell suspensions were m ade depending on 
the experiment: M n2+, nocodazole, colchicine, vanadate, calyculin A and 
serum. Cells were then incubated at 37°C. To stop incubation, duplicates 
of samples were fixed at the indicated time intervals by addition of 1 ml 
of 4% form aldehyde in PBS for 15 minutes, the fixative removed and 2 
ml of Coomassie blue added for a further 15 minutes. The coverslips 
w ere then rinsed twice w ith distilled water, air dried and m ounted on 
slides w ith Gurr's Clearmount or Depex.
Mean spread area (MSA) was measured as described by Edwards et 
al  (1987).
2.5. Immunofluorescence
Cells were allowed to adhere to sterile glass coverslips at a density of 
5X104 cells/cm 2 and grown for 48 hours. To analyse mitotic cells, 2.5 cm 
tissue culture dishes were used for synchronization as described above.
After w ashing three tim es w ith prew arm ed PBS containing Ca2+ 
and Mg2+, cells w ere fixed for 20 min. w ith  4% form aldehyde 
supplem ented w ith 5% sucrose, and washed thoroughly with PBS; cells 
to be perm eabilised were treated w ith  0.5% Triton X-100 in PBS for 3 
m inutes and washed extensively. Cells were then incubated for 1 hour 
w ith rabbit anti-human as pi or a vp3 antisera, diluted 1 :2 0  from the stock 
solution, washed w ith  PBS, incubated for 30 minutes w ith rhodam ine- 
conjugated anti-rabbit IgG, diluted 1:100 from the stock solution, and 
w ashed  three tim es w ith  PBS. Coverslips w ere th en  m ounted  in
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undiluted glycerol, to which 5% n-propylgallate was added to inhibit 
photobleaching, and sealed w ith clear nail polish.
Representative fields of cells were photographed using a Vickers 
Photoplan microscope equipped for epifluorescence and Kodak T-Max 
400 film.
2.6. Flow cytometry
Flow cytometry was used to m onitor cell synchronization and to 
analyze integrin expression.
Cell synchronization
- 106 cells trea ted  for synchron iza tion  w ith  thym id ine  and  
nocodazole as described above were centrifuged (5 min. lOOOrpm), and 
resuspended for 5 min. in 70% ethanol at -20°C. Ethanol w as then 
rem oved by centrifugation and cells resuspended in 1ml. PBS. Propidium  
iodide was added to a final concentration of 50 |ig /m l and cells analyzed 
im m ediately  using a FACScan m achine (Beckton Dickinson & Co. 
Oxnard, Ca), in the Departm ent of Im munology and Bacteriology at the 
University of Glasgow.
Integrin expression
Cells were detached from culture flasks as follows: for mitotic cells, 
a 175 cm2 culture flask enriched in m etaphase-arrested cells as described 
above was used: nocodazole-containing m edium  was poured off, HS was 
added and cells were then collected by gentle shaking. Interphase cells 
were detached by adding 1 mM EDTA for 20 min. at 37°C, after washing 
tw ice w ith  HS. Both sam ples w ere then  w ashed  twice w ith  PBS 
containing Ca2+ and Mg2+, and  aliquots containing 5x10s cells were 
incubated for 1 hour w ith anti-hum an as Pi or a v p3 antisera. Cells were 
then washed again and incubated for 30 min. w ith FITC-conjugated anti­
rabbit IgG diluted 1:100 from the stock solution.
Finally cells were washed three more times, resuspended in 0.5 ml 
PBS and analysed using a FACScan machine.
Propidium  iodide to a concentration of 2 p g /m l was used in the 
final incubation from a stock solution of 100 ^ g /m l in PBS, to gate out 
dead cells.
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2.7. Immunoprecipitation of cell surface integrins
Im m unoprecipitation of integrins and SDS-PAGE analysis was 
carried out as follows:
Interphase cells (-107) w ere w ashed  tw ice w ith  w arm  HS. 
Prewarmed versene was then added and changed for fresh versene after 5 
min. Cells were incubated at 37°C until rounded. After pouring off the 
versene carefully, 10 ml HH  were added. The resulting cell suspension 
w as transferred to a plastic universal and cell clum ps rem oved by 
pipetting . After centrifugation for 5min at 1,000 r.p.m ., cells were 
resuspended in 10ml HH, centrifuged again and finally resuspended in 
2ml HH + 5mM PMSF, l |ig /m l leupeptin.
Im m ediately, cells w ere transferred to an iodogen-coated glass 
universal and lm Ci 125I was added, in a well ventilated fume hood. After 
iodination (20 min., 20°C, occasional agitation), cells were transferred to a 
glass conical bottom ed tube containing -20m l I-HH. Cells were then 
centrifuged, 5min., 1,000 r.p.m ., supernatant discarded down the sink 
w ith plenty of water (tap was left on for a few minutes) and resuspended 
w ith  another 20ml of I-HH. Centrifugation and discarding of supernatant 
was repeated again.
All subsequent steps were carried out in a cold room, at ~4°C:
1 ml per 1 0 7 cells lysis buffer was added to the cell pellet and left for 2 0  
m in. w ith  occasional agitation. To rem ove nuclei and  cytoskeletal 
structures, cells were transferred to an Eppendorf tube and centrifuged at 
13,000 r.p.m. for 18 min. The supernatant (detergent-soluble fraction) was 
recovered and 0.05 volumes of preim mune rabbit serum  +25pl proteinA- 
agarose beads were added for preclearing. This solution was left on a 
rotary mixer (Emscope) for 30min. Agarose beads were then centrifuged 
for 1 min. at 13,000 r.p.m. and supernatant split into several aliquots in 
Eppendorf tubes. Appropriate antibodies (specific or preim m une serum, 
1 0 pl) were then added and incubated for 2  hours.
After incubation w ith  antibodies, 30pl of proteinA-agarose were 
added to each aliquot and incubated for a further hour. The suspension 
w as centrifuged for 1 m in.at 13,000 r.p.m. and supernatant carefully 
removed w ith a disposable pipette tip.
For washing, 0.4ml. of lysis buffer were added to each aliquot and 
the agarose beads were resuspended by vortexing. After a few minutes,
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the operation was repeated. Finally, a wash w ith buffer w ithout detergent 
(same composition as lysis buffer, b u t detergent-free) was carried out, 
taking care to remove all traces of buffer from walls of the Eppendorf 
tube. Samples were then analysed by SDS-PAGE, under reducing or non 
reducing conditions. Gels w ere dried under vacuum  and radioactive 
proteins detected by autoradiography, using X-Omat film (Kodak) and 
intensifying screens (DuPont). Films were exposed at -70°C for 1-2 weeks, 
depending on the experiment.
2.8. Measurement of radioactivity by TCA precipitation
Radioactivity from radioiodinated samples was determined by TCA 
precipitation as follows: one ml of 0.1% calf serum  in H H  to act as a 
carrier was mixed w ith one volume of 10% trichloroacetic acid (TCA) in a 
test tube and 5pl of radioactive sample added. This mixture was left for a 
m inim um  of 15 min. at room  tem perature. Radioactive proteins were 
then collected on a Millipore filter (0.22 pm) and radioactivity counted on 
a y-counter (for 125I) or a scintillation counter (for 35S).
2.9. Protein measurement from 32P-labeled cells
Bradford's reagent was used to measure protein concentration in 
samples to be compared in im m unoprecipitation experiments.
20 pi of different concentrations of BSA in lysis buffer (0.25pg/ml to
0.5m g/m l) were added to 10 ml Bradford 's reagent and absorption 
readings at A,=595nm were obtained, in order to make calibration curves. 
20pl from the samples to be compared were also added to 10ml Bradford's 
reagent and the readings at 595nm used to calculate protein concentration 
w ith the calibration curve.
2.10. Immunoblotting
Preparation of samples
For interphase samples, cells were grown in 10cm Petri dishes until 
near confluent, and mitotic cells rem oved by washing three times w ith
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HH. Cold lysis buffer (0.5ml per plate, the same as described for 
im m unoprecipitation, including 100pg/m l PMSF, ImM  NaF and 5mM 
N H 4VO3 ) was then added and left at 4°C for 20 min. Cells were then 
scraped off, transferred to an Eppendorf tube and insoluble m aterial 
pelleted by centrifugation 18 min. at 13,000 r.p.m. The supernatant was 
transferred to another Eppendorf and 0.25 volumes of boiling mix were 
added.
W hen the effect of calyculin A was to be studied, samples were 
prepared  as follows: cells w ere grow n and w ashed w ith  HH as w ith 
interphase cells and 2ng /m l of calyculin A in 2ml of H H  were finally 
added until cells rounded up, usually less than 30 min. This solution was 
then carefully removed with a pipette and the cells lysed and prepared for 
electrophoresis as w ith inter phase cells.
Mitotic cells were obtained as described above for all other purposes, 
washed twice with HH  by centrifugation (1,000 r.p.m. for 5min.) and the 
pellet lysed (1ml lysis buffer per 1 0 7 cells) for 20 min. at 4»C. Samples 
were then cleared of insoluble material and prepared for electrophoresis 
as w ith interphase cells.
SDS-PAGE and protein analysis
W estern blotting was carried out as follows, in the CLIC laboratory, 
Departm ent of Pathology and Microbiology, at the University of Bristol: 
samples were boiled for 3min. before loading on a 10% polyacrylamide 
minigel (protein from ~105 cells per well). Electrophoresis were run  for 
40min at 200V using rainbow molecular w eight m arkers (Amersham 
In terna tional). P ro te ins w ere then  tran sfe rred  from  the gel to 
nitrocellulose paper (Hybond-ECL, Am ersham  International) w ith  a 
transblot apparatus (Bio-Rad). The electroblotting was left for 1 hour at 
100V. After dism antling the blotting sandwich, blocking of non specific 
sites was carried out using milk blocking buffer overnight. Filters were 
then placed in polythene bags and incubation w ith first antibodies (anti 
OC5 P1 at 1:1000 or anti phosphotyrosine at 1:500) took place for a minimum 
of 3  hours on a rocking platform, followed by a series of washes: twice 
w ith milk blocking buffer (10 m in each), twice with Tween buffer (10 min 
each) and finally once w ith milk block buffer (10 min). These washes 
were performed in a sandwich box w ith continuous agitation.
Filters were then placed in new polythene bags and incubated with 
second antibodies (goat anti-rabbit IgG conjugated to  horse radish
61
2 M aterials & M ethods
peroxidase (HRP) at 1:2000 or goat anti-mouse IgG-HRP at 1:2000) for 1 
hour at room  tem perature on a rocking platform . Subsequent washes 
w ere perform ed in a sandw ich box as follows: twice w ith milk block 
buffer (20 m in each), four times w ith Tween buffer (10 m in each) and a 
last rinse w ith distilled water.
P ro te in  d e te c t io n  w as p e r fo rm e d  u s in g  e n h a n c e d  
chem ilum iniscence (ECL) according to the m anufacturer's protocol 
(A m ersham  International). H orse rad ish  peroxidase catalyses the 
oxidation of luminol in the presence of hydrogen peroxide. Immediately 
after oxidation, luminol is in an excited state, returning to the basal state 
by the em ission of light, w hich is detected on a film (hyperfilmECL; 
A m ersham ).
2.11. Isolation of fibronectin
Fibronectin w as isolated from calf serum  (Gibco) on a gelatin- 
Sepharose column, as described by Engvall and Ruoslahti (1977). Briefly, 
the gelatine-Sepharose colum n (20 ml, p repared  according to the 
m anufacturer instructions, Pharmacia) was washed w ith three volumes 
of citrate buffer, and 500 ml of calf serum  (Gibco) were added at a flow 
rate of 40 m l/h , followed by citrate buffer until the ultraviolet absorbance 
(280 nm) of the eluent reached that of the citrate buffer. Fibronectin was 
then eluted w ith 8 M urea and stored at 4°C at a concentration of -1  
m g /m l until used. Fibronectin purity was assessed by SDS-PAGE.
2.12. Affinity chromatography
Isolation of the cell-binding fragment from fibronectin
Fibronectin, isolated as described above, was dialysed extensively 
from 8 M urea against digestion buffer, and proteolysed by incubating 
w ith  2 |ig /m l chym otrypsin at 37<>C for 30 min. Normally, -100ml of 
fibronectin, at 1.6-1.7 m g /m l were used. The digestion was stopped by 
adding DPCCI2 and PMSF to a final concentration of ImM  each.
The digested fibronectin solution w as fractionated on a gelatin- 
Sepharose column, and m aterial that did not bind to the colum n was 
directly used as the cell-binding fraction (CBF). Usually, -50 mg of protein
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w ere recovered in this fraction, and w ere concentrated to lm g /m l 
through vaccuum  dialysis for coupling to Sepharose 4 B. The digestion 
was monitored by SDS-PAGE under reducing conditions.
Proteolytic fragments that did not bind to gelatin were coupled to 
c y an o g e n -b ro m id e -a c tiv a ted  S ep h aro se  4B acco rd in g  to the 
m anufacturer's instructions. This resulted in the coupling of an average 
of 4.2 mg of protein per millilitre of gel.
Isolation of the fibronectin receptor from CBF-Sepharose columns
The procedure was based on that described by Pytela et al. 1985. For 
each cell sample (i.e. interphase, mitotic or calyculin-treated cells), one 
milliliter columns of CBF-Sepharose were equilibrated in washing buffer, 
w ith  or w ithout phosphatase inhibitors (NaF 5mM, N H 4 VO3 ImM ). 
Radioiodinated cell lysates from ~2xl07 cells per sample, prepared exactly 
as for im m unoprecipitation (except that p-octylglucoside was used as 
detergent instead of Triton X-100), were passed through the columns at 
the lowest rate possible, using a peristaltic pum p (2132 Microperpex®, 
LKB). The columns were then  w ashed w ith  10ml of w ashing buffer 
containing ImM  M nCh (Gailit and Ruoslahti, 1988) and bound material 
eluted w ith 20mM EDTA (eluting buffer).
W hen phosphatase inhibitors were used, care was taken to include 
them  in every buffer, from cell lysis to elution of the fibronectin receptor 
from the CBF-Sepharose column.
M aterial eluted with EDTA was directly analysed by SDS-PAGE, 
lo ad in g  50 pi p e r w ell, and  a u to rad io g rap h ed , o r p rev iously  
im m unoprecipitated w ith polyclonal anti-aspi antibody.
Radioactivity, determined by TCA precipitation as described above, 
w as m easured for every fraction from the application of the cell lysate to 
the colum n, in order to m onitor the presence of w ashed and eluted 
m aterial.
2.13. Analysis of integrin phosphorylation
Im munoprecipitation of integrins from cells radiolabelled w ith 32P 
w as carried  ou t in  o rder to find  ou t possib le  d ifferences in 
phosphorylation  betw een m itotic and in terphase integrins. Integrins 
from calyculin-treated cells w ere also analysed using 32P. Differences in
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phosphotyrosine protein  levels were analysed using the monoclonal 
PY20 antibody against phosphotyrosine, in all sam ples (i.e. mitotic, 
interphase and calyculin-treated cells). The procedure was as described for 
im m unoprecip itation  using rad io iod inated  cells, w ith  the following 
modifications:
Mitotic cells (~3xl06) were harvested exactly as described above, 
placed in a plastic universal and w ashed twice w ith  phosphate-free 
m edium  by centrifugation at 1 ,0 0 0  r.p.m. for 5min. Cells were then 
resuspended in 1ml of phosphate-free m edium  and lm C i of 32P was 
added. This cell suspension was kept for 3 hours at 37°C, w ith occasional 
agitation. After incubation, cells were transferred to a cold room, at 4°C, 
w ashed twice by centrifugation (1000 rpm, 5min), using cold Tris buffer, 
w hich was the same as lysis buffer, bu t w ithout detergent, and the final 
pellet was lysed for 20 min. w ith 1ml of lysis buffer. All subsequent steps 
were exactly as described for im m unoprecipitation from radioiodinated 
cells.
For interphase cells, 10cm Petri dishes were used. Usually, ~1- 
1.2X106 cells per dish were seeded and grown at 37°C for 36 hours. Cells 
were then washed twice w ith Tris buffer in order to remove mitotic cells, 
and twice w ith phosphate-free medium. Finally, lm l of this m edium  and 
lm C i of 32P were added and cells placed in a 37°C incubator for 3 hours, 
w ith  occasional agitation, in order to keep cells from drying. After 
incubation, cells were transferred to a cold room, at 4°C, washed twice 
w ith Tris buffer, and lysed for 20 min. w ith 1 ml of lysis buffer. Lysed cells 
were scraped off using a rubber spatula and transferred to an Eppendorf 
tube for preclearing. All subsequent steps were exactly as described for 
im m unoprecip ita tion  from rad io iod ina ted  cells. Equal am ounts of 
p ro te ins w ere used  for each sam ple. P ro te in  concentration  w as 
determ ined  in detergent-soluble fractions using Bradford's reagent. 
Radioactive proteins were detected by autoradiography, after 48 hours of 
exposure.
2.14. Biosynthesis of the fibronectin receptor during the cell cycle
Im m unoprecipitation of integrins from cells metabolically labelled 
w ith 35S was carried out exactly as described for 32P labelled cells. 50 pCi of 
T ran 35Slabel, diluted in 100 pi, were used for each sample, and washes
64
1 M aterials & M ethods
were done using methionine-free and cysteine-free medium. All samples 
were pre-incubated for 15 min. in this m edium  prior to the addition of 
Tran35Slabel. Mitotic cells were collected as described for 32P labelled cells. 
Asynchronous cells were seeded and treated as described for interphase 
32P labelled cells, w ith  more gentle washes, in order to keep the mitotic 
population. Cells in Gl+S w ere obtained from 10 cm Petri dishes by 
seeding 1-I.2xl06 cells and grow ing them  in the presence of 2.5mM 
thym idine for -20  hours. The m edium  was then  rem oved, and fresh 
grow th m edium  w ithout thym idine added for a further 2  hours, after 
which cells were treated for im m unoprecipitation as w ith asynchronous 
cells. Synchronization was m onitored by flow cytom etry (see fig. 3.17, 
Results chapter).
AIMS OF MY RESEARCH
The aim of my project was to gain some insight into the role of 
integrins in the transition from  G2 to mitosis in HeLa cells, and thus 
perhaps to contribute to understanding of how the activity of integrins is 
regulated.
D uring this transition, most cells in culture undergo  dram atic 
morphological changes, which eventually lead to cellular rounding-up. It is 
well known that cytoskeletal components participate in such changes (see 
Cell Cycle section, in Introduction). However, nothing seemed to be known 
about the state of integrins during mitosis. It was im portant to know if 
integrins continued to be expressed at the cell surface throughout mitosis. 
Two polyclonal antisera raised against hum an integrins were available to 
identify integrins in Hela cells (anti-asp! and an ti-avp3), which could be 
used in flow cytometry and imm unoprecipitation to answer this question. 
Assays of the spreading activity of mitotic and interphase cells could then be 
used to give an indirect measure of integrin activity at the level of intact 
cells, and affinity isolation of integrins from detergent extracts co u ld  
measure such activities in cell-free preparations. Since phosphorylation of 
integrins is a known mechanism for the regulation of their acitivity (see 
Integrins section, in Introduction) I planned to analyse the phosphorylation 
state  of in teg rins in HeLa cells in m itosis and in te rphase  by 
im m unoprecipitation from 32P-labelled cells.
Immunofluorescence was intended to localise integrins either at the 
cell surface on fixed cells, or intracellularly in perm eabilised cells. I also 
considered of interest to study whether synthesis of integrins was regulated 
during the cell cycle or whether it was constitutive. Therefore, I intended to 
immunoprecipitate integrins from 35S-labeled cells at different stages of the 
cell cycle. W hile optim ising synchronisation  procedures using th e  
microtubule inhibitor nocodazole, I realised that serum seemed to have a 
positive effect on the transition from metaphase to anaphase after release of 
nocodazole block. Therefore, I planned to quantify the rate of exit from 
metaphase at different times after release of the nocodazole block.
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During the course of the work, the phosphatase inhibitor calyculin A 
became available, offering a possible model in asynchronous cells for 
changes taking place at mitosis.
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RESULTS
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1. ISOLATION OF CELL-BINDING FRAGMENT FROM FI BRONECTTN
Bovine fibronectin isolated from serum was used  as a substrate for 
cells in spreading assays and as a source for the  isolation of the cell- 
attachm ent site on the fibronectin molecule. Figure 3.1 shows the  protein 
recovered in each step  of fibronectin and cell-binding fragment isolations. 
The fraction recovered from  the  gelatin-Sepharose colum n with 8 M urea 
contained mainly fibronectin, showing as tw o bands of ~200kDa under 
reducing conditions (lanes 5 and 6 ). Fibronectin d igested with 2^ig/m l 
chym otrypsin  was then  p a sse d  again through the gelatin-Sepharose 
colum n. The m aterial im m ediately  eluted, show ed in lanes 3 and 4, 
constituted the cell-binding fraction (CBF). It consisted of a main band of 
~130kDa, the cell-binding fragment, together with m inor contam inants. 
The digested fragments bound to  gelatin are shown in lanes 1 and 2.
2  SPREADING EXPERIMENTS
2 1 . Inierphase cells versus m itotic cells
Fig3.2 shows the ability of m itotic and interphase cells to  spread on 
glass surfaces pre-coated with fibronectin. Interphase cells responded readily 
to  fibronectin and fully spread  within one hour, unlike mitotic cells, which 
rem ained rounded and unable to  spread. N ocodazole added  to interphase 
cells during sp read ing  had  a negligible effect on spreading. Further 
experiments using different concentrations of M n2+, and haem oglobin and 
fibronectin as substrata, were then carried out. As fig.3.3 shows, in terphase 
cells need concentrations of Mn2+ higher than lO ^M  to  spread readily on 
fibronectin, and higher than  1 0 '^M  to do so  on haem oglobin, although 
there is a weak response to  low er concentrations. Mn2+ at 10'^M induces 
higher spreading of in terphase cells on fibronectin than  Ca2+ and Mg2 + 
bo th  at lO'^M. As for mitotic cells, although there is a significant increase in 
their MSA on fibronectin in the presence of >10"5m M n2+, as com pared 
with the sam e cells in the absence of M n2+ (nearly 50% increase), this effect 
is negligible when com pared with the area of fully spread interphase cells. 
Further experiments using several approaches (see below, section 2) proved 
that, given the right conditions, mitotic cells could be induced to spread to a 
lim ited extent, these results being com patible with the spreading results 
show n above. The ap p aren tly  b e tte r  sp read ing  of m itotic cells on
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Figure 3.1. Isolation of the cell-binding fragment by affinity chromatography. Lanes 1 and 2, 
gelatin-bound fraction from fibronectin digest. Lanes 3 and 4, fraction of the fibronectin digest directly 
eluted from the gelatin column. It contains the cell-binding fragment as the main component. Molecular 
weight markers (lane 7) are 205, 116, 97.4, 66,48 and 29kDa.
haem oglobin at low concentrations of Mn2* (observed in all experiments) is 
probably accounted for by the bigger size of mitotic cells.
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figure 3L2. Time course of cell spreading on fibronectin (25 pg/ml). Cells were diluted 
in HH, incubated at 37°C, and analysed at different times as described in Materials and 
Methods. Results are expressed as mean spread area relative to interphase cells after 
60 minutes incubation (value 100). Data from two different experiments
22 . Effect o f serum  an m etaphase-* anaphase transition
Cells w ere blocked in m etaphase  as described  in M aterials and 
Methods, washed twice and plated on fibronectin in the presence or absence 
of nocodazole and serum. After different incubation times, cells were fixed 
and stained as for spreading essays. As seen in figure 3.4, cells which were 
incubated with nocodazole did not go through m etaphase, as expected. 
N ocodazole-released cells, however, progressed faster in the presence of 
serum. Post-m etaphase cells w ere defined as th o se  show ing a c le a r  
anaphase m orphology (see figure 3.8b).
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Figure 3.3. Spreading of mitotic and interphase cells in response to vario u s 
concentrations of M n r* , using hemoglobin (top figure) and fibronectin is substrates. 
Cells were allowed to spread for 2 hours at 37°C in HS. Glass surfaces were pre-coated 
with fibronectin, from solution at 25 fig/ml, or haemoglobin, at 500 fig/m l. Data are 
expressed as mean spread area relative to spread interphase cells on fibronectin in 10' 
Ca^+, 10'^M Mg2+, without Mn^+ (value 100). Results are representative of 3 
experiments.
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Figure 3.4. Effect of serum on metaphase-»anaphase transition. Metaphase- 
arrested cells were prepared as described in Materials and Methods, and further 
incubated with or without serum. Nocodazole was included in control samples. Data 
from two experiments. Duplicate samples were counted each time.
3. IMMUNOLOCALIZATION OF MITOTIC AND INTERPHASE a 5p! 
AND a v p3 INTEGRINS
Indirect imm unofluorescence was used to identify the pattern  of 
expression of « 5pi and a vp3 integrins. Mitotic and interphase cells, fixed as 
described in Material and Methods, were stained with anti-aspi and anti- 
ayP 3 antibodies. Some samples were also permeabilised.
N on perm eabilized interphase cells (fig.3.5a,b) show clear staining 
only at the edge of the cells. Mitotic cells showed positive staining for both 
antisera, in the form of a double ring pattern, (fig.3.5c,d). One possible 
explanation for the mitotic pattern of staining is that, as cells undergo a pre­
trea tm en t of several hours in  nocodazole before being fixed for 
immunofluorescence, there is a percentage of the cell population w hich  
stays blocked in metaphase long enough to initiate spreading although, as
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Figure 3.5. Immunolocalization of a sP i and a v p 3 * Non permeabilised cells, a. Interphase cells 
stained with rabbit anti-human 015P1 . b. Interphase cells stained with rabbit anti-human ayP3- c. Mitotic 
cells. Staining as in a. d. Mitotic cells. Staining as in c. Bar, 10pm.
AS SEEN BY 
IMMUNOFLUORESCENCE
A. 77777777777777777777 O
B. 77777777777777777777
c - S / 7 7 / / 7 7 / / / / / / / / / / / / /
Figure 3.6. Limited spreading of mitotic cells, as seen by immunofluorescence, a . The cell rounds 
up at the onset of prophase and is blocked with nocodazole as it enters metaphase, b. After a few hours the 
cell starts spreading, c. Spreading stops at its early steps.
Figure 3.7. Immunolocalization of CC5 P 1 and a y P 3 from nonblocked, mitotic cells, a. Late 
telophase cell stained with an ti-a sP j. b. Anaphase/early telophase cell stained with anti-ay P3 . c. Daughter 
cells after parental cell has undergone cytokinesis. Staining as in a. d Cell in early prophase, in the process 
of rounding up. Staining as in a. Bar, 10pm.
Figure 3.8. a. Mitotic cells harvested as described in Materials and Methods were washed twice with full 
medium and incubated on glass coverslips at 37°C for 4 hours in the presence of 0.05ug/ml nocodazole. 
Cells were fixed and stained as for spreading assays, b. Cells underwent same treatment, except that final 
incubation with nocodazole was omitted. Bar 20pm.
Figure 3.9. Immunolocalization of a s P i  and <xv P3 . a. Interphnse cells stained with a n ti-a sP i.b . 
Interphase cells stained with anti-Oy^. c. Mitotic cells. Staining as in a. (X5 P1 . Mitotic cells. Staining as in b. 
Bars, 10pm.
imm unofluorescence, there is a percentage of the cell population w hich 
stays blocked in m etaphase long enough to  initiate spreading although, as 
show n in spreading experim ents using optimal conditions (fig. 3 .3 ), this 
spreading is very limited. Figure 3.6 shows the sequence of steps involved 
in the  process. The fact that the two rings in the same cell are situated at 
different focal planes (fig.3.5c,d) supports this hypothesis.
Further experim ents w ere m ade to  test this hypothesis. Cells were 
thym idine-blocked as in p rev ious experim ents, but blocking with 
nocodazole was omitted. Ten hours after the release of the thymidine block, 
when the percentage of mitotic cells is higher than usual, cells were treated 
for imm unofluorescence. As seen in figure 3.7, this time no  double ring 
pattern  could be found in m itotic cells. Instead, a single ring pattern was 
identified in cells actually undergoing anaphase (fig.3.7a,b) o r even after 
cytokinesis (fig.3.7c). Figure 3.7d shows a cell in early prophase in the 
process of rounding up.
These results were further confirmed by observing the m orphology of 
Coom asie blue-stained m itotic cells which had been incubated in medium 
with o r w ithout nocodazo le  (fig.3.8). As w ith im m u n o flu o rescen ce  
experim ents, when cells w ere released from the nocodazole block and 
therefore allowed to  pass into G1 phase, only cells undergoing mitosis 
could be  identified ( fig.3.8b) rather than cells trying to  spread (fig.3.8a).
Im m unofluo rescence  experim en ts w ere also carried  out with 
perm eabilised cells. In this case, a neat cytoplasmic, Golgi-like, pattern could 
be  seen in interphase cells treated  with anti-aspi antiserum, the staining at 
the  cellular edges being apparently weaker than in non perm eabilised cells, 
possib ly  due to the cytoplasm ic brightness (fig. 3.9a). W hen cells were 
trea ted  with anti-avP3 antiserum, a m ore diffuse and w eaker cytoplasm ic 
pattern  of staining could be seen (fig.3.9b). Mitotic perm eabilised cells were 
fully stained with both antisera (fig.3.9c,d).
4  EXPRESSION OF MITOTIC AND INTERPHASE INTEGRINS
Two different approaches were used to detect and com pare relative 
am ounts of integrins at both stages of the cell cycle: flow cytom etry and 
im m unoprecipitation of cell surface integrins. Im m unoblotting w as also 
carried out in interphase cells in order to test the presence of integrins in 
HeLa cells.
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Figure 3.10. Analysis by flow cytometry of cell surface expression of integrins. a. Interphase cells, 
b. Mitotic cells. Control samples were incubated with preimmune serum as first antibody.
3 R esults
4.1. Flow cytometry
Flow cytometry was used to compare surface expression of mitotic and 
interphase integrins. As seen in figure 3.10, no significant difference was 
found in the relative amount of either (X5P1 or a vp3 integrins, as detected by 
our polyclonal antibodies, when unfixed mitotic and interphase cells were 
compared.
4.2. Im m unoprecipitation of cell surface integrins
Mitotic and interphase integrins from radio iodinated  cells were 
immunoprecipitated using three polyclonal antibodies (anti-a5P ia n ti-a vp3 
and anti-p3), as described in Materials and Methods.
Figure 3.11 shows the typical pattern of bands obtained using anti- 
(X5P1. Since a polyclonal antibody is being used, it is not possible to be sure of 
the identity of these bands. However, the lower one has a mobility expected 
of a pi subunit, and as pi, it runs faster when reducing agents are added to 
the boiling mix (figure 3.12).
The mobility of the two upper bands apparently did not depend on 
the presence of reducing agents and their identity cannot be established 
w ithout the use of fu rther specific antibodies (but see section 3 , in 
Discussion chapter).
When the a n ti-a vp3 antibody was used, no reproducible pattern of 
bands was obtained.
When the anti-P3 antibody was used, again no bands were detected. 
The absence of P 3 w as con firm ed  by im m u n o b lo ttin g  a n d  
im m unoprecipitation using 35S-labeled cells (see below, this section).
These results indicate that P3 integrins are not present in HeLa cells. 
As for the relative amounts of protein recovered, the two upper bands sum 
up to 80-90% of the lower band, as measured by y-counting of the bands 
excised from the dried gels, both in interphase and mitosis.
m itosis
(5:1 au: 0.48±0.16 oil: 0.40±23
interphase
(5:1 au: 0.57±0.29 aL: 0.29±0.21
Table 3.1. Relative amounts of integrin bands in interphase and mitosis, a^ : lower a  
subunit. Data from four immunoprecipitations, means ± S.D.
subunit; a u : upper a
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Figure 3.11. Analysis of cell surface expression of integrins by immunoprecipitation. Lane 1, 
preimmune rabbit serum. Interphase cells. Lane 2, anti-015 P i. Interphase cells. Lane 3, anti-P3 - Interphase 
cells. Lane 4, preimmune rabbit serum. Mitotic cells. Lane 5. anti-asPi. Mitosis
1 2  3
20S
116
9 4 7
* 5
1 2
-205
-116
9 4 .7
Figure 3.12. Immunoprecipitation as in 3.11. a. Interphase cells. Lane 1, anti-asP i, reducing conditions. 
Lane 2, as lane 1, nonreducing conditions. Lane 3, preimmune serum, b. Mitotic cells. Lanes 1 and 2, as in a.
1 2
Figure 3.13. Immunoblots of interphase cells. ECL detection as described in Materials and Methods 
was used. Lane 1, an ti-asP ]. Lane 2, anti-P3 .
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4.3. Immunoblotting
Integrin subunits were identified by im m unoblotting using ECL 
detection as described in Materials and Methods. A nti-asp i and anti-fo 
antibodies were used. As shown in fig. 3.13, with anti-asPi, a reproducible 
pattern  of two bands was obtained, instead of the usual 3 from the 
immunoprecipitations (see also below, fig. 3.21). This is an expected pattern, 
since incubation w ith antibodies takes place on the nitrocellulose filter, 
where integrin subunits have previously been separated by SDS-PAGE. The 
apparent molecular weights of the two bands are -130 kDa and 125 kDa 
under reducing conditions, and they represent 0 5  (upper band) and fo. 
However, no bands were detected using the anti-^ 3  antiserum.
5. ANALYSIS OF THE CELL-FREE ACTIVITY OF THE FIBRONECTIN 
RECEPTOR IN MITOSIS AND INTERPHASE
A lthough the spreading ability of mitotic and interphase cells on 
fibronectin  (see above, section 2 ) may be an indirect m easure of the 
fibronectin receptor activity on those cells, it is obvious that a more direct 
approach was needed to assess such activity. This consisted of the isolation 
of the fibronectin receptor in viti'o , using affinity columns.
Cell lysates were passed through CBF-Sepharose columns as described 
in M aterials and Methods. The effect of a possible cell cycle-dependent 
phosp h o ry la tio n /d ep h o sp h o ry la tio n  on the activity of the fibronectin 
receptor (see below, Discussion chapter) was taken into account. Thus, cell 
lysates obtained and eluted from the columns using buffers containing 
phosphatase  inhibitors w ere com pared w ith sim ilar sam ples where 
phospha tase  inh ib ito rs had  been om itted. Figure 3.14 shows the 
radioactivity recovered from each fraction, after EDTA was applied, for 
interphase and mitotic samples.
It is clear that the presence of phosphatase inhibitors does n o t 
influence the recovery of protein with EDTA. However, there is a difference 
in recovery between interphase and mitosis. Table 3.2 shows the counts 
recovered from postEDTA fractions as a percentage of the total counts 
applied to each column.
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Figure 3.14. Affinity isolation of the fibronectin receptor. Mitotic and interphase cells were lysed with 
or without phosphatase inhibitors as described in Materials and Methods, c.p.m. are indicated for each 
postEDTA fraction.
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Figure 3.15. Affinity isolation of the fibronectin receptor, a. interphase cells, phosphatase inhibitors 
used. b. interphase cells, no phosphatase inhibitors, c. mitotic cells, phosphatase inhibitors, d. mitotic cells, 
no phosphatase inhibitors. Films were exposed for 28 days.
Interphase; phosphatase inhibitors 
0.09%
bitevphase; no phosphatase inhibitors 
0.108%
M itosis; phosphatase inhibitors 
0.058%
M itosis; no phosphatase inhibitors 
0.054%
counts applied in each case
Aliquots (50[il) from postEDTA fractions were electrophoresed and 
the presence of radioactive bands detected by autoradiography. A persistent 
problem  occurring in this type of experiments (see also below, section 6) was 
a lack of sensitivity, which translated into very long times of exposition 
required to detect recognizable bands, thus lowering the quality of the film. 
Unfortunately, the use of m ore radioactivity and higher num bers of cells 
per sample did not im prove the final result (not shown). Figure 3.15 shows, 
in all samples, the recovery of two bands of a mobility expected of a  (upper 
band) and p integrin subunits. Further experim ents (see below, fig.3.23, 
section 6 ) show ed that, under reducing conditions, b o th  bands ru n  
similarly, as a single band, which is a typical behaviour of a s  and Px (see 
below, Discussion chapter).
6. IM M UNOPRECIPITATION OF INTEGRINS FROM * * P - A N D  “ S 
LABELED CELLS
6_1_ A nalysis o f integrin phosphorylation
Im m unoprecipitation of integrins from cells labeled with 32P, using 
an ti-asp i and  anti-phosphotyrosine (PY20) antisera was carried out as 
described in Materials and Methods. Fig. 3.16 shows the absence of integrin 
bands in mitosis and interphase . No bands were either detected using the 
antibody PY20.
6 2  Cell cycle-related biosynthesis of integrins
Im m unoprecipitation of integrins using cells m etabolicaly  labeled  
with 35S was carried out as described in Materials and Methods. Cells w ere 
partially synchronised in Gl+S phase by one thymidine block, as described 
in M aterials and M ethods, followed by 2 hours incubation in n o rm a l 
m edium  (treatm ent T2). At this stage cells have recovered  from the 
thym idine block and  a significant percen tage  have en te red  S phase. 
A ttem pts to  synchronise cells in G2 phase were unsuccessful, p o ss ib ly
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Figure 3.16. Immunoprecipitation of integrins and phosphotyrosine-containing proteins from cells labeled 
with ^ P .  Lane 1, preimmune rabbit serum. Lane2, mitosis, anti-anti-015 P i . Lane3, mitosis, PY20. Lane 4, 
interphase, anti-anti-asPi • Lane 5, interphase, PY20.
16°
8-
Figure 3.17. D NA content curves from synchronised samples, a. Mitotic cells, b. Asynchronous cells, 
c. T2 cells.
Figure 3.18. Im m unoprecipitation of integrins from ^ S -lab e led  cells, a. Lane 1, asynchronous 
culture, preimmune rabbit serum; lane 2, asynchronous culture, anti-P3 antibody; lane 3, T2 cells, anti-as Pi 
antibody; lane 4, asynchronous culture, as in lane 3. b. lane 1, T2 cells, an ti-asp i antibody, reducing 
conditions, lane 2, as in lane 1, nonreducing conditions; lane 3, asynchronous culture, anti-asPi antibody, 
nonreducing conditions
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because the length of G2 is very short compared with the partial de- 
synchronisation that occurs in the 6-7 hours required to pass through S 
phase, after the thymidine block. Synchronisation was monitored by flow 
cytometry using propidium  iodide, as described in Materials and Methods. 
Figure 3.17 shows the typical curves obtained from the different 
synchronised samples.
Asynchronous and partially synchronised cells were incubated with 
T ran35S-label™ for 3 hours, and integrins immunoprecipitated using anti- 
(X5P1 and anti-P3 antibodies. Equal amounts of radioactivity were used for 
each aliquot. Figure 3.18 shows the pattern obtained for the two samples. 
Asynchronous cultures have a stronger Pi band, and a  subunits are not 
detected in T2 cells (fig. 3.18a). However, a further experiment (fig.3.18b) 
show ed that both subunits are also present in T2 cells, although 
asynchronous cells still show stronger bands. These bands are probably the 
same as those obtained from radioiodinated cells (see above, figure 3 .1 2 ).
Table 3.3 shows the intensity of the bands relative to the p subunit, as 
measured by y-counting of the excised bands from dried gels.
Asynchronous cells (fig.3.18a, lane 4)
pT____________________ aL:0.08±0.025____________________0^:0.1610.02
T2  cells (fig.3.18b, lane 1 )
P:1 cxl:0.15±0.6 au:0.2±0.65
Table 3.3. Relative amounts of integrin bands from 33S-labeled cells. Band intensities relative to p. 
Bands were escised from dried gels and and c.p.m. obtained three times from a y-counter. <*]_/ lower a 
subunit; a u: upper a  subunit. Data represent the means±S.D.
Stronger bands were detected in asynchronous cultures. The presence 
of a much wider Pi-like subunit in this sample corresponds probably to the 
w idely reported Pi precursor, further supporting the idea that the lower 
band is indeed P i. The differences in intensity  c o m p ared  w ith  
radioiodinated samples (table 3.3) could be due to the higher content in Cys 
and Met residues in the Pi subunit (see above, Integrins section, in 
Introduction chapter) and to the presence of the Pi precursor. The Pi 
subunit contains 58 Cys and 15 Met, whereas as contains 15 Cys and 8  Met 
residues (Argraves et al. 1987). Tran35Slabel (see radioactive m aterials 
section, in Materials and Methods) contains 70% L-methionine (35S) and 
20% L-Cysteine (35S). Assuming that the m iddle a  subunit is a 5 and that 
there is no significant difference in Met and Cys content between a 5 and the
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upper a , the expected relative intensities of a  and the sum of both  a  
subunits are as follows:
58Cys x 0.2 + 15Met x 0.7= 22.1 (p subunit)
15Cys x 0.2 + 8 Met x 0.7= 8.6  (a subunit)
As two a  subunits are present, the ratio is 2 a /p =  17.2/22.1= 0.78. These 
calculations give an approxim ate estimation of the expected intensities of 
integrin bands as detected  by autoradiography. However, the actual ratio 
encoun tered  is 0.25-0.35 (see table 3.3). The presence of a large pool of 
cytoplasmic p subunit could then account for the difference.
No p3 bands were detected, in accordance with the results shown in 
im m unoblots and im m unoprecipitation from radio iodinated  cells (see 
above, section 4).
7. EFFECTS OF CAI.YCUUN A  ON HeLa CELLS
The effects of calyculin A (CL-A) on the spreading ability and integrin 
activity of HeLa cells were studied.
7.1. Spreading of CL-A treated cells
Cells were prepared for spreading assays as described in Materials and 
M ethods. Different concentrations of CL-A w ere used and cells w e re  
allowed to  spread on fibronectin (from solution at 25 ng/ml) or hemoglobin 
(0.5mg/ml). CL-A was added at time zero.
The results are shown in figures 3.19a to  3.19d. As expected, cells 
sp read  best on fibronectin, in the p resence of Im M  Mn2+. On bo th  
fibronectin and hemoglobin, CL-A it appears to have a negative effect on 
spreading after one hour. However, spreading at its early stages (at 30 
minutes after plating) is not affected in the presence of CL-A. The apparent 
difference betw een controls and CL-A trea ted  cells was not statistically 
significant, as m easured by Student's t test (P<0.001). However, m orphology 
of control and  CL-A trea ted  cells was different. Control cells sp read  
uniformly since the early stages until fully spread. However, CL-A trea ted  
cells adopted a stellate shape in all cases, after 30 minutes of spreading (see
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fig. 3.19e). At longer times (lh and 2h), they had clearly retracted and had an 
appearance similar to  that showed in figure 3.20.
Experiments with fully spread cells (see below, this section) showed 
that at least 50nM CL-A was needed to induce changes in cell shape. At that 
concentration, cells undergo a dram atic change of shape and becom e 
rounded  after -30 m inutes (figure 3.20). O ther concentrations had no 
detectable effect (InM and 5nM) after 2 hours, or the effects were very slow 
(cell retraction and eventual rounding-up required longer than 1 hour 
with 25nM CL-A).
72. Effect o f calyculin A  on  the integrin «sPl
As m entioned above, fully spread  cells trea ted  with 50nM CL-A 
becom e rounded after -30 minutes. In order to study the possible role of 
integrins in the CL-A-induced cellular rounding up, several a p p ro a c h e s  
were used.
Integrin a sp i was detected by immunoblotting. Figure 3.21 shows the 
presence of tw o bands whose apparent molecular weights are 130kDa and 
125kDa, under reducing conditions (see also fig. 3.13).
The activity of the fibronectin recep tor from interphase, fully spread 
cells, and  from cells trea ted  with CL-A (2nM) was m easured by affinity 
c h ro m a to g ra p h y  on th e  cell-b ind ing  fragm en t of fib ro n ec tin . 
R adio iod inated  cell lysates from norm al cultures (in terphase) w ere 
p repared  as described in Materials and Methods. Lysates from CL-A-treated 
cells w ere prepared after cell rounding had taken place. Figure 3.22 shows 
the radioactivity recovered from post-EDTA fractions. Higher counts are 
p resen t in in terphase fractions. The to ta l c.p.m. recovered am ount to
0.095% of the to tal c.p.m. applied to  the column, com parable to o ther 
experim ents (see table 3.2), whereas counts from CL-A-treated cells were 
negligible at this scale.
Aliquots (50^1) from post-EDTA fractions were electrophoresed and 
radioactive bands detected by autoradiography on dried gels, as described in 
Materials and Methods. Figure 3.23 shows the result of an autoradiograph 
from in terphase  post-EDTA fractions. Only fractions 5 (shown un d er 
reducing and nonreducing conditions) and 6 showed bands after 3 weeks of 
film incubation at -70°C. No bands appeared  from post-EDTA fractions of 
CL-A-treated cells (not shown).
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Substrate: hemoglobin. 1mM Ca2+/Mg2+
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0 . 2 5
time (min)
control 1 InM CL-A ■  2nM CL-A
H  0.5nM CL-A
figure 3Ll9a Spreading of CL-A treated cells on hemoglobin in the presence of ImM Ca2+/ Mg2+. 
Cells were processed for cell spreading as described in Materials and Methods. Bars represent means 
+ S.D.
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Substrate: hemoglobin. 1mM Mn2+
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Figure 3.19^ Spreading of CL-A treated ceils on hemoglobin in the presence of ImM Mn2+. Cells 
w ere processed for cell spreading as described in Materials and Methods. Bars represent means ± S.D.
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Substrate: fibronectin. 1mM Ca2+/Mg2+
o
time (min)
0 control 3  InM CL-A B  2nM CL-A
I I 0.5nM CL-A
Figure 3L19c Spreading of CL-A treated cells on fibronectin in the presence of ImM Mg2+/Ca2+. 
Cells w ere processed for cell spreading as described in Materials and Methods Bars represent means 
± S.D.
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Substrate: fibronectin. 1mM Mn2+
3 0 6 0 1 2 0
time
0 con tro l 3  InM CL-A ■  2nM CL-A
□ 0.5nM  CL-A
1 . 2 5
0 . 7 5
0 . 2 5
Figure 3L19d_ Spreading of CL-A treated cells on fibronectin in the presenoe of ImM Mn2+. Cells were 
processed for cell spreading as described in Materials and Methods. Bars represent means ± S.D.
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Figure 3.19e. A. Spreading of HeLa cells. Incubation of cells with Ca^+/ Mg^+ on fibronectin or 
with Mn^+ on a nonadhesive substrate (see fig. 3.3) causes cells to  spread uniformly from the 
early stages. B. W hen cells are incubated with nM concentrations cf CL-A (see fig. 3.19a-d) they 
adopt a more stellate m orphology after 30 minutes. Longer times of incubation cause cellular 
rounding (see fig. 3.20b). See p. 98 for discussion,
Figure 3.20. Effect of CL-A on the shape of HeLa cells, a. HeLa cells under physiological conditions, 
b. Same culture 30 minutes after the addition of 50nM CL-A. Bars, 10pm
Figure 3.21. Immunoblotting using a polyclonal an ti-a sP i antibody. Cell extracts were 
electrophoresed, transferred to nitrocellulose filters and integrins detected by ECL as described in 
Materials and Methods, a. Calyculin A treated cells, b. Interphase cells c. Interphase cells, preimmune
post-EDTA fractions
0.04
interphase
calyculin
0 .0 3 -
0.02  -
0.01
0.00
121086420
fraction no.
Figure 3.22. Affinity chromatography isolation of the fibronectin receptor. An aliquot (lOul) from 
eluted fraction, starting from cell extract application, was taken and its radioactivity measured as described 
in Materials and Methods. Only post-EDTA fractions are shown, c.p.m. are expressed relative to the peak 
fraction of each sample.
Figure 3.23. Detection of integrin bands from affinity chromatography isolated fractions. Lanes 
shown are from interphase cells. Numbers of tracks coincide with numbers of fractions from figure 3.22. 5a. 
Fraction 5 under reducing conditions. 5b. Fraction 5 under nonreducing conditions
Figure 3.24. Analysis of integrin phosphorylation from interphase and CL-A-treated cells. 
Samples were analysed by SDS-PAGE under nonreducing conditions, using 7% running gel. Lanel. 
Preimmune rabbit serum. Lane 2. Interphase cells. Anti-asPi. Lane 3. Interphase cells. PY20. Lane 4. CL- 
A-treated cells. Anti-a5 p i . Lane 5. CL-A-treated cells. PY20. Films were exposed for 48 hours.
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C hanges in in tegrin  ph o sp h o ry la tio n  w ere also stud ied  b y 
im m unoprecip ita tion  from 32P-labeled cells, using anti-aspi and anti- 
phosphotyrosine (PY20) antibodies. Immunoprecipitation was carried out as 
described in M aterials and Methods. CL-A (50nM) was added to  cells 30 
m inutes before incubation time with 32 P was due to finish (i.e. 2.5 hours 
after addition of 32P). The sam e am ount of protein, as m easured with 
Bradfords' reagent, was applied for each fraction. Figure 3.24 shows th e  
absence of integrin bands in both samples. The interphase track shows a 
possible band  in the range of 97 and 116kDa, com patible with being a pi 
subunit. However, this band was not detected in three further experiments 
and p robably  represents an artefact (see also above, figure 3.16). A more 
interesting result appears in the anti-phosphotyrosine tracks. CL-A clearly 
raises the level of tyrosine phosphorylation in a wide range of proteins.
8. OPTIMISATION OF SYNCHRONISATION METHODS
The approach considered to generate populations enriched in m itotic 
cells was the use of reagents that block cells at certain stages of the cell cycle 
(thymidine and Nocodazole), com bined with serum -starvation of the cells 
in som e experiments. I will discuss briefly the current knowledge on the  
m echanism  of action of N ocodazole and thym idine, and why they are 
useful in synchronisation m ethods for cells in culture. Then I will describe 
the  s tep s  involved in the optim isation  of a m eth o d  suitable for 
synchronisation of HeLa cells.
8.1. N ocodazole and thym idine blocks
N ocodazole is an alkaloid similar to  colchicine, which interferes 
reversibly  with the  polym erization of m icro tubules (MTs). Since the 
segregation of replicated chrom osom es depends on the formation of a 
b ipolar spindle com posed  primarily of MTs, N ocodazole can be used to  
inhibit form ation of the  m itotic spindle, therefore  arresting cells at the 
onset of mitosis. Furthermore, concentrations of Nocodazole effective on  
m itotic MT polym erization have no effect on the  MTs from interphase 
cells. Thus, trea ted  cells will proceed  normally through the cell cycle until 
m itotic spindle formation, which cannot be achieved. Removal of the drug 
allows the cells to continue through mitosis (Vandre et al. 1992).
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Reversible inhibition of DNA synthesis allows the synchronisation of 
a high percentage of cells at the boundary G l/S . This can be accomplished by 
the  use  of high concentrations of thymidine, which will interfere with the  
synthesis of the necessary  nucleotides. Uptaken thym idine is rapidly 
converted  into dTTP, which is an allosteric inhibitor of ribonucleotide 
reductase. This enzyme is responsib le  for reducing all ribonucleotide 
diphosphates to  the corresponding deoxy form (from NDP to  dNDP). It is 
believed that high concentrations of dTTP reduce the supply of dCTP from 
CDP, which eventually will cause DNA polym erase to stop. In fact, addition 
of dCTP bypasses the thymidine block (reviewed by Adams, 1980).
A way to  arrest cells before S phase is to  stop their growth by removing 
serum  from the medium. Serum contains growth factors and possibly other 
com ponents which are essential for cell growth. Therefore, deprivation of 
serum  causes m ost cells to  withdraw from the cell cycle and remain at Go. 
Readdition of high concentrations of serum  causes a high percentage of cells 
to  reen ter the cell cycle in Gl.
8 2  Synchronisation m ethods
My first synchronisation experim ents involved the use of 0.05 Jig/ml 
N ocodazole on exponentially growing cultures, during 15-20 hours, and  
then isolation of the m itotic pool by  shaking off. Although it has been 
rep o rted  that reversibility of N ocodazole effect is gradually lost after 
incubation of the drug for m ore than 8 hours (Zieve et al 1980), treatm ent 
with N ocodazole for m uch longer tim es has been  widely reported as a 
successful approach to  block reversibly several cell types in mitosis. This 
suggests that N ocodazole reversibility could be  to  som e extent cell type 
dependent.
In my hands, a single N ocodazole treatm ent of 0.05 Jig/ml for 18 
hours allowed the collection of 30-40% of all cells, with a m itotic index of 
>85% as m easured by flow cytom etry (fig. 3.25). However, when cells were 
extensively w ashed to rem ove N ocodazole, and plated with fresh medium, 
a high m ajority did not divide, and cells were clearly unhealthy after 24 
hours (fig. 3.26). This result is in accordance with Zieve e t al (1980). 
Therefore, a milder treatm ent was needed  in order to  obtain viable mitotic 
cells. This consisted of the use of serum -starvation of cells to obtain 
populations in Go which, after restim ulation, would progress in a highly 
synchronised way tow ards mitosis. This would allow the use of a short 
block with Nocodazole, fully reversible. The actual protocol was as follows:
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1. Plating of cells in fresh m edium  containing 0.1% fetal calf serum
2. After 24 h, restimulation with 20% fetal calf serum
3. After 20 h, addition of 0.05 Jig/ml Nocodazole
4. After 8h, collect m itotic cells
This p rocedure did not yield significant am ounts of m itotic cells. 
Modification of the time betw een restimulation and addition of N ocodazole 
(from 10 h to 24 h), or lengthening of serum starvation period up to  48 h did 
not im prove the result (not shown). The m ost likely explanation at this 
stage was that cells were not being arrested at Go and, therefore, treatm ent 
with N ocodazole for 8 h could not yield high am ounts of m itotic cells. 
Com parison of DNA profiles betw een serum-starved cells and control cells 
(i.e. incubated with serum -contain ing  m edium ) show ed no  significant 
difference (see fig. 3.27) indicating that cells were no t arresting at Go, b u t 
rather proceeding through the cell cycle. It is likely that, as HeLa cells are a 
transform ed cell line (cervix carcinoma, containing several copies of the 
hum an papillomavirus genome), high growth is a default situation, and 
requirem ent of growth factors a n d /o r  o ther com ponents from serum is 
bypassed  by constitutively active signal transduction pathways involved in 
cell growth.
Therefore, I considered the use of a thymidine block in order to obtain 
m ost of the cell population in G l/S , followed by  a block with Nocodazole 
several hours after rem oval of thymidine, when m ost cells are at the end of 
S phase or in G2. Thus, a N ocodazole block of no m ore than 8  hours will 
suffice to arrest reversibly a high proportion of cells in mitosis.
The actual protocol was as follows:
1. Addition of 4mM thymidine to  an exponentially growing culture
2. After 20 h, change m edium  for fresh medium without thymidine
3. After 7 h, add 0.05jig/ml Nocodazole
4. After 8 h, collect m itotic cells
Initially, results w ere sim ilar to  those  ob ta ined  with s e ru m -  
starvation. It was possible that cells needed m ore than 7 hours to  recover 
from the thymidine block. Therefore, I com pared m itotic recovery from 
sam ples differing in the length of time betw een removal of thymidine and 
addition of Nocodazole. N one of the samples yielded significant amounts of
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m ito tic  cells (not shown), suggesting that the thym idine block was 
som ehow  cytotoxic. Indeed, the use of 2.5mM thymidine instead of 4mM, 
following the above protocol, yielded high am ounts of mitotic cells at the 
end of the treatm ent (see fig. 3.28). This concentration was the lowest at 
which cells becam e blocked at G l/S  and could recover fully. Cell viability 
was analysed by flow cytom etry and by replating m itosis-arrested cells in 
Nocodazole-free medium. Cells started to  divide within a few hours. This is 
show n if figure 3.29, which rep resen ts  the DN A  profile of a m itotic 
population 5 hours after Nocodazole release. Note the high percentage of 
cells that have already entered in Gl. Full recovery was obvious 48 hours 
after plating (fig. 3.30).
Figure 3.31 show s the appearance of a culture after 20 hours of 
treatm ent with 2.5mM thymidine. N ote the com plete absence of mitotic 
figures.
Figure 3.32 shows the actual duration of mitosis for an untreated cell. 
A bout 2 hours are required betw een cell retraction (G2/M boundary) and  
com plete separation of the two daughter cells. The period from m etaphase  
to  cell separation is -1.5 hours.
My attem pts to  synchronise cells at the G2 stage for analysis of integrin 
biosynthesis were unsuccessful. The approach used  involved a block with 
thymidine to  arrest m ost cells at the G l/S  boundary, and collection of cells 
at different times. Flow cytometry was then used  to m onitor exit from S 
phase. DNA profiles showed that desynchronisation occurs very early after 
release of the thym idine block. In fact, although relatively synchronised 
cells could b e  obtained in Gl+S (see fig. 3.17), DN A profiles typical of an 
asynchronous culture were obtained after m ore than  5 hours (not shown). 
Using a double thymidine block to obtain m ore cells at the G l/S  boundary 
gave similar results.
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Figure 3L25. DNA profile of cells treated with O.Sjig/ml Nocodazole for 18 hours. Statistics at the right 
show percentage of cells in G1 (3.75%, defined as Ml), S (12.25%, defined as M2) and G2+M (8295, 
defined as M3). Note that, although this method does not allow separation of G2 from Mitosis* the 
method of collection (shaking off of loosely attached cells) makes it unlikely that the population 
defined as M3 (82.95%) contains any significant amount of cells in G2.
figu re 3.26. Cells treated with Nocodazole for 18 hours as described in the text were washed  
extensively w ith  medium without Nocodazole and replated. Photograph was taken 24 hours after 
plating. Magnification x20
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Figure 337. DNA profile of a) asynchronous untreated c d ls  and b) cells serum-starved for 48 
hours. Note that, although the serum-starved sample has a higher percentage cf cells in G1 (defined 
as section Ml in the graph), there is still a significant proportion of cells in S and G2+Mitosis (17%, 
defined as section M2 and M3 in the graph), suggesting that cells are able to divide; even in the 
absence o f serum.
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Figure 3L28. DNA profile of mitotic cells. Cells were arrested at pro-metaphase using 2.5mM 
thymidine for 20 h, incubation with fresh medium for 7-8 hours and a final incubation with 0.05 
Jig/ml N ocodazde for 7-8 hours. Cells were collected fcy shaking off and immediately processed 
for flow cytometry as described in Materials and Methods.
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fig u re  3l 29.  Mitotic cells w ere extensively washed with full medium to remove Nocodazole and 
allow to proceed through metaphase in suspension. The DNA profile of this population after 5 
hours of Nocodazole release is shown. Ceils were processed for flew cytometry as described in 
Materials and Methods.
f ig u re  33n  Mitotic cells w ere washed extensively to remove N ocodazde and replated. Cells were 
photographed after 48 hours. Magnification x20.
Figure 3L3I. HeLa cells after treatment for 20 h with Z5mM thym idine Note the absence of mitotic 
figures, indicating that most cells have been arrested after m itosis in G l/S , or during S phase  
Magnification x20.
Figtire 132. Time-lapse video recording of the mitotic process in He La cells Asynchronous cultures 
were treated with 2.5mM thymidine for 20 hours to obtain a high percentage of cells at phases Gl / S  
and S. Cultures were then allowed to grow in thymidine-free medium for a further 15 hours. At this 
stage, cells were placed on a 37°C chamber attached to a TMS Nikon m icroscope and video-recorded.
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4 Discussion
1. SPREADING EXPERIMENTS
1-1- Spreading of m itotic cells
The spreading ability of m itotic and interphase 'cells under different 
conditions was assessed. It seem ed reasonable to think that, if integrins (the 
fibronectin receptor(s) in this case) play a role in the cellular rounding at 
mitosis, optim um  conditions might be  found under which spreading of 
m itotic cells could be  prom oted. For example, the use of fibronectin as 
substrate and the optimum concentration of Mn2+ in the incubation medium 
might trigger mitotic cell spreading; Mn2+ is known to  support spreading on 
fibronectin, p robab ly  via integrins, of variant BHK cells o th e rw is e  
unresponsive to  that surface (Edwards et al 1987; Edwards e t al 1988; section 
4, in Final Conclusions chapter). Furthermore, Rabinovitch and D eStefano 
(1973) show ed that sarcom a ascites cells, unable to spread  in Ca2+/M g2+- 
containing media, were induced to spread by the addition of Mn2+.
A problem  affecting the results of spreading assays is the presence of 
nocodazole in m etaphase-arrested cells. This presence is unavoidable, as 
re lease  from  nocodazo le  s ta r ts  m e ta p h a s e —> a n ap h a se  transition , 
accom pan ied  by m orphology changes, thus distorting the  results. The 
objective was to assess the ability of rounded mitotic cells to  spread under 
various conditions, and m etaphase block with nocodazole was appropriate, as 
its effects, at the concentrations used, are fully reversible for the length of 
time of m y experiments, and there are no cytotoxic effects (Zieve et al 1980). 
Interphase cells incubated with nocodazole were included as appropriate 
control.
Figure 3.2 shows that mitotic cells are unable to spread significantly on 
fibronectin. Although this could be due to nocodazole this is unlikely, as its 
effects on interphase cells are negligible (see also below, section 4.2).
W hen Mn2+ is added to  the  m edium  (figure 3.3), m itotic s p re a d in g  
im proves significantly in relation to  the sam e cells without Mn2+. However, 
the absolute values of spreading rem ain in the same range. Thus, neither the 
presence of an adhesive substrate nor Mn2+ in the m edium  can induce full 
spreading of mitotic cells. It is likely that cytoskeletal com ponents essential 
for spreading are comm itted to the process of mitosis, therefore preventing 
full spreading. However, the m achinery involved in the initial steps does no t 
seem  to  b e  com m itted to  the cell cycle, as mitotic cells, under the right
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conditions, are ab le  to  sp read  to  a limited, b u t significant, extent. 
Furthermore, if cells are blocked in m etaphase for a few hours in normal 
medium, spreading is also detectable (see also figs. 3.7 and 3.10).
1.2. Effects o f serum on  m itotic cells
While analysing the reversibility of nocodazole effects on m etaphase- 
blocked cells, I noticed that cells seem ed to advance faster through anaphase 
if foetal serum was present in the medium (F-10 Hams'). Therefore I decided 
to quantify the rate of exit from m etaphase in cells with and without serum. 
As shown in figure 3.4, when serum is present, the m ajority of cells have 
clearly divided and daughter cells are in the process of spreading. This is not 
the case in the absence of serum. It is noteworthy that even in the presence of 
serum, progression through anaphase is still slow (~4 hours). This is probably 
due to the time required by the cells to recover from nocodazole  (Rieder, 
1992).
The serum requirem ent for mitosis exit shown by He La cells is rather 
surprising, since serum -starvation of cells is a well known m ethod to arrest 
cells in G1 phase (Morla et al 1989), and there is no published evidence, to 
my knowledge, of mitotic arrest by serum-starvation. However, an important 
difference between G1-arrested cultures and my mitotic sam ples is that I was 
using highly synchronised cells, which could account for the  different 
behaviour. For instance, in cultures deprived of serum, factors (normally 
present in serum) secreted from interphase cells, could allow progression 
through anaphase for the small percentage of mitotic cells existing at all 
times, until all cells are stopped at Gl. However, if m itotic cells represent 
m ore than 90% of the total, as in my experiments, these factors might not be 
present, thus keeping cells in m etaphase. N evertheless, w hatever the 
m echanism, it is no t sufficient to  arrest all cells in mitosis, since a small 
percentage of cells by-passes the necessity for serum and progresses through 
anaphase. Obviously, all possibilities must be considered speculative, since 
no m ore data are available.
These are potentially im portant observations, and further investigation 
will be  necessary in o rder to confirm a role for serum  in the G2/m itosis 
transition .
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2_ IMMUNOLOCAIIZATION O Fasfr AND INTEGRINS
Indirect im m unofluorescence was carried out in order to  confirm the 
presence of aspi and a vP3 integrins in HeLa cells, as pi is a fibronectin receptor 
which binds to fibronectin through the central cell binding fragment, which 
contains the sequence RGD (Humphries, 1990). As one of the objectives of 
th is thesis was the  isolation of the fibronectin re c e p to r  by  affinity 
chrom atography  on the central cell binding fragment, the  use  of the 
polyclonal anti-asPi antibody was a reasonable choice.
The predom inant adhesive glycoprotein in culture conditions, present in 
serum , is vitronectin. The presence of a vp3, a strong vitronectin receptor 
(Hynes, 1992), was also screened with a polyclonal anti-av P3 antibody. The 
actual bands recognised by these antibodies are discussed below, in section 3.
Figure 3.5 shows a pattern of staining along the edge of interphase cells 
(figures 3.5a,b). The widely reported  punctuate pattern, typical of fibroblasts, 
indicating the presence of focal contacts, was not detected, although it is 
possible that access of antibodies to  the ventral surface of the cell is especially 
restricted. However, actin staining of HeLa cells reveals the absence of stress 
fibres and the presence of a strong staining along the  cellular edge (not 
shown), suggesting that focal adhesions are not present in these cells. The 
edge pattern  could b e  due simply to  the presence of m ore  m em brane, in 
vertical section, at the cellular edge. Something similar would occur in the 
m itotic sam ples (Fig.3.5.c,d). The bright inner ring w ould represen t the 
circumference of the rounded cell (fig.3.7.b,c), whereas the outer edge pattern 
would be analogous to  that of interphase. It is interesting that the spread 
fringe of mitotic cells seems brighter than in interphase. It is possible that this 
brightness represents the transit of integrins from the rounded area to sites of 
spreading. In a fully spread cell (i.e., interphase cells), the receptor density at 
the dorsal surface is probably too  low to  detect (fig.3.5.a,b).
However, the pattern  of spreading of nonblocked, m itotic cells m ay be 
different from that of m etaphase-arrested cells, at least as identified with our 
polyclonal antibodies. As figure 3.7 shows, bo th  antisera stain the cellular 
edges, but no inner ring is present. If we assum e that the transit of integrins 
to  the edge of the anaphase cell is relatively fast, then a bright staining at the 
cellular edge is to be expected. The difference with blocked cells is that, in the 
latter, only a small am ount of integrins is able to  function at the edge in the
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process of spreading, as this process stops at a very early stage. Thus, a 
d iscontinu ity  betw een  the main pool of cell surface integrins and the 
integrins at the spreading sites can be detected.
Figure 3.9 show s the pattern  of staining from  perm eabilised  cells. 
In terphase  cells show  a perinuclear, Golgi-like staining, revealing the 
presence of a cytoplasm ic pool of the integrins recognised by the anti-as pi 
antiserum  (fig. 3.9a). However, the an ti-avp3 antiserum  reveals a m u c h  
weaker and m ore diffuse pattern (fig.3.9b). Although a Golgi-like pattern is 
present, the  nucleus is also slightly stained.
The significance of the differences shown betw een bo th  antisera in 
perm eabilised cells in unclear. It is possible that there is a quicker turnover of 
the integrins recognised by the anti-aspi antiserum, thus showing a larger 
cytoplasm ic pool of proteins being continuously exported to the plasma 
m em brane. On the  contrary, if the turnover w ere relatively slow, only a 
small cytoplasmic pool would be required, as seem s to  be the case with cells 
stained with anti-avP3 antiserum.
Alternatively, it is possible that the p rocess of perm eabilisation m ay 
account for the differences in cytoplasmic staining. For instance, the pattern 
along the edge of cells is not present at all in perm eabilised cells stained with 
anti-avP3 antiserum  (fig.3.9b), whereas it appears in unperm eabilised cells 
(fig. 3.5b). Note also that, when flow cytometry is used to  quantify the am ount 
of antigen per cell in the plasm a m em brane  (fig. 3.10), no significant 
differences are found betw een the two antisera, further supporting this idea.
3_ EXPRESSION OF INTEGRINS
Immunofluorescence experiments perm it the cellular localisation of the 
integrins recognised by  the  polyclonal an ti-av P3 and a n ti-a s p i antisera. 
Inform ation about the identity of those integrins can be  obtained with 
im m unoprecipitation experim ents using rad io iod inated  cells. Cell surface 
pro teins are 125I-labeled, and integrins recognised  by the antisera are 
visualised by  autoradiography.
Figure 3.11 show s the  bands im m u n o p rec ip ita ted  with an ti-asP i 
antiserum. At least three subunits were recognised in all experim ents, the 
lower one of an intensity in the range of the sum of the other two (see table
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3.1). Several data suggest that the lower band is Pi. First, the  antiserum  is 
directed against the pi subunit, although other p subunits associating with as 
w o u ld  a lso  a p p ea r. S econd , its  m o le c u la r  w e ig h ts  u n d e r  
red u c in g /n o n red u c in g  conditions coincide with those published for pi 
(~125kDa/~110kDa). And finally, when the antiserum is used with 35S-labeled 
cells, a w ider p band  appears (Fig.3.18), which may be  indicative of the 
presence of a precursor, also reported for the pi band (Akiyama et al 1990).
However, the identity of the two upper bands (~150kDa and ~135kDa) is 
less clear. Their mobility is not apparently affected by the presence of reducing 
agents. With no m ore data available, there are several possibilities. One could 
expect the presence of as together with Pi, as the antiserum  should a lso  
recognise as epitopes. Im m unoblotting experim ents w ere carried out to 
confirm this possibility. Figure 3.13 shows the  p resence  of tw o bands 
recognised by the anti-asPi antiserum. Since the  antigen-antibody reaction 
takes place after the integrin subunits have separated  by SDS-PAGE, these 
bands are bound to be a s  and Pi. Furtherm ore, the fibronectin receptor 
affinity-isolated on the cell binding fragment of fibronectin (to which a s  pi 
binds; see fig. 3.23) consists of a Pi-like subunit associated to  an a  subunit 
which runs faster under reducing conditions, as expected from as.
On the other hand, figure 3.12 shows that the central band  (the one with a 
m olecular weight similar to as: ~135kDa) m oves identically under reducing 
and nonreducing conditions. A possible explanation is that there are several 
subunits associated with the Pi subunit. At least two of them  would be 
present in the central band (e.g. a 2 , 0 3  and as have similar mobilities, and all 
associate with Pi; Hemler e t  al, 1987) and, under reducing conditions, as  
could m ove faster and run as a single band with p i. N ote that, although 
relative intensities of bands under reducing conditions w ere not compared, 
the  in tensity  of the central b an d  in relation to  the rest, if anything, 
dim inishes with respect to  non reduced  subunits, thus supporting  this 
hypothesis.
Although the presence of the as and pi subunits is reasonably clear, the 
identity of the accom panying a  bands cannot be  firmly established without 
the use of an tibodies against specific a  subunits. U nfortunately, such 
antibodies were not available, and I continued m y work on the assum ption 
that m y polyclonal antiserum recognised several Pi integrins, one of them  
probably as Pi.
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Im munoprecipitation with the anti-avP3 antiserum  proved unsuccessful. 
A polyclonal antiserum  raised against the p3 subunit did not recognise any 
ban d  either. This antiserum  was also used in im m u n o p re c ip ita tio n  
experim ents with 35S-labeled cells and in immunoblottings (fig. 3.13), always 
with the same negative results. With these data, it is reasonable to  conclude 
that there are no P3 integrins in HeLa cells. However, it is obvious that, 
although the idea that no P3 integrins are present in HeLa cells may be 
correct, the anti-avP3 antiserum  seem s to recognise o th er integrins, since 
im m unofluorescence and flow cytometry experiments give a positive result. 
However, the affinity for these integrins is probably weak, as the best results 
are achieved with unfixed, living cells (flow cytometry), and with cells mildly 
fixed with 5% sucrose in 4% form aldehyde (see M aterials and M ethods 
section). N egative results, undistinguishable from th e  con tro ls, w ere 
obtained if sucrose was om itted during the fixation. It is also clear that any 
integrin recognised by  this antiserum should contain the a v subunit, as P3 
subunits are not present. Note also that the upper a  band identified using the 
anti-aspi antiserum has a mobility expected of a v, suggesting that the integrin 
a vpi is also present in HeLa cells.
In conclusion, then, it is reasonable to assert that n o  P3 integrins are 
present in HeLa cells, and that there are several Pi integrins, a sP i amongst 
them. We can also conclude that there is no apparent difference in Pi integrin 
expression betw een mitosis and interphase as m easured by flow cytom etry 
and im m unoprecipitation.
4. ACTIVITY A N D  PHOSPHORYLATION STATES OF MITOTIC A N D  
INTERPHASE INTEGRINS
Great advance has been m ade in our understanding  of how  integrins 
achieve different s ta tes of activity (see integrin regulation section, in 
Introduction chapter). Phosphorylation is a mechanism known to affect such 
activity in cultured cells. Tapley et al (1989) reported that phosphorylation of 
th e  pi subunit by pp60src in Tyr diminished binding of pi in tegrins to  
fibronectin and talin. Possibly, this inactivation b y  phosphorylation helps to 
m aintain the rounded  phenotype typical of cells transform ed with Rous 
sarcom a virus. In fact, transformation with a m utant pp60src unable to  induce
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cell round ing  and loss of fibronectin, is no t accom panied  by  p i 
p h o sp h o ry la tio n  (H orvath  e t al. 1990). Hirst et a l  (1986) show ed that 
transform ation of cells with oncogenes encoding tyrosine kinases correlated 
with phosphorylation of the fibronectin recep to r and rounded morphology, 
although receptor activity was not assessed.
The above d a ta  relate phosphory lation  of integrins with rounded  
pheno types in transform ed cells. An obvious connection is the cell cycle. 
Cells in m itosis are also rounded, and it is reasonable to  think tha t the 
m echanism  of cell rounding in transform ed cells may be related to  that of 
mitosis. Thus, it is possible that, as phosphorylation of integrins is very likely 
to  play a role in cell rounding in transformation, the same m ay apply for cell 
rounding in mitosis. In fact, pro tein  phosphory lation  is central to  cell 
division. As already m entioned in the Introduction of this thesis (section 6 ), 
CDK kinase activities form part of a conserved mechanism by which cells are 
driven into cell division. Theses activities are responsible for the structural 
reorganisation taking place at the G2—>Mitosis transition, which includes 
disassem bly of nuclear laminae, rearrangem ent of cytoskeletal co m p o n en ts  
and  arrest of endom em brane traffic, and  coincides in tim e with cell 
round ing .
There are several substrates for CDK activity participating in these  
changes, of obvious interest for the work described in this thesis (see 6 .1 .2 . in 
Introduction). pp60c"src is one of them  (Shenoy et al 1992). Its dow nstream  
candidates might well include cytoskeletal com ponents, o r even integrins. 
Caldesm on is another substrate for CDK Yam ashiro and M atsum ura (1991) 
have  suggested  tha t phosphory la tion  of caldesm on w ould cause its 
disassociation from microfilaments, and that this would help in the process 
of rounding up at mitosis. Vimentin, an in term ediate filament (IF) protein, 
is also phosphorylated by CDK, and this is accom panied by  vimentin IF 
diassem bly (Chou e t al 1991). Interestingly, microinjection of CDK into cells 
at any tim e of the cell cycle except in S phase  caused cell rounding  and 
reorganisation of microfilaments and m icrotubules (Lamb et al 1990). Thus, 
correlation of cytoskeletal rearrangem ents and cellular rounding is apparent. 
However, it is also imaginable tha t a regulated  control of rounding at 
G 2 /p ro p h ase  and respread ing  at an ap h a se  should  involve n o t only 
cytoskeleton re-organisation, but also inactivation of the interactions betw een 
the ECM and their receptors at G 2/prophase, followed by reactivation after
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m etaphase. Therefore, one of the objectives of my work was to  find o u t 
w hether integrins played a role in the cellular rounding up at mitosis, and a 
reaso n ab le  hypo thesis was that integrins m ight be involved in th e  
phosphorylation cascades triggered by CDK. For example, as m entioned 
above, pi integrins m ay be phosphory lated  by  pp60src, which in turn is a 
substrate for CDK.
It is also notew orthy that to date there are no  published data on the role 
of any ECM receptor in the cellular rounding up at m itosis. Nevertheless, 
Hynes (1992) m akes reference to  unpublished  results from his group 
(C.Grandori and R Hynes, unpublished data), mentioning that a Ser in the Pi 
subunit of the fibronectin receptor asPi is phosphorylated in mitosis and the 
receptor no  longer binds to fibronectin. However, these results remain to b e  
confirmed. There is som e work published about cell-cell in teractions at 
mitosis, in epithelial cells. Baker and Garrod (1993) reported  that confluent 
epithelial cell layers retained cell-cell junctions (see 3.2., in Introduction) at 
m itosis. From their work it seem s clear tha t these junctions rem ain 
functional during cell division and are not involved in the processes 
triggered by  CDK. The authors also report that hem idesm osom es are retained 
during mitosis, in basal epiderm al keratinocytes. Thus, it appears th a t  
retention of cell-basal lamina contacts through hem idesm osom es m ay be 
im portant in retaining dividing cells in the basal layer.
In conclusion, the above data present sufficient evidence in the direction 
of som e role for integrins in mitosis. An obvious approach to test this idea 
was the use of affinity columns to analyse cell cycle-related differences in the 
binding ability of the fibronectin recep to r a s  Pi, to g e th e r  with integrin 
im m unoprecipitation from 32P-labeled cells, using anti-asPi antiserum. This 
would allow detection of changes in the phosphorylation state of integrins 
which might correlate with different states of activity.
41 Isolation o f the fibronectin receptor using affinity chromatography
The use of the fibronectin cell-bin ding fragment to isolate the fibronectin 
receptor(s) was first reported by Pytela et al 1985. The material coupled to the 
isolation colum n was a highly purified fragm ent obtained from digested 
fibronectin (Pierschbacher et al 1981), which contains the RGDS sequence (see 
fibronectin section, in Introduction chapter).
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I followed basically the same procedure. As described in Materials and 
M ethods, the fibronectin digest fraction directly eluted from the  gelatin 
column (unbound fraction) was used as the coupling material for re c e p to r  
isolation. Two differences from the published procedure were the use of 
Mn2+ in all buffers up  to receptor elution, as Mn2+ improves receptor binding 
(Gailit and Ruoslahti, 1988), and the use of the cell-binding fragment as 
obtained from the gelatin column, instead of further purified from heparin 
and gel filtration columns (Pierschbacher et al 1981). In my experiments, the 
cell-binding fragment eluted from the gelatin column constituted practically 
the only m ajor com ponent (fig.3.1). Furthermore, this fraction has already 
been succesfully used to  isolate the fibronectin receptor from BHK cells in our 
lab (Edwards and Campbell, unpublished results).
A m ajor problem  found using this approach was a very low sensitivity in 
the detection of the fibronectin receptor eluted with EDTA, which needed 
several weeks of film incubation. Although technical problem s m ay account 
for this low sensitivity, it is also possible that very low am ounts of the 
recep tor are present in HeLa cells. In fact, although relatively high am ounts 
of pi integrins are detected by immunoprecipitation using 1251 from as little as 
-10? ce]is (figs. 3.11 and 3.12), the percentage of a sP i seem s in fact much 
smaller (see section 3, this chapter). This low percentage m ay have also been 
the cause of the negative results achieved with imm unoprecipitation of the 
eluted receptor using anti-as Pi antiserum  (not shown).
Nevertheless, the main objective sought with this approach, namely the 
com parison of the activity of the fibronectin receptor betw een m itotic and 
interphase cells, was successfully carried out (see also below, section 6 , for 
discussion on the activity of the fibronectin receptor in CL-A-treated cells).
Figure 3.14 show s the c.p.m. eluted from the colum ns with EDTA. 
Am ounts in the same range are recovered from both interphase samples, and 
from both  m itotic samples. Table 3.2 shows the  to tal post-ED TA  c.p.m. 
recovered from each sample as a percentage of the total c.p.m. applied to each 
column, c.p.m. recovered from mitotic cells represent -50-60% of those from 
interphase, regardless of the presence of phosphatase inhibitors.
A lthough  the  high an d  u n ev en  b ack g ro u n d  p re s e n t in the  
autoradiographs (fig.3.15) prevents a clear com parison betw een samples, the 
point that m ust be stressed is that integrin bands are present in all samples. 
Therefore, full inactivation of the mitotic fibronectin receptor does not occur.
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If we com pare the 50-60% of m itotic recovery (table 3.2) with the poor 
spread ing  (£1 0 % of that of interphase cells, and only using  optim um  
conditions) shown by  m itotic cells, it becom es apparen t that the loss 
fibronectin receptor activity alone, as detected in solution, cannot account for 
m itotic rounding. ,
4 2  Changes In phosphorylation
Figure 3.16 shows clearly the absence of phosphory lated  integrins in 
interphase and mitosis. No bands were either im m unoprecipitated with the 
antibody PY20 (see also fig. 3.24).
Although the partial inactivation of asP i cannot account for the poor 
spreading shown by mitotic cells, it is clearly significant. Phosphorylation of 
either subunit is a possible m echanism  to account for such changes in 
activity. However, my resu lts  indicate th a t Pi in teg rin s  are not 
phosphorylated. Also, they are in contradiction with the results m entioned 
by Hynes (1992), where as pi is inactivated and Pi becom es phosphorylated in 
mitosis, although in this latter case the results remain to  be  confirmed.
Therefore, a m echanism  for the partial inactivation of the  mitotic 
fibronectin receptor rem ains to be identified. On the other hand, it is quite 
possible that the poorer recovery from mitotic samples could be due solely to 
the differences betw een sam ples in cell harvesting for radioiodination. 
Integrins bind to the ECM and also to com ponents in the cystoskeleton to 
achieve fully active conform ations (section 5, Introduction chapter; Hynes, 
1992). In mitotic cell rounding G2 cells re-organise their cytoskeleton as they 
en te r m itosis, which is likely to  be accom pan ied  by  inactivation of 
com ponen ts interacting with integrins, which in turn m ay affect integrin 
activity. The final result is cellular rounding. T herefore there  is an 
inactivation of cell-ECM interaction initiated from inside the cell. On the 
o ther hand, interphase cells are detached from the substrate  by removing 
divalent cations from the medium, so that cytoskeletal structures linked to 
integrins m ay not be  essentially modified, as they are in mitosis.
Thus, it is possible that interactions of cytoskeletal com ponents (e.g. talin 
or vinculin) with interphase integrins are not disrupted in the solubilisation 
procedure with nonionic detergent. However, such interactions have been 
already disrupted from inside in mitotic cells. The hypothesis is that this 
difference causes in te rp h ase  and m itotic integrins to  keep different
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conform ations when solubilised with p-octyl-glucoside, which could account 
for the different recovery from the fibronectin fragment columns. Note also 
that, although these  considerations are speculative, they explain the 
irrelevance of using phosphatase inhibitors, while keeping the importance of 
the phosphorylation events triggered by CDK activity. In interphase, as no 
phosphorylation is involved, the use of phosphatase inhibitors is irrelevant. 
In mitosis, as the cytoskeleton is already rearranged when cells have rounded 
up, lysis is extremely unlikely to restore integrin-cytoskeleton interactions 
that are already disrupted, regardless of the effect of the absence or presence of 
phosphatase  inhibitors.
In conclusion, then, it is possible that, in HeLa cells, 015 Pi is indeed less 
active in mitosis, due not to post-translational changes, but to  modification of 
its interaction with the cytoskeleton. This would also explain the spreading 
results obtained with mitotic cells. Since much of the spreading machinery is 
com m itted to cell division, very limited spreading is possible in mitosis.
It is also possible that the use of Mn2+ in the affinity isolation accounts for 
the results obtained. It could be that the mitotic receptor has lost its activity, 
and that the presence of Mn2+ stimulates its activity to the extent of be ing  
detectable by affinity chrom atography (see Integrin regulation section, in 
Introduction chapter). However, this possibility does no- explain satisfactorily 
the irrelevance of the use of phosphatase inhibitors.
Future work should test the validity of these  hypothesis. A possible 
experim ent could be  the use of e lectrophoresis under n o n d e n a tu r in g  
conditions, so that any changes in integrin mobility due to the presence of 
bound  proteins are detected. These proteins could then be  identified by 
im m unoblotting using antibodies against vinculin, talin, ct-actinin, etc.
5. BIOSYNTHESIS OF Pi INTEGRINS
The results from figure 3.18 show m etabolic labelling of the putative pi 
subunit, together with its precursor and two a  subunits, and the absence of p3 
integrins. This pattern of three bands is probably  the sam e of that obtained 
from  rad io iod inated  cells. However, the relative intensity of p is much 
higher from 35S-labeled cells. This difference cannot be explained by the 
different contents of Cys and Met residues betw een a  and p subunits (see
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Biosynthesis of Integrins, in Results chapter). It is likely then that there is a 
h igher tu rn -over of p subunit. There is a lso  a difference be tw een  
asynchronous and Gl+S (T2) cells. Asynchronous cultures have a stronger pi 
band  (fig. 3.18a), and a  subunits are not p resent in T2 cells. A fu r th e r  
experim ent (fig.3.18b) showed that, although asynchronous cells still show 
stronger bands, a  subunits were detectable in T2 cells. The main difference 
between asynchronous and T2 samples is the presence of a higher proportion 
of G2 cells in asynchronous cultures. Taking these results at face value, it 
would suggest that there is a peak of synthesis of integrins at G2, especially of 
a  subunits. However, further work is clearly needed in order to  understand 
the synthesis of integrins during the cell cycle. Analysis of m RNA at different 
stages of the cell cycle should clarify whether there is a regulated synthesis of 
integrins in G2 or such synthesis is constitutive during the cell cycle.
6 .  EFFECTS OF CALYCULIN A  O N CELL SPREADING A N D  ON f a  
INTEGRINS
Two po ten t inhibitors of phosphatases PP1 and PP2A (see section 4, in 
Introduction), nam ely okadaic acid (OA) and calyculin A (CL-A) have 
recently  been  discovered (see Cohen e t al 1990; Ishihara e t al 1989 for 
reviews). ID50 values for OA are ~lnM  for the catalytic subunit of type 2A, 
lOOnM for the multisubunit 2A1 and 0.5[iM for the catalytic subunit of type 1. 
Values for CL-A are similar, with the exception of type 1 phosphatase. ID50 
values with CL-A in this case are l-2nM (Chartier et al 1991). Treatm ent of 
cells with these inhibitors enhances the overall state of phosphorylation due 
to  phosphatase inhibition, and is a useful approach to investigate processes 
involving phosphorylation-dephosphorylation events.
These inhibitors have been shown to  induce m orphological changes 
similar to those in mitosis. For example, Kipreos and W ang (1990) showed 
that jiM OA activates cdc2 kinase and induces cell rounding. Furthermore, c- 
abl protooncoprotein becom es phosphorylated at the same site as in mitosis. 
Y am ashita et a l (1990) reported  that treatm ent of cells synchronised in S 
phase with 0.5jiM OA caused cellular rounding nuclear envelope breakdow n 
and chrom osom e condensation. In fact, cdc2 kinase may be activated by OA at
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concentrations that inhibit PP2A bu t no  PP1 (Cohen et al. 1990; see also 
section 4, in Introduction).
CL-A also induces shape changes in 3T3 cells at 0.1 jiM, accom panied by 
reorganisation of IFs, microfilaments and microtubules. These effects were 
fully reversible (Chartier et al 1991).
The effect of both OA and CL-A on cellular shape, and their possible link 
to  the cell cycle make these inhibitors ideal reagents to  study the activity and 
phosphorylation state of integrins in a m odel that closely mimicks the 
changes taking place in mitosis. As a small quantity of CL-A was available in 
our lab, I undertook such studies, using approaches similar to  those used to 
com pare mitotic and interphase integrins.
Figure 3.20 shows the typical m orphology of normal HeLa cells (3.20a) 
and of cells treated with 50nM CL-A Removal of CL-A restored  the normal 
m orphology (not shown). Spreading experim ents (figS. 3.19a-d) show ed that 
CL-A-treated cells spread to a limited extent, but retract after a short time. The 
negative effect of CL-A is clear only after 1 hour of incubation. There is no 
significant difference in spread area betw een control and CL-A treated cells 
after 30 min. However, the morphology of all CL-A treated cells after 30 min 
was different from that of control cells (fig. 3.19e). It showed a m ore irregular, 
stellate  shape. With no m ore data available, it is no t possib le to  know 
w hether CL-A treated  cells spread  uniformly at the very early stages of 
spreading and then retract in a way that would cause the stellate shapes, or 
th e ir spreading involves initially the  ado p tio n  of such m orphology. 
Obviously, analysis of spreading at the very early stages (less than 30 min) 
will be  necessary in order to  understand b e tte r the effect of CL-A on the 
spreading of HeLa cells.
Integrin subunits, presum ably as and pi, are shown in figure 3.21 (see 
also fig. 3.13). The activity of a sp i was analysed by affinity chrom atography on 
the cell binding fragment of fibronectin. Figure 3.22 show s the difference 
betw een  spread, interphase cells and cells trea ted  with CL-A. Very little 
counts are present from CL-A-treated cells, and these counts do not translate 
into bands, even after long times of film incubation (>4 weeks). It seem s then 
that the fibronectin receptor does not bind to fibronectin after CL-A has been 
a d d ed  to  the cells. However, as in m itotic cells, no phosphorylation  of 
integrins could be detected in CL-A-treated cells, although a general increase
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in tyrosine phosphorylation appears in proteins larger than ~60kDa (smaller 
bands are also present in other lanes and are probably nonspecific).
Therefore, it appears that there are at least two basic differences in the  
behaviour of the m itotic and CL-A-treated cells concerning the fibronectin 
receptor and the pattern of tyrosine phosphorylation. The mitotic fibronectin 
recep to r still binds to  fibronectin, although with a reduced affinity. On the 
contrary, the receptor from CL-A-treated cells apparently loses all its activity. 
Also, the level of tyrosine phosphorylation in m itosis does not c h a n g e  
appreciably (fig. 3.16) w hereas a clear rise in tyrosine phosphorylation is 
detected in CL-A-treated cells. A similar increase in overall phosphorylation 
has been reported by Chartier et al (1991) using O.IjjlM  CL-A
It might be  expected that mitosis and addition of CL-A would have a 
similar effect on the fibronectin receptor. The effect of CL-A at l-2nM is 
thought to  be  the inactivation of PP2A, which w ould cause cdc25 
hyperphosphorylation, increasing its cdc2 phosphatase activity. At the end, a 
m echanism  similar to m itosis is triggered. However, activation of cdc2 also 
requ ires the  ap ro p ria te  level of cyclin A a n d /o r  B (see section 5 in 
Introduction). If that level is not met, CL-A-treated cells will pass normally 
through all phases of the cell cycle until they are blocked in m etaphase. This 
is indeed the case with LLC-PK cells (Vandre and Wills, 1992). BHK cells, on 
the other hand, accum ulate cyclin B from early S phase (Yamashita et al 
1990), and treatm ent with OA induces prem ature mitosis in many of them. 
Accumulation of cyclin B in HeLa cells occurs at G2 (Pines and Hunter, 1989). 
Therefore, a result similar to that with LLC-PK cells is to be  expected. My 
results are in accordance with these data. ~l-5nM  and indeed much higher 
concentrations of CL-A have no effect on spread HeLa cells. In other words, 
no prem ature m itosis is induced with concentrations that would inactivate 
PP2A In consequence, it must be assum ed that the rounding induced by CL- 
A in my experim ents is due to  m ore  general, cell cycle-un re la ted  
phosphorylation processes, m ost likely taking place in the cytoskeleton, and 
involving m any phosphatases. It is not un reasonab le  to  think that the 
differences encountered in the activity of the  fibronectin receptor betw een 
interphase, mitotic and CL-A-treated cells m ay depend on the way cells have 
rounded prior to  cell labeling with 1251. In interphase, rem oval of cations 
from  the m ed ium  c au se s  cell ro u n d in g  b u t m ay leave s o m e  
cytoskeleton/in tegrin  interactions untouched. Mitosis may inactivate such
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in teractions m ore com pletely from inside but, obviously, is a h ig h ly  
r e g u la te d  p ro c e ss , la s tin g  on ly  from  early  p ro p h a s e  un til 
m e ta p h a s e -* a n a p h a s e  transition. Finally, in CL-A-treated cells, th e  
concentrations of CL-A used may disrupt a wider num ber of interactions in 
the cytoskeleton, achieving total inactivation of the receptor, as measured by 
affinity chrom atography.
Also, as shown by imm unoprecipitation of integrins from 32P-labeled 
cells, I could find no evidence that integrin phosphorylation is involved in 
m odulating the different degrees of activity (fig. 3.24). However, it is likely 
that phosphorylation of o ther com ponents from  the cytoskeleton must 
participate in integrin inactivation, as both treatm ent with CL-A and mitosis 
involve changes in the phosphorylation state of cytoskeletal com ponents (see 
above, this section).
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Expression erf integrin subunits in HeLa cells
The use of the an ti-asP i and anti-p3 antisera in im m unoprecipitation 
experim ents show the presence of Pi, but not P3 integrins. The presence of 
(X5 P1 is reasonably clear, and there is evidence to suggest that a vpi is also 
present. First, positive results are obtained with anti-avp3 antiserum  in flow  
cytom etry and im m unofluorescence experiments, although no p3 integrins 
are detectable by immunoblotting and immunoprecipivation, suggesting the 
presence of a v associated with a p subunit different from P3 . Second, when 
an ti-asp i antiserum is used, at least three bands are detected, one of which 
corresponds to an a  subunit of a mobility expected of a v, suggesting the 
p resence of the heterodim er a vPi. Further work using an tibodies against 
specific a  subunits will be  needed to  confirm the presence of a vPi and asp i *n 
HeLa cells.
Expression o f integrins; interphase versus m itosis
Flow cytom etry experiments showed that integrins recognised by anti­
asp  1 and an ti-avp 3 antisera are not expressed differently in m itosis and 
in terphase. This result is also su g g e s te d  b y  im m u n o p re c ip ita tio n  
experim ents.
A ctivity of integrins; interphase versus m itosis
Spreading assays have revealed that rounded, m etaphase-arrested cells do 
not spread on fibronectin. Only a very limited spreading ability is achieved 
when Mn2+ is present in the medium. Also, when arrested in m etaphase for
2-3 hours in normal medium, cells are able to spread to a very limited extent 
(less than 1 0 % of in terphase cells), and im m unofluorescence experim ents 
reveal that integrins are involved in such process, and also in the process of 
respreading in mitotic, nonblocked cells. These experim ents also showed the 
absence of focal contacts, although it cannot b e  discerned w hether such 
absence is due to restricted acces of antibodies to  the ventral surface or such 
structures are really absent. However, the absence of stress fibers, as detected  
with actin staining, suggests that focal contacts are not present.
Affinity chrom atography show ed that the fibronectin recep to r a sp i 
partially loses its ability to bind to  the cell binding fragment of fibronectin in
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m itosis. However, th e  rem aining  activity is h igher than  expected if 
fibronectin  recep to r inactivation alone w ere responsib le  for m itotic 
rounding-up. Also, as spreading  experim ents have show n that m ito tic  
sp read ing  is very limited, even under optim um  conditions for integrin 
activity, it is likely that the cytoskeletal spreading m achinery in mitosis is 
m ainly com m itted to  the  cell cycle. However, when such limited mitotic 
spreading is detected by  immunofluorescence, it is apparent that integrins are 
present at the cellular edge, in the spread fringes, suggesting that, although 
integrin activity is modified at mitosis, it may b e  resto red  under optimum 
conditions. If this were the case, full spreading would no t be achieved only 
because the cytoskeletal spreading machinery is com m itted to  the cell cycle.
»
M echanism o f regulation o f cell cyde-rdated activity o f integrins
Integrin phosphorylation could not be detected in im m unoprecipitation 
experiments. However, it is likely that phosphorylation events are involved 
in the m itotic partial inactivation of the fibronectin receptor, due to the 
nature of the mitotic events. They are triggered by  CDK activities, and affect 
several cytoskeletal com ponents (see introduction, phosphorylation section). 
It is possible that interactions of some cytoskeletal com ponents with integrins 
are disrupted in mitosis via cytoskeletal phosphorylation, which in turn may 
m odify integrin conform ation and activity. Thus, the  conditions of the 
experimental procedure m ay account for the different recovery  betw een 
interphase and mitosis. Radioiodination of m itotic sam ples takes place on 
rounded cells, with a reorganised cytoskeleton. It is likely that com ponents 
interacting with integrins are inactivated, which in turn m ay affect integrin 
conformation and activity. Thus, there would be an inactivation of cell-ECM 
interaction initiated from inside the cell. On the o ther hand, radioiodination 
of interphase samples takes place on cells previously detached from the 
substrate by removing divalent cations from the m edium  (outside—>inside 
inactivation of integrins), so that cytoskeletal structures linked to integrins 
(e.g. talin or vinculin) m ay not be disrupted in the  solubilisation procedure 
with p-octylglucoside. In conclusion, this difference could cause in te rphase  
and  mitotic integrins to  keep different conform ations w hen solubilised, 
which could account for the different recovery from the fibronectin fragment 
columns. It also would explain that the use of phosphatase  inhibitors does 
not affect the recovery of fibronectin receptor, as phosphorylation would not
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be involved in interphase cells, and in mitosis, as the cytoskeleton is already 
rearranged, lysis is extrem ely unlikely to  re s to re  in tegrin-cytoskeleton 
interactions that are already disrupted by cytoskeletal phosphorylation, even 
in the presence of phosphatases.
Alternatively, it is possible that the use of Mn2+ in all buffers up to 
recep to r elution m ay explain the results ob tained . It could be  th a t  
inactivation of the mitotic receptor is complete, and that Mn2+ stimulates its 
activity to the extent of being detectable by affinity chrom atography (see 
above, integrin section, Introduction chapter). Future work will be needed to  
assess the validity of these hypothesis.
Effect o f calyculin A  on  integrin activity
Treatm ent of cells with calyculin A was a reasonable approach to create a 
m odel mimicking the conditions of m itotic cell rounding. However, H eLa 
cells do not respond to concentrations (l-2nM) at which this m ay be the case, 
and therefore cell rounding caused by larger concentrations cannot be 
com pared  with that of mitosis, as effects becom e unspecific. The use of 
calyculin A has also confirmed that phosphorylation events affect cell shape. 
The fibronectin recep to r is fully inactivated w hen cells are treated  with 
calyculin A and, similarly to  mitosis, receptor phosphorylation could not be 
detected . C om plete disruption of cy toskeletal/in tegrin  interactions may 
account for these results, in a m odel similar to  that proposed for mitotic cells. 
In CL-A-treated cells, such disruptions would achieve total inactivation of 
the receptor, as m easured by affinity chromatography. The presence of Mn2+ 
does not cause an active recep tor conformation, as might be  the case for 
mitosis. Interestingly, sp read ing  results show ed that CL-A-treated cells 
respond faster than normal cells when spreading is at its early steps (less than 
30 min.). Further work using calyculin A or okadaic acid in short-term  
spreading essays should give further inform ation about a role for these 
phosphatase inhibitors in cell spreading.
B iosynthesis o f Integrins during th e cell cycle
Integrin synthesis is de tec ted  in asynchronous cells and in cultures 
enriched in Gl+S phases. A putative pi subunit is detected, together with its 
precursor. Two a  subunits are also present, in a pattern  similar to  that 
obtained with radioiodinated samples. The evidence shows that there m ay be
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a peak of synthesis at G2, especially of a  subunits, although a basal level of 
synthesis seem s to be present throughout the cell cycle. Further work using 
N orthern b lo ts and protein synthesis inhibitors should clarify w hether there 
is G2-specific integrin synthesis or such synthesis is not cell cycle-dependent.
Effect o f serum  In m etaphase—>anaphase transition
It has been  shown that serum  im proves the  recovery of m etaphase- 
arrested  cells after release of the nocodazole block. It is well known th a t 
serum -starved cells will arrest at G1 phase in the cell cycle. However, my 
results show that there is a clear im provem ent in the rate of recovery from 
m etap h ase  to  anaphase w hen serum  is p resen t in the m edium . This 
discrepancy m ay be explained by the fact that I am using highly synchronised 
cells. In cells synchronised in mitosis, a com ponent from serum  m ay be 
needed for exit from m etaphase. This com ponent may be synthesised by non 
mitotic cells in asynchronous cultures, thus bypassing the necessity of serum 
for the  small population in m etaphase. However, these considerations are 
merely speculative, and further work will be required to  assess a possible role 
for serum  in mitosis.
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